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SUMMARY.
Resistance to androgens in yi^io and at puberty causes 
a dysfunction of male sexual differentiation, and results in 
a form of male pseudohermaphroditism. From whole cell bind­
ing studies, using cultured human genital skin fibroblasts 
(GSF) a number of defects in the androgen receptor have been 
discovered, these have been classified as: absent,
deficient, thermolabile, defective activation to the DNA/ 
nuclear binding form, and finally, failure to "up-regulate" 
the basal binding level in response to prolonged (i.e. 24h)
incubation of cells with hormone. There is, however, a need
to study the receptor protein directly, without relying on
3
the reversible binding of H ligand.' Therefore, in the 
present study the androgen receptor from human GSF was 
extracted using 0.5M-KC1, and partially purified by 35% 
ammonium sulphate preciptitation prior to further studies.
Normal and variant forms ,of the androgen receptor were 
then searched for by comparing the proteins in receptor 
enriched fractions from control and androgen insensitive 
cells, by a dual-labelling technique and high resolution 
two-dimensional gel electrophoresis (2-DGE) . As a complement 
to the electrophoresis studies, normal and variant forms of 
the receptor were analysed on 5-20% linear sucrose density 
gradients and by ADP-Sepharose chromatography. The activated 
form of the androgen receptor from normal cells was also 
characterised by FPLC-anion exchange chromatography and 
HPLC-size exclusion chromatography. Finally, attempts were
vii
made to covalently label the fibroblast receptor using the
3
photoactive ligand [ HUmethyltrienolone (R1R81): a synthetic
steroid known to bind specif icaily to the androgen receptor.
3
After incubating cells in culture with C Hi DHT or 
mibolerone, the partially purified receptor complex from 
normal cell lines was found to sediment at 4S on sucrose 
gradients and from gel filtration studies to have a relative 
molecular mass of around 60000, a Stokes radius of 3.16nm 
and a frictional ratio of between 1.21-1.43. After HPLC-gel 
filtration a second peak of bound steroid was observed (at 
about Mr.15000 ), believed to represent a fragment of the 
receptor containing the steroid binding domain.
The receptor complexes from androgen insensitive cell 
lines also sedimented at 4S on linear sucrose gradients. 
However, the receptor profiles from cells shown to have 
absent, deficient, or unstable binding in whole cell assays 
were quantitatively altered from controls. Furthermore, this
r-
procedure may be a useful means of distinguishing 
quantitative and qualitative defects of the androgen 
receptor, since for one cell line (TCF) found to have normal 
levels of receptor (Receptor positive, unstable binding) in 
the whole cell binding assay, the profile on sucrose 
gradients resembled that of receptor negative (Absent) 
cells. The complexes from one cell line (T4) diagnosed as 
receptor positive (whole cell studies) also sedimented at 
4S. The receptor from these cells interacted with ADP- 
sepharaose in a manner indistinguisable from the receptor 
complexes from control cells (SW): both were eluted with
0 .5-1. 0M-KC1. From v/hole cell binding and in yitio studies 
it appears that the androgen receptor from this cell line is 
normal, implying that the androgen resistance mutation lies 
at some subsequent step in androgen action and that other 
factors could play important roles in steroid hormone 
action.
The comparison of proteins from receptor enriched
fractions from control and androgen resistant cells labelled 
35 75
with [ Slmethionine and [ Se]selenomethionine respectively,
failed to show differences that could be related to the
androgen receptor protein or the androgen insensitive
phenotype. Similar results were seen for the comparison of
two-dimensional patterns of whole cell protein, labelled 
3 5
with C Slmethionine only.
Finally, after partial purification and U.V,
irradiation, the receptor complexes from rat ventral
prostate cytosol and calf uterus cytosol were succesfully
3
photolinked with C Hi R1881: peaks of specifically bound
radioactivity were recovered after SDS-PAGE, at Mr. of 50000 
and 100000 respectively. However subsequent attempts to 
covalently label the human GSF androgen receptor, either 
after partial purification or in siijj were unsuccessful. 
This was thought to be due to instability of the receptor 
complexes during the partial purification protocol, and also 
a reflection of the low efficiency of the photoactivation 
reaction.
ix
INTRODUCTION
1.1 Androgen Action
Androgens are C-19 steroids, which are synthesised and 
secreted mainly by the Leydig cells of the testes and to a lesser 
degree, by the adrenals and ovaries (Gower 1979). In common with 
other classes of steroid hormone, androgens act on the genome of 
target cells to effect a change in the pattern of gene 
transcription: this action being mediated through a specific 
intracellular receptor mechanism (Chan oc O’Hally 1976; Higgins 1 
Gehring 1978; Katzenellenbogen 1980; Mainwaring 1977;Yamamoto 
1985; Yamamoto & Alberts 1976).
Jensen and associates (Jensen et al 1968) were the first to 
descibe the action of a steroid by the "two-step mechanism" 
(Fig.1.1). Although recently, the location of the receptor in the 
absence of hormone has been the source of growing controversy, 
the model in principal remains valid (Jensen 1984; Schrader 
1984). Once inside the target cell the free steroid must first 
bind to the high-affinity „ low capacity receptor sites, and 
secondly, the steroid-receptor complex must interact with sites 
in the nucleus to effect specific changes.
The two-step model was proposed originally to describe the 
action of oestrogen in the rat uterus (Jensen et al 1968; Jensen 
& de Sombre 1973), and the key features of this scheme were 
subsequently described for all classes of steroid hormone (Chan « 
O'Mally 1976; Higgins & Gehring 1978; Lan et al 1984). The 
conversion of testosterone, the main circulating andogen, to the 
more potent 5<X-reduced metabolite dihydrotestosterone (DHT; 
Fig.1.1) in certain target tissues is a unique feature of
1
TARGET CELL
NUCLEUS
T
ANDROGENIC RESPONSE
DHT >  DHT A
RECEPTOR DEGRADATION I and/or 
RECEPTOR RECYCLING
Figure 1.1 Scheme for androgen action.
T, testosterone; DHT, 5(X-dihydrotestosterone; 50<-red., 5(X- 
reductase; R, androgen receptor.
androgen action (Wilson and Glonyna 1970).
The relevance of the above model (Fig. 1.1) to the mechanism 
of androgen action will now be discussed in more detail, with 
reference to other classes of steroid where appropriate.
A. Uptake of Steroid Hormones.
In Man and other higher vertebrates there are a number of 
circulating serum proteins that bind steroid hormones in a 
specific or non-specfic manner: sex hormone binding globulin 
(SHBG), corticosteroid binding globulin (CBG) and albumin 
(Anderson 197*0. As a result, only a small percentage of the 
total circulating hormone will be free (i.e. 1 to 3% of total 
testosterone and oestradiol); it is this fraction that is 
biologically active and which determines the intracellular 
concentration of steroid (Anderson 1974).
It is generally thought that because of their lipophilic 
nature, steroid hormones enter cells by passive or simple 
diffusion (Gorski & Gannon 1976; Higgins 1 Gehring 1978;
r<
Katzenellenbogen 1980). Despite the technical difficulties 
inherent in studies of this phenomenon, passive uptake of 
progesterone, glucocorticoids, oestrogens and androgens by cells 
(hamster fibroblasts and rat hepatoma cells) grown in culture was 
demonstrated by Giorgi (1980; Giorgi & Stein 1981). The 
contamination of assays by serum binding proteins and 
intracellular binding sites has complicated the search for 
facilated or active transport mechanisms. Therefore, the 
physiological significance of studies apparently showing such 
uptake mechanisms remains, at best, unclear (Gorski & Gannon
B. Receptor Localisation.
Steroid receptors are intracellular proteins, characterised 
by their ability to reversibly bind steroids in a high affinity, 
low capacity manner. Evidence for their existence came initially 
from the use of radiolabelled steroids, which were preferentially 
retained by target tisses (Anderson & Liao 1968; Baulieu & Jung 
1970 Bruchovsky & Wilson 1968; Fang, Anderson & Liao 1969; 
Higgins and Gehring 1978; Katzenellenbogen 1980; King & Gordon 
1966; Mainwaring 1969a,b; Stumpf & Madhabananda 1975; Toft & 
Gorski 1966; Tveter & Attramadal 1968; Unhjem, Tveter & Aakvaag 
1969). Further progress was made with the introduction of 
synthetic analogues of various hormones, which bound to receptors 
but not to contaminating serum proteins (Higgins 1 Gehring 1978; 
Katzenellenbogen 1980).
Since steroid receptors, in the absence of hormone, could be 
isolated in the soluble fraction of cell extracts, it was 
generally assumed that they were located in the cytoplasm in the 
absence of ligand (’'cytoplasmic exclusion hypothesis"), and that 
translocation of receptor complexes to the nucleus occured after 
hormone binding (Jensen et al 1968; Katzenellenbogen 1980). 
However recent experimental evidence, from two independent 
groups, suggested that receptor molecules may always be 
associated with the nuclear compartment, irrespective of hormone 
binding status (Greene et al 1984; King u Greene 1984; Welshons, 
Lieberman & Gorski 1984).
Greene and co-workers (Greene et al 1984; King and Greene
1984) using a panel of five monoclonal antibodies (specific for
3
the oestrogen receptor) and an indirect immunoperoxidase 
technique, demonstrated that in frozen sections of human breast 
carcinoma, human and rabbit uterus, and MCF-7 cells,specfic 
staining was localised in the nucleus, in the presence or absence 
of oestrogen. Gorski and co-workers (Welshonset al 1984) using a 
different experimental approach, isolated "cytoplast" and 
"nucleoplast" fractions by cytochalasin B-induced ennucleation of 
GH^ cells (derived from a rat pituitary tumour), and showed that 
the unoccupied oestrogen receptor was associated with the nuclear 
fraction. The presence of receptors in the soluble extracts of 
earlier studies could have been due to the isolation procedures 
used and/or the possible weak association of unoccupied receptors 
with nuclear components (Green et al 1984; Jensen 1984; Yamamoto
1985).
If the above results are shown to be relevant to steroid 
receptors in general the question that arises, is where in the 
nucleus are the unoccupied receptor molecules located; on the 
nuclear membrane, chromatin or nuclear matrix (scaffolding) 
structures ?
However, the findings of an other immunocytochemical study, 
using antisera raised against the glucocorticoid receptor, 
supported the more classical view of the intracellular 
distribution of receptor molecules. Antakly and Eisen (1984) 
observed specfic staining in both cytoplasm and nuclei of rat 
liver hepatocytes and cells of the anterior pituitary. The 
staining in hepatocyte nuclei was reduced in adrenalectomised 
animals, but could be recovered after cortisol treatment. These
4
authors surgested that the differences between their findings end 
those of the above groups may reflect: 1. differences in the 
distribution of oestrogen and glucocorticoid receptors in their 
respective target tissues; or 2. the antibodies raised against 
the oestrogen receptor only recognise antigenic determinants on 
the nuclear form of the receptor.
C. Receptor Structure.
Androgen binding has been extensively studied in the 
classical androgen target tissue, the rat ventral prostate 
(Baulieu 1 Jung 1968; Brinkmann et al 1985a,b; Davies 1983; 
Davies & Griffiths 197*1; Davies et al 1980; Davies, Thomas & 
Griffiths 1976; Fang A Liao 1971; Fang et al 1969; Feit u Muldoon 
1983; Goueli, Holtzman 1 Ahmed 1984; Katsumata A Goldman 1974; 
Liao et al 1973; Mainwaring 1969a,b; Mainwaring d Irving 1973; 
Mulder et al 1984; Shain <1 Boesel 1975; Unhjem et al 1979). 
Subsequently, androgen receptors have been found and 
characterised in a wide variety of tissues and species: the 
mechanism of androgen action was assumed to be similar in all 
tissues containing the androgen receptor (Mainwaring 1977). Table
1.1 gives a brief summary of the physico-chemical properties of 
the receptor protein from a number of different sources.
The androgen receptor (complex II; Fang U Liao 1971) has 
been shown to be essentially acidic in nature (Table1.1; Chang and 
Tindal 1983; Chang et al 1982; Mainwaring and Irving 1973; Razel 
et al 1985; Valladares and Minguell 1975), and has been partially 
purified by ammonium sulphate precipitation (25 to 405 
saturation; Chang and Tindal 1983; de Boer et al 1986; Kyakumoto
Table 1.1 Physico-chemical properties of the androgen 
receptor from different sources and laboratories.
Tissue
a
Kd
(nU)
b
Qk
c
Hr. 
xl 0-3
d
pi
e
Ref.
Rat Ventral Prostate 2.4-4.0 8 . 0 280 5.8 1,2,3
4.2 100 6.5n ti it 6 . 0 0 4.5 87 - 4i i H 6.50 4.5 85 6.3 5i n ii - 4.0 50 - 6,7
Prostatic Tumour 0.3 0 8.5-9. 3 265 - 8
- 4.4 120 -
Rat Pone Farrovz 5. 90 3.0 - 4.9 q
Rat Uterus 2 . 1 0 6 . 0 167 5.9 10
Calf Uterus 0.26 4. 5 80-100 - 7,11
Steer Seminal Vesicles 1.40 3.8 60 6 . 6 12
Uouse Kidney 1.70 3.6 - - 13
Human Liver 0.95 — 75 — 14
Human Prostate 2.38 3.0 3 4 4.7 15
Human Foreskin 0.51 4.0 - 5.7 16
Human CSF 0
 
. fO 1 J—J • O'! 4.0 114.3 — 17,18
a. Equilibrium dissociation constant (ligand: DPT, 
Testosterone, R188J. or Uibolerone).
b. Sedimentation coefficient from 5-20% sucrose density 
gradient centrifugation; activated (3. 0-4.5S) and 
unactivated (0.0-10.OS) complxes.
c. Relative molecular mass, determined from gel 
filtration or SPS-PEGE.
d. Isoelectric point.
e. References:
1 . Fa i nv;a r ing 15 6 9a 1 2 . Chang et al 19 82
2 . Fa inwaring 196 9b 13. Fullock & Hardin 197 4
q «.>' • Fainv/aring 0 Irving 1973 1 4 . Bannister,Sheridan &
4. Goueli et al 1984 Losov/sky 1985
5. Chang et al 19 83 15. Lehoux ,Penard. &
6 . Fulder et al 1983 Elhilali 1985
7. Brinkmann et al 1985b 16. Pazel et al 1975
8 . Powley,Chang & Tindall 1984 17. Keenan et al 1975
q ~ • Valladares &. Finguell 1985 18. Keenan,Greger &.
10. Chang & Tindall 1903 Hedge 19 86
11. deEoer et al 1986
et al 1986), DNA-cellulose chromatography (Brinkmann et al 1985b, 
1986; de Boer et al 1986a), 2'5' ADP-sepharose chromatography 
(Mulder et al 1984), FPLC-anion exchange chromatography 
(Brinkmann et al 1985a; Brinkmann et al 1986) and finally, by 
affinity chromatography (Chang et al 1982; de Larminat et al 
1984).
It remains unclear whether the reported differences in 
receptor properties (Table 1.1) are a true reflection of tissue 
and/or species receptor heterogeneity or are simply the result of 
differences in experimental procedures.
Subunit nature of steroid receptors.
The observation that receptors can aggregate with themselves 
or with "cytosolic" proteins (Fig.1.2a), has led to the 
suggestion that they are oligomeric proteins (Higgins & Gehring 
1978). O'Mally and co-workers (Schrader et al 1981) were the 
first to describe the detailed structure of a steroid receptor. 
They proposed that the avian progesterone receptor contained two 
dissimilar subunits, A and B, both of which bound steroid but 
differed in their affinities for nuclear structures. The A 
subunit (approximately 70000-daltons) bound to DNA, while the B 
subunit (approximately 110000-daltons) bound to chromatin 
(Schrader et al 1981). Further, two proteins having similar 
molecular masses were recovered after in sitp photoaffinity 
labelling of the progesterone receptor from human breast cancer 
cells (Horwitz & Alexander 1983), and two peaks of specifically 
bound steroid were observed after non-denaturing gel 
electrophoresis (Smith et al 1986).
However, more recent evidence has led to a modification of
6
(a)
SH
POij
POPO
HOMO-/HETERO-DIMER
+/-
90K PHOSPHOPROTElli
5-10S
(b)
h2n
cys/arg/lys rich Hydrophobic Residues 
1
Homology with er'o-A
Homology with 
Homeobox genes
(Glucocorticoid receotor only)
Figure 1.2 Schematic representation of steroid receptor, (a) 
domain structure: A, steroid binding; 3, DMA-binding; C,
"modulator" domain containing the .major antigenic determinants. 
Steroid binding pocket ▼  , DNA/nuclear binding site # #  ;
SH, sulohydryl groups and PO^, phosphate groups, (b) summary of 
amino acid sequence data, showing regions of homology between 
different steroid receptors and other regulatory proteins. 
Three main regions of homology between the chicken oestrogen 
receptor, the human oestrogen receptor,and the human 
glucocorticoid receptor, fcssfes}
the above model of the chicken oviduct receptor. Immunological 
studies have shown that the "activated" (US form) receptor was a 
mixture of two steroid binding polypeptides (the A and B subunits 
above), while the "non-activated" (8S form) receptor was made up 
of a hormone binding polypeptide (A or B) associated with a non­
steroid binding protein (two molecules per complex) (Renoir & 
Hester 1984). This non-steroid binding protein was found to be 
phosphorylated on serine residues and to have a molecular weight 
of 90000-daltons. It has also been described associated with the 
8S forms of the androgen, oestrogen, and glucocorticoid receptors 
(J oab et al 1984; Puri, Dougherty & Toft 1984; Renoir U Hester 
1984; Schuh et al 1985). This 90K protein was indistinguishable 
from a protein associated with the Rous Sarcoma Virus 
transforming protein (pp60v“src) by peptide- mapping anc 
immunological studies, and it may also represent one of the 
major heat shock proteins, which are induced under a variety of 
stress conditions (Schuh et al 1985). The implications of these 
different associations to hormone action remain to be determined; 
however; it is tempting to speculate that cellular reponses to 
stress, mediated through steroid receptors, could be controlled 
via interactions involving this 90K phosphoprotein.
Milgrom and co-workers (Logeat et al 1985; Loosfelt et al 
1984) have demonstrated that the rabbit uterine progesterone 
receptor contained only one steroid binding subunit (11 OK) , if 
precautions were taken during homogenization to prevent 
proteolytic degradation of the receptor; if not, smaller 
fragments of 72000, 70000, and 64000-daltons were observed.
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Finally, after large scale purification of the chicken ovicuct 
progesterone receptor, both the A and B forms of the receptor vyere 
found to be immunologically similar (Gronemyer, Govindan « 
Chambon 1985).
The transformation of the 43 oestrogen receptor to the 53 
form has been associated with dirnerization of the 4S subunits 
(Hiller et al 1985; Muller, Traish & Wotiz 1983; Scholl & 
Lippman 1934), or alternatively, with the interaction of the 4S 
receptor with an unidentified protein "X" (Bailly et al 1980). 
Further studies by Miller et al (1985), using chemical cross- 
linking and dense amino acid labelling, concluded that the 5S 
nuclear receptor form was a homodimer of 4S (65K) monomers. 
Steroid receptor domains.
Gustafsson and co-workers (Carslstedt-Duke et al 1982; 
Wrange and Gustafsson 1978) showed that the glucocorticoid 
receptor contained three distinct domains: A, steroid-binding 
(1 9A); B, DNA-binding (36A); and C, "modulation” (Fig.1.2a). The 
wild-type receptor has a Stokes radius of about 6.0 nm (87-90K 
Mr; A+B+C) which could be converted, by partial proteolysis with 
trypsin or 0(rcnymotrypsin, to a form of about 3.0 nm (39-50K Mr; 
A+B), while more extensive enzymic digestion resulted in a 2.0 nm 
fragment (20-30K Mr;A)(Carlstedt-Duke et al 1982; Wrange et al 
1984). Subsequently, limited proteolysis has been used to 
separate the steroid and nuclear binding domains of the oestrogen 
(Greene et al 1984), progesterone (Protein B: Edwards et al
1984), and 1,25-dihydroxyvitamin (Mellon 1985) receptors.
Steroid-receptor binding is a reversible, second-order 
reaction (Higgins U Gehrin^ 1978). Early work on the nature of
the androgen binding site, suggested that the receptor bound 
steroid from theoC-face, ^0-face and peripheral sides, and that 
steric not electrostatic properties of the ligand were important 
in this interaction. The hormone therefore seemed to be 
"enveloped" by a hydrophobic pocket (Liao et al 1973; Tyrnoczko, 
Liang & Liao 1978). Studies with the rat ventral prostate 
androgen receptor showed that the conformation around the A:B 
ring junction had a marked effect on androgenic activity; 
steroids with a cis-conformation were not bound by the prostate 
receptor (Tyrnoczko et al 1978). Cunningham et al (1983) 
correlated plannar A and 3 rings and the presence of the 3-keto 
group with steroid binding. The presence of the 17p-hydroxy group 
was also important, and the addition of a 17p-hydroxy group 
enhanced binding. This latter group, together with a Ttf-methyl 
group may explain the obseved tighter binding of the synthetic 
androgen dimethyl-nortestosterone (Mibolerone) over DHT (Fang et 
alr. 1969; Hodgins and co-workers unpublished observations; Liao et 
al 1973; Traish, Muller & Wortiz 1986; Tyrnoczko et al 1978). 
Testosterone and DHT have both been shown to be bound by the same 
receptor, although DHT was found to have a higher relative 
binding affinity (Tyrnoczko et al 1978; Griffin, Leshin & Wilson
1982). Furthermore when the dissociation rate of steroid 
complexes in cultured genital skin fibroblasts (GSF) was 
measured, testosterone-receptor complexes were found to 
dissociate four times faster than DHT-eomplexes (Hodgins 1982; 
Kaufman and Pinsky 1983; Wilson 6c French 1976).
Recent advances exploiting immunological (hybridoma) and
9
genetic engineering techniques have enabled the isolation of mRI'A 
and the cloning of cDNAs for the rat (Miesfeld et al 19G4) and 
human (Hollenberg et al 1985) glucocorticoid receptors, chicken 
(Krust et al 1986) and human (Green et al 1986; Walter et al
1 9 8 5) oestrogen receptors, and more recently the rabbit 
progesterone receptor (Loosfelt et al 1986). Analysis of the 
deduced amino acid sequences has, in turn, allowed the 
identification of putative functional domains, and homology with 
other known or suspected regulatory proteins (Fig. 1.2b).
The hydrophobic nature of the C-terminus, suggested that 
this was the location of the steroid-binding domain. The 
predicted secondary structure included C<— helices and j3-strands, 
which were compatable with the formation of a hydrophobic pocket 
(Green et al 19S6 ; Krust et al 1986; Weinberger et al 1985). The 
assignment of steroid-binding activity to this region was based 
on two pieces of evidence. The cDMAs for the human glucocorticoid 
receptor predicted two proteins (of 777 arnino acids and 7^ +2 amino 
acids) which differed at their carboxy termini, and were found to 
differ in their ability to bind hormone (Hollenberg et al 1985). 
Secondly, the introduction of mutations in the relevant region of 
the oestrogen receptor cDNA was also found to impair hormone 
binding of the receptor protein after in vitro translation (Kumar 
et al 1986).
The DNA-binding domain was defined as a cysteine, lysine, 
arginine-rich region near the middle of the receptor molecule 
(Fig.1.2b)(Green et al 1986; Hollenberg et al 1985; Krust et al 
1986; Kumar et al 1936; Weinberger et al 1985). This domain was 
linked to the steroid binding domain by a "hinge-region", 'which
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allowed direct contact between these two domains; this could be 
an important feature for the regulation of receptor function 
(Krust et al 1986). Analysis of the amino acid sequence of 
nucleic acid binding proteins has led to the discovery of 
repeated sequences that can form, so called, "metal-binding 
fingers", which it was suggested were capable of binding nucleic 
acids (Berg 1986; Hartsnarne et al 1985). The basis of this 
repeated motif were two cysteine residues which could form a 
tetrahedral complex with another two cysteine or histidine 
residues and a Zn ion; twelve to thirteen residues separated 
the pairs of cysteineand histidine residues, forming the finger 
structure (Berg 1986; Hartshorne et al 1985). The consensus 
sequences from a number of different nuclear binding proteins can 
be summarized as follows, Tyr-Phe-X-Cys-Xjj-Cys-X^-Phe-X^-Leu-O^- 
His-X3-His-X2_.fi* Although this motif was not found repeated 
within the suspected DHA-binding domain of the oestrogen or 
glucocorticoid receptors, a single consensus sequence did occur, 
and the high proportion of cysteine residues in the remainder of
this region may form a finger-like domain by a different
mechanism (Krust et al 1986).
Perhaps the most unexpected and intriguing finding to emerge
from the primary structure of steroid receptors was the homology
with other classes of protein. The glucocorticoid, the oestrogen 
and the progesterone receptors all have homology with the v-erb A 
gene product (p7 5 5 ag~erbA) fr0m the oncogenic Avian 
Erythroblastosis Virus (Krust et al 1986; Loosfelt et al 1986; 
Weinberger et al 1985); and the human glucocorticoid receptor was
found to have limited homology with the products of the homeo-box 
genes, Antennepedia and fuhsi tarazu, from the fruit fly 
Drosophila (V/einberger et al 1985). Chambon and co-workers (Krust 
et al 1986) showed that there was 80£ hornology between the 
chicken and human oestrogen sequences, in three "highly 
conserved" regions; two of these regions (containing the steroid 
and DNA-binding sites) shared homology with the human 
glucocorticoid receptor and the v-erb A fusion product, and the 
third region (at the N-terminus) was absent from the truncated 
p75gaS~er8A protein, but had homologywith the glucocorticoid 
receptor. Although the function of the cellular erb A protein or 
how the product of the v-erb A gene enhances transformation in 
erythrobi asts remain unknown, it would appear that the 
protooncogene and steroid receptors share a common ancestor 
(Krust et al 1986; Weinoerger et al 1985).
Phosphorylation of steroid receptors.
Evidence supporting the role of phosphorylation in the 
regulation of receptor function has been reviewed recently by 
Dougherty, Puri & Toft (1985); both indirect and direct 
experimental evidence for the phosphorylation of receptor 
proteins was reported.
Indirect evidence conies from four lines of investigation: 
steroid binding activity of receptors has been correlated with 
ATP and cyclic nucleotide (cAMP, cGMP) levels (Dougherty et al 
1985; Fleming, Blumenthal & Gurpide 1983; Holbrook, Bodwell u: 
Munck 1983b; Munck & Brink-Johnsen 1968; Sando et al 1979); 
treatment of cytosolic glucocorticoid and progesterone receptors 
with alkaline phosphatase was found to reduce the ability of
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these receptors to bind steroid (Dougherty et al 1985; Nielsen, 
Sando & Pratt 1977; Puri et al 1984); rnolybdate, a known 
inhibitor of phosphatase activity, prevented the loss of steroid 
binding activity of the unactivated (8S) form of the androgen, 
oestrogen, and glucocorticoid receptors (Noma et al 1980; Sando 
et al 1979); and lastly, signal sequences for cAMP-dependent 
phosphorylatilon (lys/arg-lys/arg-X-ser/thr) and also 
phosphorylation on tyrosine residues (tyr-acidic/basic residue) 
were found in the amino acid sequence of the human oestrogen 
receptor (Green et al 1986).
Auricchio and co-workers (Auricchio et al 1981; Auricchio et 
al 1984; Auricchio et al 1985; Migliaccio et al 1982) have 
purified a Ca^+-dependent protein kinase from calf uterus and a 
nuclear phosphatase activity, which they claimed, regulated the 
binding of oestradiol by means of phosphorylation- 
dephosphorylation of the oestrogen receptor. Phospho-amino acid 
analysis showed phosphorylation on tyrosine residues (Auricchio 
et al 1985). The nonactivated, molybdate stabilised, progesterone 
receptor was resolved by DEAE-sephadex chromatography into two 
components (I and II): receptor A (80K) plus the 90K protein and 
receptor B (11 OK) plus the 90K protein respectively. 
Incorporation of [^P]orthophosphate showed that receptor B and 
the 90K protein were phosporylated on serine residues, receptor A 
was also thought to be phosphorylated as both forms A and B were 
substrates in. vitro for a cAMP-dependent protein kinase 
(Dougherty 1985; Puri et al 1984; VJiegel et al 1981). Similarly 
Goueli et al (1984), found that the purified androgen receptor
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from rat ventral prostate was specifically phosphorylateci by a 
nuclear cAMP-independent protein kinase. Finally the 
glucocorticoid receptor from L-cells (Housley & Pratt 1983) and 
rat liver (Grandics et al 1984; Kurl & Jacob 1984) has been shown 
to be phosphorylated by an endogenous protein kinase.
Phosphorylation - dephosphorylation cycles have long been 
recognised as important elements in metabolic regulation, 
controlling the activities of proteins and enzymes, therefore, it 
has been suggested that phosphorylation could regulate the 
binding of ligand by the unactivated and activated forms of the 
receptor (Dougherty et al 1985). Another intriguing possibility, 
is that phosphorylation could integrate steroid hormone action 
with other signal transducing mechanisms (Dougherty et al 1985). 
It is of interest, therefore that Ghosh-Dastidar et al (1984) 
observed that both the A and B forms of the hen oviduct 
progesterone receptor were phosphorylated by epidermal growth 
factor (EGF) via the EGF-receptor.
Receptor heterogeneity.
The rat prostate cytosol was found to contain at least two 
proteins that specifically bound DHT, which could be separated by 
ammonium sulphate precipitation (0-40% complex II; 55-70% complex 
I) and by gel filtration; only complex II was retained by the 
nucleus (Fang and Liao 1971). Two populations of high affinity 
DHT-binding protein have also been identified by Fiet and Muldoon 
(1983). They could be distinguished by their rates of association 
with steroid and the differential susceptability of the complexes 
to protamine sulphate precipitation. It was suggested that the 
interconversion of receptor forms was controlled by a "cytosolic
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factor", which was ribonuclease resistant and precipitated by 
percholoacetate and (55-70$) ammonium sulphate (Feit d Muldoon
1983).
A second class of cytosolic and nuclear oestrogen binding 
sites (Type II) have also been described (Katzenellenbogen 1980). 
The cytoplasmic Type II sites had a 40-fold lower affinity for 
oestrogen than the classical receptor (Type I sites), with 
dissociation constants of 30nM and 0.8nM respectively: these 
sites were found in target tissues and at lower levels in other 
tissues. However, they were not translocated to the nucleus, and 
were thought to be a means of concentrating steroid in target 
cells. The Type II nuclear sites were not related to either Type 
I or II cytoplasmic proteins, and had a lower affinity for 
steroid compared to Type I sites (Kd=20nM and 0.6nM respectively) 
but were present atamuch higher concentration; the 
phyisological role remained unclear (Katzenellenbogen 1980). More 
recently McNaught and Smith (1986) characterised a second 
oestrogen receptor species in the chicken oviduct; this receptor 
form (Y) had a slower rate of association than the higher 
affinity (X) form, and was apparently involved with increases in 
ovalbumin gene transcription (McNaught & Smith 1986; Raymoure, 
McNaught & Smith 1985).
Finally, Smith and Hermon (1985) using affinity labelling, 
immunoprecipitation and high resolution two-dimensional gel 
electrophoresis, were able to show at least two isoforms of the 
glucocorticoid receptor (binding protein) with isoelectric points 
of 5.7 and 6.0-6.5 ; analysis of crude cytosol revealed an add­
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itional isoform with an isoelectric point of about 5.2. These 
species could be competed out when excess cold triamcinolone 
acetonide was included during the affinity labelling step: there­
fore charge heterogeneity was a feature of the structure, and 
possibly function, of the glucocorticoid receptor from the IH-9  
lymphoid cell line.
D. Activation and Transformation of Receptor Complexes.
For the purposes of this discussion the term "activation"
will be used to describe the conversion of the steroid-receptor
complex into a form that bound tightly to nuclei in vivo, and was
capable of binding to DNA-cellulose and translocating C^H]steroid
into target cell chromatin jj] vi tro. The process could be
mimicked in vitro by heating, increasing ionic strength, ammonium
sulphate precipitation, gel filtration, ultracentrifugation,
alkaline pH, dilution, ATP, and dialysis (Goidl et al 1977;
Katzebnellenbogen 1980; Mainwaring and Irving 1973; Moudgil et al
1985; Munck and Foley 1979; Munck G Holbrook 1984).
Posssible mechanisms for receptor activation that have been
suggested include: dissociation of subunits and/or conformational
changes (Bailly et al 1980; deBoer et al 1986a; Greenstein 1984;
Higgins oc Gehring 1978; Kovacs, Griffin & Wilson 1983; Mainwaring
and Irving 1973; Milgrom, Atger & Baulieu 1973; Moudgil et al
1985; Muller et al 1983; Raaka et al 1985; Renoir  ^Mester 1984;
★ *
Sato, Ohara-Nemotc u Ota 1986), however; the dissociation of the 
9.65 glucocorticoid receptor (236000-daltons) to the 4.65 (95500- 
daltons) form was reported by Weatherill and Bell (1982) to 
preceed activation; limited proteolysis (Puca et al 1977),
The following references have been omitted from the text:
Schmidt et al 1975 ( * )
Holbrook et al 1985a; Raaka & Samuels 1985? Vedeckis 1985 (**)
although the conversion of the 8S oestrogen-receptor complex from 
calf uterus by an endogenous endopeptidase yielded a modified US 
form that was distinct from the native receptor (Gregory and 
Notides 1982); the action of cytoslic factor(s)(Goidl et al 1977; 
Noma et al 1980; Sato et al 1979; Thrower et al 1976); and 
finally because molybdate stabilised the unactivated complex and 
inhibited activation in a concentration dependent manner (Kovacs 
et al 1983), this was taken as circumstantial evidence for 
dephosphorylation being involved in receptor activation.
Activation of the androgen receptor has been associated 
with: changes in sedimentation coefficient (deBoer et al 1986a; 
Kovacs et al 1983; Mainwaring and Irving 1973); a shift to a more 
basic isoelectric point (Greenstein 1984; Mainwaring and Irving 
1973); increased affinity for DNA-cellulose (deBoer et al 1986; 
Kovacs et al 1983; Mainwaring and Irving 1973); and an increased 
affinity for steroid (deBoer et al 1986; Kaufman and Pinsky 1983; 
Kaufman et al 1982a,b): the last has also been descibed for the  ^
oestradiol-receptor complex (Muller et al 1984). In a recent 
study Keenan et al (1986) found that activation of the human 
androgen receptor, from cultured fibroblasts, was accompanied by 
a decrease in molecular radius and a loss of negative charge, 
with a possible loss of a 20000-dalton macromolecular component. 
However, in a recent study, Smith and co-workers (Smith, Elasser dc 
Harmon 1986) showed that the alteration of surface charge 
accompanying activation of the glucocorticoid receptor (IM-9 
cells) was the result of a conformational change rather than a 
covalent charge modification.
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Kaufman and co-workers from Kinetic studies with the 
androgen receptor from cultured GSF, proposed a model for 
activation invoving three conformational states (Fig.1.3; Kaufman 
and Pinsky 1983; Kaufman et al 1982a,b). Dissociation of the 
activated complexes was normally monophasic, however in the 
presence of sodium thiocyanate, purified, DHT-receptor complexes 
dissociated with complex kinetics: it was suggested that this 
chaotropic salt was affecting the van der Waals forces and 
hydrogen bonding within the receptor molecule resulting in 
deactivation of the activated complexes and the observed complex 
dissociation kinetics (Kaufman et al 1982a,b). Interestingly 
sodium thiocyanate has also been shown to affect the activation 
of the rat hepatic glucocorticoid receptor (Kalimi and Hubbard 
1982).
The term "transformation” has also been used to describe the 
above process; however; work by different groups suggests this 
term should be restricted to describing the oestrogen receptor 
system. Activation has been described for all classes of steroid 
receptor, but to date only the nuclear form of the oestrogen- 
receptor complex shows an increase in sedimentation coefficient 
(4S to 5S)(Yamamoto 1974). Subsequent work has shown that this 
transition was distinct from receptor activation (Bailly et al 
1980; Muller et al 1983; Muller et al 1984). Activation of the 
oestradiol-receptor complex was first-order, and was stimulated 
by an increase in temperature or ionic stength; subsequent 
transformation of the activated complex followed second order 
kinetics, and involved either receptor dimerization (Muller et al 
1983, 1984) or the interaction of a cytosolic protein "X" (Bailly
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Figure 1.3 Postulated conformational status for the androgen 
receptor after binding steroid. Taken from Kaufman et al 1982b.
RM.H”: dysactivated complex
R.H": preactivated complex
R’.H": activated complex
k _-\, k_2 » ^~3 : dissociation rate constants
Kact: rate constant of activation
Ke: equlibrium constant
et al 1980; Gorski « Gannon 1976; Higgins Gehring 1976; 
Yamomoto 197*0.
Although the precise mechanism of receptor activation 
remains open to discussion, it is clear that it is an essential 
step leading to receptor-mediated changes in gene transcription. 
Transformation, on the other hand, has only been observed for the 
oestrogen receptor and the phyisiological significance remains 
unclear.
E. Steroid Receptor Interactions with Nulear Structures.
The main action of steroid hormones result from receptor 
mediated changes in gene transcription, in a tissue specific 
manner: regulation of gene expression by steroids can either be 
positive or negative (Chan 6c O’Mally 1976; Feigelson et al 1978; 
Jensen et al 1968; Jensen and deSombre 1973,' Tymoczko et al 1978; 
Yamamoto 1985; Yamamoto and Alberts 1976).
The ability of steroids to act on the genome of target pells 
in this way, was elegantly demonstrated in the studies with the 
insect hormone ecdysone, reviewed recently by Dwarniczak et al 
(1983). This hormone controls insect growth and development; and 
effects were shown most dramatically on the giant polytene 
chromosomes from the salivary glands of Drosophilia larvae. 
Metabolic labelling experiments showed that the "chromosomal 
puffs" induced by hormone treatment were associated with gene 
transcription; it was subsequently demonstrated that this was a 
complex response, initially involving only a few genes (early 
puffs) and progressing, after a delay, to a much larger number
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(late puffs); the latter appeared to be dependent upon the early 
puffs as shown by the use of inhibitors of protein synthesis
(Dwarniczaak et al 1983).
The problem facing steroid-receptor complexes, and gene 
regulatory molecules in general, is how to find and interact with 
the appropriate target gene(s). In the field of steroid receptor 
research therehas been a considerable debate as to the existence 
and nature of nuclear acceptor sites for receptor complexes 
(Gorski and Gannon 1976; Tyrnoczko et al 1978; Yamamoto 1985; 
Yamamoto and Alberts 1976). A number of investigators have 
described the interaction of receptor complexes with nucleotide 
sequences (Birnbaun and Baxter 1986; Cato et al 1984; Chandler, 
Maler u Yamamoto 1983; Dean et al 1983, 1984; Eliard et al 1985;
Giesse et al 1982; Groner et al 1984; Goner, Lakey & McBlain
1984; Jost, Seldran d Geiser 1984; Karin et al 1984; Kumar and 
Dikerman 1985; Lee et al 1984; Payvar at al 1983; Renkawitz et al 
1982; Romanov et al 1984; Schreidereit et al 1983; von der Ahe et 
al 1985, 1986; Yamamoto 1985), chromosomal proteins (de Boer et 
al 1986b; Kaye et al 1986; Liao, Liang & Tyrnoczko 1972; 
Mainwaring, Syms & Higgins 1976; O’Mally et al 1972; Pratt et al 
1984; Ruh et al 1986; Spelsberg et al 1983, 1984; Tanuma, Johnson 
& Johnson 1983; Webster, Pikler & Spelsberg 1976), the nuclear 
envelope (Jackson <1 Chalkley 1974; Lefebvre & Novosad 1980) and 
the nuclear matrix (Brown and Migeon 1986; Buttyan et al 1983; 
Gonor et al 1984), in an attempt to characterise possible nuclear 
acceptor sites.
DNA:recognition of specific nucleotide sequences.
Despite the experimental evidence that steroid receptors
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could bind to DNA and polynucleotide sequences, the detection of 
specific DNA-binding sites was hindered by the masking effect of 
a large number of non-specific sites (Kumar and Dikerman 1985; 
Yamamoto 1985). This was resolved by enrichment of the putative 
(specific) binding sequences, initially by nitrocellulose filter 
binding (Riggs, Suzuki & Bourgeois 1970), and subsequently using 
competition assays, electron microscopy, immunoprecipitation and 
nuclease footprinting techniques (Yamamoto 1985).
Early studies focused on glucocorticoid control of mouse 
mammary tumor virus (MTV) gene expression as a model for 
receptor-DNA binding (Ringola et al 1983; Rousseau 1984). Payvar 
et al (1983) mapped five regions of MTV DNA that were bound 
specifically by purified glucocorticoid receptor; one site was 
upstream of the transcription start site, while the others were 
distributed within the transcribed sequence. Other studies have 
found that both the 40K and 90K molecular weight forms of the 
receptor bound restriction fragments including the f'ight 400-500 
nucleotides of the MTV-long terminal repeat (LTRXGeisse et al
1982); a further two regions at positions -124 to -72 and -220 to 
-140 were shown to bind receptor, and were necessary for 
glucocorticoid control of transcription (Chandler et al 1983; Lee 
et al 1984; Scheidereit et al 1983; Rousseau 1984).
Receptor binding sites 5* to and within transcribed sequen­
ces of hormone regulated genes have subsequently been reported 
for the glucocorticoid receptor at the growth hormone, lysozyme, 
uteroglobin, metallothionein 11^ and placental lactogen genes 
(Birnbaum and Baxter 1986; Cato et al 1984; Eliard et al 1985;
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Karin et al 1984; Renkawitz et al 1982; von der Ahe et al 1985, 
1 9 8 6); for the progesterone receptor at the ovalbumin, 
transferrin, ovomucoid, lysozyme, and uteroglobin genes (Bailly 
et al 1983; Dean et al 1983, 1984; Renkawitz et al 1982; von der 
Ahe et al 1985, 1986; Yamamoto 1985); and for the oestrogen 
receptor at the ovalbumin, and vitellogenin genes (Dean et al 
1984; Jost, Geiser & Seldran 1985; Jost et al 1984). Nuclease 
protection studies have identified directly the sequences bound 
by the glucocorticoid receptor within or near DNA encoding for 
MTV (Karin et al 1984; Payvar et al 1983; Scheidereit et al 1983; 
von der Ahe et al 1985), human metallothionein 11^ (Karin et al
1984) and growth hormone, and chicken lysozyme (von der Ahe et al
1985) genes; from this work the consensus sequence 5’- 
T/cGGTA/TCAA/TTGTT/cCT-3! and related octanucleotide 5'- 
AGAAZ-j-CAGA/^-R’ and hexanucleotide 5l-TGTTCT-3t sequences have 
been described (Ringold et al 1983; Yamamoto 1985). However other 
sequences and/or factors must also play a part in receptor 
recognition since the above consensus sequence has been found in 
DNA not associated with receptor binding or steroid action 
(Yamamoto 1985). The functional and biological significance 
of the DNA-receptor binding sites observed in vitro was shown 
using gene fusion, the introduction of specific deletions, and 
gene transfection techniques. Putative hormone control sequences 
(with or without deletions) could be linked to selectable marker 
genes, not normally under hormonal control, and the hybrid 
gene(s) introduced into suitable host cell, where expression 
could be assayed under basal and hormone stimulation conditions. 
From such studies it became clear that the in yivo
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"glucocorticoid response element"(GRE) and in vitro receptor 
binding sites were co-incident (Chandler et al 1983; Lee et al 
1984; Payvar et al 1983; Romanov et al 1984). It was also found 
that the activity of the GRE was independent of distance and 
orientation from the transcription start site; this has led to 
the suggestion that receptor binding sites function as steroid- 
dependent enhancer elements, that act by providing a 
"bidirectional entry site" for the machinary of transcription 
(Karin et al 1984; Parker 1983; von der Ahe et al 1985; Yamamoto
1985). Enhancer elements were originally identified as short cis- 
acting regulatory elements that were capable of increasing the 
transcription efficiency of genes independently of their 
orientation and position relevant to the gene, in the DNA-tumor 
virus SV40 (Khoury & Gruss 1983). Enhancers have subsequently 
been found associated with a number of cellular genes in a tissue 
specific manner, the best characterised being the immunoglobulin 
gene enhancers (Boss 1983; Dunn and Gough 1984; Khoury^ . and Gruss 
1983; Voss, Scholkat & Gruss 1986). More recent research, 
reviewed by Voss et al (1986), has suggested that enhancer 
activity involves both cis- and trans-acting elements, which 
allows for the interaction of general and/or tissue specific 
factors.
Chromosomal proteins and alterations in chromatin structure.
In eukaryotes the genetic material is organised into 
chromatin, and as a result of several levels of packaging (10nm 
to 30nm fibres) with histones and non-histone proteins the DNA is 
inaccessible to the transcriptional apparatus, therefore the
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structure of chromatin must differ at regions of gene activity. 
It was subsequently found that active genes are generally in 
regions of more open chromatin (euchromatin); and these regions 
were found to be preferentially digested with the endonuclease 
DNase I. This phenomenon was also found to be tissue specific 
since globin genes were nuclease-sensitive in erythroid tissue 
but not oviduct, and the reverse being true for the ovalbumin 
gene (Weisbrod 1982). Subsequently, Elgin and co-workers (Elgin 
1981, 1983) showed that within regions of DNase sensitivity there 
were so called hypersensitive sites, thought to be generated by 
the binding of non-histone proteins; such sites at or near the 5' 
end of genes are beleived to indicate the potential for 
transcription of a particular locus.
Hypersensitive sites have also been correlated with steroid 
hormone regulated gene expression. Pratt et al (1984) found that 
oestrogen receptors bound to pre-existing nuclease-sensitive 
sites in uterus, lung, and kidney nuclei. Fritton et al (1984) 
reported that the pattern of hypersensitive sites upstream from 
the lysozyme promoter changed depending on whether the gene was 
under constitutive or hormonal control. Furthermore, a recent 
report from Chambon and co-workers (Kaye et al 19 8 6) described 
four regions of nuclease-hypersensitivity in the 5’-flanking 
region of the ovalbumin gene, that were also dependent upon 
steroid stimulation.
In addition to increased sensitvity to nuclease digestion, 
regions of active chromatin may contain non-histones proteins 
(especially "high mobility group" species HMG14 and HMG 17), 
modified histones and altered base structure (V/eisbrod 1982).
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HMG proteins are low molecular weight proteins with highly 
conserved and unusual amino acid sequences: evidence for their 
involvement with gene activity comes from fluorescent antibody 
studies, which showed "HMG-like" proteins associated with the 
chromosomal puffs of polytene chromosomes, and from the 
observation that erythrocyte chromatin depleted of HMG 14 and 17 
was no longer preferentially sensitve to DNase-I digestion 
(Weisbrod 1982). HMG 14 and 17 are associated with active genes, 
at the end of the nucleosome core and internucleosome regions, 
where they are thought to replace histone H1 and thereby generate 
a more open structure (Weisbrod 1982). Tanuma et al (1983) 
observed that glucocorticoids caused a reduction in endogenous 
ADP-ribosylation of HMG 14 and 17; furthermore, they concluded 
that a loss of (ADP-ribose)n moieties from these proteins may 
play a role in MTV gene expression. Post-translational 
modification of histones (phosphorylation or acetlyation) may, 
similarly play a part in steroid action (Yamamoto 1985).
Although it is feasible that receptor complexes binding to 
"steroid responsive elements" upstream and/or within transcribed 
sequences could initiate the changes in chromatin structure 
discussed above, there is a strong opinion that non-histone 
proteins play a more direct role in receptor-acceptor 
interactions (de Boer et al 1986b; Gorski & Gannon 1976; 
Mainwaring et al 1976; O’Mally et al 1972; Pikler et al 1976; Run 
et al 1986; Spelsberg et al 1972, 1983, 1984; Webster et al 1976; 
Yamamoto & Alberts 1976). Extensive studies by Spelsberg and 
associates (O’Mally et al 1972; Pickier et al 1976; Spelsberg et
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al 1972, 1983, 1984; Webster et al 1976) on a subfraction of 
nuclear acidic proteins (AP^ or CP^), extracted from avian 
oviduct nuclei, have concentrated on the role of this fraction in 
the nuclear binding of the progesterone receptor. Construction of 
"hybrid” chromatin with the acidic proteins from one tissue and 
the histones from another revealed that the ability to 
specifically bind receptor resided with the donor tissue of the 
acidic protein fraction. Furthermore, these acidic proteins were 
responsible for masking acceptor sites in non-target tissues and 
about 1 0 % of the sites in target tissue as well. The 
reconstituted "native-like" acceptor sites also required specfic 
DNA sequences in addition to the nucleoacidic fraction (Spelsberg 
et al 1984). However, because of the technical difficulties 
inherent in this type of study, the above conclusions have been 
questioned (Yamamoto 1985; Yamamoto and Alberts 1976).
Mainwaring et al (1976) using a different approach to the 
above, immobilised nuclear components on a Sepharose 2B column, 
identified a non-histone, basic fraction showing apparent 
acceptor activity.
Finally, changes in chromatin structure have also been 
associated with modifications to the bases in DNA; in vertebrates 
the principal one being methylation of certain cytosine residues 
to 5-methylcytosine (Bird 1984,1986; Jahner et al 1982; Weisbrod
1982). Undermethylation at key CpG doublets has been associated 
with the 5*-end of a number of active genes (Bird 1984; Jahner et 
al 1982), and also with steroid stimulation of the ovalbumin 
(Mandel and Chambon 1979), vitellogenin (Burch and Wientraub 
1983; Jost et al 1984, 1986; Saluz, J iricny <1 Jost 1986; Wilxs et
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ai 1982; Wilks, Seldran U Jost 1984), and prostatic steroid 
oinding protein (component C3(1); Parker, Hurst d Page
1984)genes. This has led to the suggestion that demethylation may 
play a role in the control of gene expression. However 
transcription of X.laevis sperm rRHA was unaffected by heavy 
methylation of spacer and promoter regions (Bird 1984), and 
although the hypomethylation site at the 5' end of the chicken 
vitellogenin gene was co-incident with an oestrogen receptor 
binding site (Jost et al 1984), the demethylation of this site 
appeared to be an effect of gene transcription rather than the 
cause (Burch L Weintraub 19&3; Wilks et al 1982,1984). The 
emerging picture, is that house-keeping genes are associated with 
clusters of CpG sequences in "C+G rich islands” that escape the 
normal suppression of this dinucleotide sequence by methylation 
as a result of bound "factors". De novo methylation of these 
regions occurs secondary to inactivation of the gene (loss of 
trans-acting factor(s) ? ) and serves to reinforce the silence of 
the gene. These TIG+C rich islands" are not associated with tissue 
specific genes, which it is suggested depend on tissue-specific 
factors to fufil a similar role, and the observed demethylation 
at such genes would be an effect of transcription and not the 
cause (Bird 1986; Mar 1984).
Nuclear matrix.
The nuclear matrix was first described by Berezney and 
Coffey (1974) as a residual protein skeleton after depletion of 
nuclear membrane phospholipids and chromatin from rat liver
nuclei: it was 98.45 protein (5-105 of total nuclear protein)
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consisting mainly of three acidic protein fractions, 0.1 £ DNA, 
and 0.55 phospholipid. It has been associates with OKA 
replication (Berezney & Coffey 1975; Pardoll, Vogelstein & Coffey 
1980; Vogelstein, Pardoll a Coffey 1980), anchorage sites for OKA 
supercoiled loops (Vogelstein et al 1980), and actively 
transcribed genes (Ciejek, Tsai & O'Malley 1983; Robinson et al
1983). In view of the latter finding it is of interest that 
specific binding of oestrogens and androgens, which is tissue 
specific and sensitive to hormone manipulation, has been 
associated with this structure (Barrack & Coffey 1930). 
Furthermore, steroid-receptor complexes have also been isolated 
bound to this nuclear substructure (Brown & Migeon 1986; 3uttyan 
et al 1983; Kaufman et al 1986; Rennie, Bruchovsky & Cheng 1983).
Androgen receptor-nuclear associations.
Androgen receptors have been found to bind to RNA (Conor et 
al 1984; Mulder et al 1984), polynucleotides (Mulder et al 1984), 
DNA (Davies and Thomas 1984; roekens et al 1985; Kanaala, Kistler 
& Kistler 1985; Lin and Ohno 1981; Mulder et al 19&4; Page and 
Parker 1983; Parker et al 1984), chromosomal proteins (Davies and 
Thomas 1984; Foekens et al 1985; Liao et al 1972; Mainwaring et 
al 1976), and the nuclear matrix (Brown and Migeon 1986; Buttyan 
et al 1983).
Clones of the gene(s) encoding the C3 component of the 
prostatic steroid binding protein and fusion genes containing the 
C3 promoter sequences have been successfully expressed in the 
androgen reponsive Shionogi 115 cell line (Page & Parker 1983; 
Parker et al 1984). However in a competition assay specfic
2o
binding of the androgen receptor to C3 restriction fragments 
could not be demonstrated, and this was thought to be due to an 
absence of specfic binding, sequences on the clones used and/or 
the loss of the DNA-binding domain from the receptor (Mulder et 
al 1984). Interestingly, the C3 gene and another androgen 
reponsive gene, encoding for seminal vesicle secretory protein 
IV, were found to share sequence homology from position -330 to - 
190 upstream of the main transcription start sites; the factional 
significance of this sequence for receptor binding and in vivo 
expression of these genes was not determined (Kandala et al
1985).
The involvement of nuclear proteins in androgen-acceptor 
function was shown by the concomitant release of oligonucieosome 
fractions, RNA polymerase b and androgen receptors from the rat 
prostate nuclei; all three parameters were dependent upon steroid 
status (Davies d Thomas 1984). After in situ chemical 
crosslinking of receptors to nuclear structures, with 
formaldeyde, Foekins and associates (Foekens et al 1985) observed 
that *18% of receptors could be released with microccocal nuclease 
treatment, 745 with trypsin digestion and 975 when both were used 
together. The conclusion was that two classes of receptor binding 
site, involving either DNA or protein, were present in the rat 
prostate. However the significance of these putative acceptor 
sites to androgen action in this tissue was still to be 
investigated.
Conclusions.
In conclusion, this section has described the different 
interactions that have been observed between steroid-receptor
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complexes and target cell nuclei. Yamamoto (1985) in an excellent 
review, has recently attempted to explain the many facets of 
steroid control of specfic genes, including the possible 
existance of gene domains (Schrader et al 1981),multi-factor 
control of a single gene, and tissue specfic gene expression. The 
model was based on receptor complexes binding to specfic steroid 
response elements ("modulatory” enhancer sequences), and tne 
triggering of secondary trans-acting transcription factors which 
could act within gene-networks similar to those proposed by 
Britten and Davidson (1969). The role of specfic DNA sequences 
was central to this model, however the possible involvement of 
non-DNA component in receptor recognition was not ruled out, and 
it would seem prudent to assume that such structures do have a 
part to play in the steroid control of gene expresion. Finally, 
the studies of Jost and co-workers (Jost et al 1986) on the in 
vitro secondary activation of the chicken vitellogenin gene 
("memory effect") has suggested that other factors, in addition 
to receptor complexes, are necessary for gene transcription, 
since stimulation of the gene was only partly reduced by the 
addition of inhibitors of protein kinase II and calmodulin- 
dependent kinase ( 5 5 % ) or by removing oestrogen receptors (403).
F. Control of Receptor Levels by Hormone.
The regulation of receptor concentration by the 
corresponding ligand could play an important role in controlling 
the cellular response to a given steroid. Glucocorticoids, 
oestrogens and progesterone have all been found to reduce
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receptor levels by increasing the rate of receptor Degradation. 
On binding glucocorticoids, the receptor from the GH-j rat 
pituitary cell line dissociates from a 10S oligomeric structure 
to a 3-4S species, with a concomitant decrease in receptor half- 
life (19h to 9.5h) and a 50% reduction in receptor levels 
(McIntyre u Samuels 1985; Raaka & Samuels 1983). More recently, 
Okret et al (1986) using a cDf.'A clone of the rat glucocorticoid 
receptor, demonstrated that after treatment of rat hepatoma cells 
with steroid the receptor mRNA was reduced by 50-95%. This was 
independent of protein synthesis; and the levels of receptor 
message were restored ;after 72 hours. Similarly a 50-705 
reduction in oestrogen receptor levels has also been observed on 
steroid binding ("nuclear processing") (Eckert & Katzenellenbogen 
1982; Horwioz a McGuire 1978); and the nuclear 5S receptor species 
was found to be rapidly turned over (t'j/2~2.25h)(Scholl & Lippman
1984), while dense amino acid and sedimentation analysis showed 
that receptor half-life was decreased in response to oestradiol
r-
(Eckert et al 1984). It was suggested that nuclear processing was
necessary for oestogen induction of the progesterone receptor
(Horwizt d McGuire 1978), however subsequent studies in MCF-7
cells (Eckert & Katzenellenbogen 1932) and rat uterus (Kassis,
receptor
V/alent a Gorski 1986) have shown that progesterone levels can be 
stimulated in the absence of oestrogen receptor processing. 
Finally in the guinea pig uterus progesterone receptor levels 
were found to be under positive control by oestrogens and 
negative control by progesterone (Milgrom et al 1973).
In contrast to the above classes of steroid hormone, 
androgens have been found to increase the level of oasal receptor
31
binding, without altering the affinity of binding (Kd) in 
cultured human GSF (Kaufman, Pinsky c Hollander 1981; Kaufman et 
al 1983; Ring & Hodgins 1984) and in the tumuor cell lines 
derived from rat prostate (DDT^MF-2) and hamster ductus deferens 
(R332?H-g8-A1 XSyms, Norris & Smith 1983; Smith, Syms a Norris
1984). In the tumuor cell lines the levels of receptor binding 
increased 2-fold within a 6 hour peroid. This increase was 
inhibited by glucocorticoids and apparently dependent upon protein 
synthesis (Smith et al 1984; Syms et al 1983). Using dense amino 
acid labelling to follow the degradation of existing receptor 
molecules, it was found that the receptor half-life was increased 
(3h to 6h) and that the rate of receptor synthesis was also 
increased (k:1.35 to 2.23fmoles/ug DNA/h)(Syms et al 1985). The 
increase in receptor binding in cultured GSF was also believed to 
be due to de novo synthesis of receptor protein (Kaufman et al 
1981,1983). More recent studies by Ring and Hodgins (1984; 
Dr.Hodgins personal communication) support an alternative 
explanation for receptor "up-regulation", which can be explained 
solely on the basis of the increase in receptor half-life, such 
that on binding ligand, the receptor attains a more stable 
conformation.
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1.2 Androgen Insensitivity
A. Hormone Resistance.
Hormone resistance or insensitivity has been defined as the
inability of target tissues to respond to normal or elevated
levels of circulating hormone. The first reported cases of end-
organ resistance to a hormone were by Albright and associates for
1,25-dihydroxyvitamin D (Albright et al 1937) and the peptide
parathyroid hormone (Albright et al 1942); the latter condition
para
was described as pseudohypothyroidisim to distinguish it from 
para A
hypothyroidism due to an absence of hormone.
End-organ insensitivity to steroid hormones has been 
described for nearly all classes: glucocorticoids (Lipsett et al
19o5); mineralocorticoids (CheeiC b Perry 1958; Oberfield et al 
1979); vitamin (Marx et al 1984); progesterone (Teller et al 
1979); and androgens (Y/ilson et al 1983). The absence of reported 
cases of inherited resistance to oestrogens is probably due to 
the essential role these hormones play in early foetal develop­
ment, and any disruption of oestrogen action is therefore 
believed to be lethal. However, a special case of oestrogen 
resistance has been observed in certain breast tumours, whose 
growth becomes independent with respect to oestrogens and 
refractory to hormone therapy. It has been suggested that this 
may arise from an abnormality in oestrogen-receptor function 
(Rornic-stojkovic A Gamulin 1980).
B. Male Sexual Differentiation and Andogen Insensitivity.
Resistance to androgens disrupts normal male sexual
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development and results in the clinical condition of male 
pseudohermaphroditism; individuals with male genetic and gonadal 
sex differentiation who develop partially or completely as 
phenotypic females (Griffin u Wilson 1980; Griffin et al 1982; 
Hodgins 1983a; Wilson et al 1983). Insensitivity to androgens has 
also been described in normal appearing men with infertility 
(Amian et al 1979; Aroian & Griffin 1982).
Mammalian embryos of both sexes differentiate in an 
identical fashion during the early stages of development (Wilson 
1978). From animal experiments and genetic disorders (i.e. 
syndromes of androgen insensitivity) it was apparent that male 
differentiation had to be actively imposed on the indifferent 
gonads and urogenital tract at key stages of development to 
prevent passive differentiation of the female phenotype (Jost 
1970, 1972; Wilson 1978). In the later stages of development, 
male differentiation of the indifferent urogenital tract 
(wolfgian and roullerian ducts) was dependent upon two hormones 
secreted by the foetal testes (Jost 1970; Wilson 1978) (Fig. 
1.4). The first, mullerian regression factor, a peptide hormone 
originating from the sperinatogenic tubules, suppresses the 
development of the rnullerian duct into the uterus and upper 
portion of the vagina (Wilson 1978). The second, testosterone, 
produced in the Leydig cells, acts indirectly as a prohormone and 
directly on the wolffian duct to give the epididymis, vas 
deferens and seminal vesicles (Siiteri & Wilson 1974; Wilson 
197 8 ). The conversion of testosterone to the 50^-reduced 
metabolite DHT was found to be a prerequisit for the development
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I. GENETIC SEX (Fertilization) 
XY
"testis-determining factor" 
(H-Y antigen ?)
II. GONADAL SEX (about sixth w e e k )
TESTIS
1. Mullerian regression factor
2. Testosterone (a DHT)
III. PHENOTYPIC SEX (40-90 days / puberty)
a. MALE INTERNAL AM) EXTERNAL GENITALIA
b. MALE SECONDARY SEXUAL CHARACTERISTICS
Figure 1.4 Sexual differentiation in Man.CJost 1970,1972; ’Wilson 
1978).
of the male external 0enitalia (Siiteri a Wilson 197 ;^ •ilsc.. 
1972; Hodgins 1383b).
Therefore male sexual differentiation was an active process 
dependent upon the Y chromosome for gonadal differentiation, ana 
On the hormonal secretions of the testes at subsequent stages.
Individuals with ancrogen insensitivity were characterised 
by the absence of mullerian duct structures, normal or elevates 
levels of plasma testosterone, and variable degrees of 
feminization at birth and puberty. The defect was associated with 
the target cell which was unable to respond to testosterone 
and/or DHT (Griffin & Wilson 1920; Griffin et al 1982; Pir.swy 
1978; Wilson et al 1983). The defects in target cells have been 
associated with mutations of the androgen receptor system or wizr. 
the enzyme 5c<-reductase.
C. Receptor Disorders.
Complete Androgen Insensitivity.
/r>
Complete testicular feminization has been described in Man, 
cattle, dogs, rats, and mice (Bardin et al 1970; 3ullock 1 Bardin 
1972; Chung et al 1983; McLean-Morris 1953; Ohno & Lyon 1970; 
Short 1967; Wieland & Fox 1979).
The disorder in man was first described by McLean-Morris 
(1953; McLean-Morris n Mahesh 1963), who used the term testicular 
feminization to describe patients with a female habitus anc 
feminine breast development and body fat distribution. There were 
no internal genitalia except for undescended testes, the external 
genitalia were unambiguously female, and there was absent o r  
scanty axillary and pubic hair growth in most cases. The testes
have been snown to respond to gonadotrophins ana to synthesise 
steroids normally (Turksoy, Mitchell L Safaii 1976). Furthermore, 
1 0 % of 17^-oestradiol in normal males and 60$ in patients with 
testicular feminization was found to be due to testicular 
secretion (McDonald et al 1960).
The aetiology of the disease was compatible with an X-linked 
recessive mutant allele or male sex limited autosomal dominant 
allele. The elegant studies of Migeon and co-workers (Migeon et 
al 1961), with human-mouse cell hybrids demonstrated that the 
locus for the androgen receptor was on the X chromosome, and that 
this was homologous to the Tfm locus in the mouse. Supporting 
evidence for the X-linked nature of the disorder comes from 
receptor studies on cultured genital skin fibroblasts from 
obligate heterozygotes, which showed receptor deficiency 
compatible with inactivation of the X-chrcrnosome (Flawady et al 
1983; Hodgins, Duke & Ring 1984; Meyer, Migeon 1 Migeon 1975).
r-
Partial Androgen Insensitivity: Incomplete Testicular
Feminization; Refenstein Syndrome; Infertile Male Syndrome.
The incomplete forms of androgen insensitivity have 
similar clinical and endocrine profiles to the complete syndrome, 
but can be distinguished from it and each other by the variable 
degrees of virilization seen at birth and puberty (Griffin et al 
1984; hodgins 1983a; Madden et al 1975; Wilson et al 1963).
D. 5c(-Reductase Deficiency.
This condition (also refered to as incomplete male pseudo­
hermaphroditism type 2 and pseudovaginai perineoscrotal
35
hypospadias: Pinsky 197o; V/ilson et al 1983) was first descrioed 
by Walsh et al (1974) and Imperato-HcGinely ana co-workers 
(Petterson et al 1977). The mutation affected the normal 
differentiation of the urogenital sinus and male external 
genitalia, resulting in ambiguity of the external genitalia 
although the general appearance was female at birth; wolffian 
structures differentiated normally ana there were no Mullerian 
structures. At puberty there were varying degrees of virilization, 
which could lead to a male habitus and genderidentity(Hodgins 
1983a; Pinsky 1978; Wilson et al 1983).
The condition was inhereted as an autosomal recessive trait, 
and the primary defect was found to be in the conversion of 
testosterone to DHT (Griffin et al 1982; Hodgins 1983a; Lay, 
Pomberton U Hilton 1978; Moore, Griffin L 'Wilson 1975; Moore .1 
Wilson 1976; Peterson et al 1977; ’Walsh et al 1974; 'Wilson et al
1983). The activity of the enzyme involved, 5<*-rebuctase, has 
been studied in tissue biopsies (Hodgins 1983a) and in cultured 
GSF (Hodgins 1983a,b; Moore et al 1975; 'Wilson 1975). From such 
studies four classes of defect have been recognised: a reduction 
in the levels of the enzyme; decreased affinity for the substrate 
testosterone (Dallas/Dominican Rebublic); decreased affinity for 
the co-factor NADPH (Los Angeles); and finally a mutation affecting 
both testosterone and i’ADPH binding (Griffin et al 1982,1984; 
Wilson et al 1981).
E. Mutations of the Androgen Receptor.
Abnormal ities of receptor function have been identified
37
across the whole spectrum of phenotypes described, reflecci;u mhe 
heterogeneous nature of androgen insensitivity in ran (Amrhein et 
al 1975; Griffin et al 1984). The routine methods of 
investigating the stuctural and functional integrity of the 
androgen receptor protein have involved the measurement of whole 
cell and cell free binding of [^Hlsteroid. The use of cultured 
human GSF has proved to be a useful model for studying androgen 
action and the mutations of androgen insensitivity, as these 
cells maintained their differentiated characteristics in culture 
and express high affinity (Kd=0.2-1.6r.M) and low capacity (1250- 
18500 sites/cell) binding activity. The levels of binding 'were 
much lower in fibroblasts derived from non-genital skin biopsies, 
which made them unsuitable for binding studies (Brown 1 Bigeon 
1981; Griffin, Punyashiti 1 Wilson 1975; Griffin et al 1954; 
Hodgins 1983a; Hodgins et al 1984; Kaufman, Straisfeid G Pinswy 
1977).
Using C^H3androgen binding as a marker of receptor activity 
a number of defects have been identified and classified as 
quantitative, qualitative or receptor positive (Table 1.2). 
Quantitative defects have been further sub-divided into ’’absent", 
where the levels of binding are too low to be measured (Donti et 
al 1982; Evans, Jones & Hughes 1984; Griffin et al 1984; Keenan 
et al 1974; Sultan et al 1983), and "reduced" where receptor 
binding could be detected, but was significantly lower than 
control levels (Perieria et al 1984; Griffin et al 1984; Kaufman, 
Straisfeid u Pinsky 1976).
Qualitative defects have been associated with reduced and 
normal levels of receptor binding. Abnormalities in receptor
Table 1.2 Types of androgen receptor ir.utation recognised 
by steroid binding assays.
Type of Nutation Description references
QUANTITATIVE
QUALITATIVE
Steroid binding absent 1-5
Steroid binding reduced 1,6
Thermolabile binding 7-.°
Instability of complexes 10-14
Failure to activate* 15-18
Failure to "up-regulate" 12,15,20
RECEPTOR POSITIVE Apparently normal receptor 1,21-2?
References:
1. Griffin et al 1.9 84 13. Pinsky et al 1984
2. Donti et al 1982 14. Pinsky, Kaufman & Chadley 1985
3. Sultan et al 1983 15. Kaufman et al 1982a
4. Evans et al 1984 16. Eil 1983
5. Keenan et al 1974 17. Kovacs et al 1984
6. Periera et al 1984 IP. Kovacs et al 1983
7. Griffin 1979 19. Kaufman et al 1981
P. P.rcv7n et al 1982 20. Kaufman et al 1983
0 Coulam, Graham, & Spelsberg 1984 21. Collier, Griffin & Kilscn 1978
10! Griffin & Durrnt 1982 22. Gyorki et al 1983
11. Uilson et al 1974 23. Amrhein et al 1976
12. Jukier et al 1984
*: failure to generate PFA-binding form in vitro.
Summary of the findings of receptor binding studies on 
intact cells or isolated receptor complexes. All studies 
used cultured human OSF, except Evans et al (1584) and 
Coulam et al (1584) who used dispersed fibroblasts and 
gonadal tissue respectively.
structure were subsequently revealed by kinetic ana functional 
criteria, and nave included: thermolability of ligand oinding 
when the assay temperature was raised to 42 °C (Brown et al 1982; 
Coulam et al 1934; Griffin 1979); general instability of receptor 
complexes, manifested as an increased Kd (decreased affinity) 
and/or dissociation rate, and failure to form an "SS" peak on 
sucrose density gradients in the presence of molybdate (Griffin a 
Durrant 1982; Jukier et al 1984; Pinsky et al 1984, 1985; Wilson 
et al 1974); failure to activate to the DNA-binding form (Eil 
1983; Kaufman et al 1932a; Kovacs et al 1984); and finally 
failure to "up-regulate" basal receptor levels in response to 
steroid (Evans L Hughes 1985; Jukier et al 1984; Kaufman et al 
1981, 19o3,). A defect in one or more of the above parameters was 
taken as evidence for an underlying structural abnormality of the 
receptor molecule, as a result of a mutation at the X-linkec 
receptor locus.
r Recent studies by Kaufman and co-workers (Jukier et al 1984; 
Kaufman et al 1983, 1984; Pinsky et al 1984, 1985) investigating 
apparent binding affinity (Kd), dissociation rates of steroid- 
receptor complexes, and augmentation of receptor levels in 
response to steroid, deserve a special mention, since the 
receptor defect in different kindreds with partial androgen 
insensitivity was found to be apparently ligand specific. 
Abnormalities in all three of the above parameters of steroic 
binding were expressed with both DHT and the synthetic androgen 
methyltrienolone (R1881) (Kaufman et al 1984), or with DHT alone 
(Pinsky et al 1984, 1385). In one kindred only up-regulaticn with
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DHT was impaired (Kaufman et al 1983). Finally the receptor from 
one individual had an elevated Kd, failed to up-regulate basal 
levels, but had normal rates of dissociation for both DHT and 
R1881 (Jukier et al 1984). The defects expressed with DHT alone 
were apparently not due to excessive metabolism of this ligand by 
cultured GSF. These findings were interpreted in terms of the 
kinetic model of receptor activation aescirbed previously (Fig. 
1.3, Introduction 1.1D). The mutation(s) was believed to affect 
the time and steroid concentration dependent transformation of 
low affinity complexes to high affinity state(s), which was 
necessary for mediating the up-regulation of recptor binding and 
presumably for the in vivo responses to androgens.
Despite the obvious heterogeneity seen between receptor 
binding activity and phenotype abnormality, it can be generalises 
that unmeasurable binding was associated mainly with the complete 
testicular feminization phenotype, while reduced binding and 
qualitative defects were found in a spectrum of phenotypes 
ranging from female to male (Griffin et al 1984).
F. Receptor Positive Resistance.
Receptor positive resistance has been associated with all 
abnormal phenotypes, and was characterised oy apparently normal 
receptor binding activity (Griffin et al 1982, 1984; Hodgins 
1983a; Wilson et al 1983). The condition was first describes by 
Amrnein et al (1976) in certain patients with complete testicular 
feminization and apparently normal uptake and receptor binding of 
steroid. Collier et al (1978) described two unrelated patients 
witn androgen insensitivity but normal 50^-reductase activity,
whole cell DHT binding, and normal nuclear up-take.
Although in most cases the nature of the mutation was un­
known, it was assumed to occur at a post-receptor binding site 
(Griffin et al 1982; Hodgins 1983a). It is of interest therefore, 
that Funder and co-workers (Gyorki et al 1983) have described 
three cases of androgen insensitivity where the defect appeared 
to lie with the nuclear acceptor site. The three patients were 
described as "nuclear transfer deficient" on the basis of 
abnormal nuclear localization of complexes, despite normal whole 
cell receptor levels and normal intracellular distribution of 
glucocorticoid receptors in parallel experiments. The conclusion 
that the defect resided with the nucleus rather than with the 
receptor protein was based on the evidence of reconstitution 
experiments, where cytosol fractions (+labelled receptor) were 
mixed with "naive" nuclei, with only the combination of mutant 
cytosol/control nuclei giving a similar distribution to control 
combinations.
The exisitance of receptor positive mutations would oe high­
ly suggestive of the involvement of additional factors in 
androgen (steroid hormone) action; however the failure to detect 
abnormalities in receptor activity may simply reflect the 
limitation of steroid binding assays used.
G. Hormone Resistance to Other Classes of Steroid Hormone.
Defects in steroid receptor systems of other classes of 
steroid hormone have also been identified by ligand binding 
assays.
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Vitamin D^.
End-organ resistance to 1,25-dihydroxy vitamin D or vitamin 
D-dependent rickets is associated with hypocalcemia and secondary 
hypoparathyroidism, and more severly affected individuals also 
exhibit alopecia (Marx et al 1984). Since the classical target 
tissues for 1,25-dihydroxy vitamin D were inaccessible for in 
vitro studies, cultured skin fibroblasts were found to be a 
suitable model system for studing the action of 1,25-dinydroxy 
vitamin D in these patients (Eil 1 Marx 1981; Simpson 1 DeLuca 
1980). As with the mutations of the androgen receptor described 
above, four classes of defect associated with the 1,25-dihydroxy 
vitamin D-receptor have been described: receptor negative
(unmeasurable); receptor deficient; qualitative defects affecting 
the interaction of receptor complexes with the nucleus; and 
receptor positive (Castells et al 1936; Eil et al 1981; Hirst, 
Hocnman &. Feldman 1985; Liberman, Eil & Marx 1983; Liberman et 
al 1986; Marx et al 1984).
Interestingly, monoclonal antibodies raised against the 
chicken intestinal receptor have identified a 3.7S protein 
irrespective of the hormone binding status (Pike et al 1981). 
This is further evidence for the limitation of ligand binding 
studies in the identification of structural mutations of 
receptor molecules.
Glueocorticoids.
Resistance tc glucocorticoids was described initially in 
certain mouse lymphoma cell lines, which were found to become 
refractory to the lethal effects of glucocorticoids. The
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insensitivity phenotype was found to te associated with defects 
of tne glucocorticoid receptor: "receptoriess" (r“); "nuclear 
transfer deficient" (nt-); and "increased nuclear transfer" (nt1) 
(Bourgeois a Gasson 1985; Gehring U Tomwins 1974; Sioley a 
Tomkins 1974; Yamamoto, Stampfer u Tomkins 1974).
Steroid binding, immunoprecipitation, and cloning studies 
have shown that the wild-type and nt” phenotypes were associated 
with a 6kb transcript coding for the 94K receptor protein, while 
r“ and nt1 cells both contained reduced levels of this 6kb 
transcript thought to code for a non-functional 94K receptor 
protein. Inaddition the nt1 phenotype was associated with a 40K 
steroid binding protein believed to be coded by a specific 5kb 
transcript (Miesfeld et al 1984; Gehring  ^Tcmxins 1974; Sibley  ^
Tomwins 1974; Westphai et al 1984; Yamamoto et al 1974). 
Furthermore, recent work by Miesfeld and co-workers (Miesfeld et 
al 1986) demonstrated that sensitivity to glucocorticoids in r” 
cells could be restored by transfecting cDMA coding for the 
glucocorticoid receptor.
Primary cortisol resistance has recently been reported in 
Man (Chrousos et al 1983s; Lipsett et al 1985). The condition was 
characterised by elevated plasma cortisol levels and the absence 
of the stigmata of Cushing’s syndrome. Steroid binding studies in 
intact mononuclear leukocytes and cultured skin fibroblasts 
showed normal levels of glucocorticoid receptors with a reduced 
affinity for ligand, however in cytosol binding assays the levels 
of receptor were also reduced suggesting instability in ligand 
binding. Other parameters of receptor structure, such as thermal 
stability, neat activation, and molecular mass after affinity
labelling, all appeared nor:;.ai (Chrousos et al 19o3a,o; Lipsett 
et al 1985). In lymphocytes, from these same patients, 
transformed with Epstein-Earr virus the levels of induced 
receptor and affinity for steroid were both reduced compared to 
control cultures (Tomita et al 1986). In an other kindred, Iida 
et al (1985) reported a patient who had a 50-60* reduction in the 
levels of receptor in mononuclear cells, the affinity of the 
remaining binding sites was normal.
Progesterone.
In contrast to the above forms of hormone resistance, Keller 
et al (1979) reported a patient who presented with infertility 
apparently due to a localised resistance to progesterone. In 
vitro studies suggested that the underlying cause was a reduction 
in the number of progesterone receptors in the endometrium, the 
remaining sites had a similar affinity for steroid as controls.
H. Hormone Resistance in Hew World Primates.
New World Primates, such as Squirrel monkey and Common 
Marmoset, have relatively high levels of circulating steroid 
hormones compared to Old World Primates, such as Cynomologous, 
and Man; leading to the suggestion that the New World Primates 
have a generalised resistance to steroid hormones, and may 
therefore serve as a suitable model for studying steroid hormone 
insensitivity in Man (Lipsett et al 1985). Table 1.3 summarises 
the results of steroid binding and metabolism studies carried out 
on New World Primates compared to Old World species.
It has been suggested that the elevated levels of
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Table 1.3 Receptor defects associated with hormone 
resistance in Fev; Tor Id primates (comparison with Old 
Torld species).
Pcrmone Peceptor
Levels
Rinding
Affinity
Other Defects Referent
Aldosterone Reduced Similar 1
Androgens Reduced? Similar 50(rreductase 
activity reduced 2
Cortisol Similar Reduced 2
Oestradiol Reduced Similar 4
Prcgestins Reduced Similar 3,4,5
Vit ,D Reduced Similar Lev? DPA-binding* <S7
(*, Finding of receptor complexes to DFA.-cellu.lcse) 
references:
1. Chrousos et al 15P4b 5. FcCluskv et al lfP4
3. Lipsett et al 1PP5 6. Shinki et al 1PP?
3. Chrousos et al 15P2 7. Takahahi et al 1PP5
4 . Chrousos et al lPP4a
circulating steroid hormones in these species was an evolutionary 
adaptation to changes in receptor function and/or steroid 
metabolism.
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1.3 Aims
r*
The broad aims of this work were to explore new methods of 
investigating the molecular mechanisms of androgen insensitivity, 
in the cultured human GSF model.
Androgen insensitivity has been shown to be associated with 
abnormalities of the androgen receptor by [^Hjsteroid binding 
assays in GSF. There is, however a need to study the receptor 
protein independently of steroid binding. Therefore in the 
absence of specfic antibodies to the androgen receptor and of 
cDNA probes for the receptor gene, variants of the androgen 
receptor have been searched for by combining two-dimensional gel 
electrophoresis with a dual-labelling technique and partial 
purification of the receptor.
Following the electrophoretic studies it was decided to 
attempt to covalently link a marker to the receptor, thereby 
allowing direct analysis of the receptor molecule (via the 
steroid-binding domain) under denaturing conditions. Studies were 
therefore undertaken with the conjugated synthetic androgen 
Methyltrienolone (R1881), which was deemed a suitable ligand for 
photoaffinity labelling of the fibroblast receptor.
Finally, since some degree of purification was essential to 
both the above approaches, extraction and partial purification of 
"functional11 receptor complexes allowed further characterisation 
of the androgen receptor from control and androgen insensitive 
cell lines by sucrose density gradients and chromatographic 
techniques.
1.4 Introduction to I-Jethods Used
This section describes the rationale behinG the approaches 
taken during this project.
A. Double-label Autoradiography and Two-dimensional Gel 
Electrophoresis.
The use of the double-label autoradiography technique 
(Lecocq, Hepburn & Lamy 1982) allowed proteins metabolically 
labelled with either [3-*S]methionine or [^Se]selenomethionine to 
be mixed and resolved concomitantly by two-dimensional gel 
electrophoresis (2-DGE). This had the advantage that variations 
between gels and/or running conditions were avoided when 
comparing complex protein patterns from control and androgen 
insensitive fibroblast cultures.
Both sets of labelled protein were detected by fluorography 
(film exposed, -80°C) while only the [^Selselenometnionine 
labelled proteins were picked up by subsequent autoradiography 
(film exposed room temperature) of the same gel, the light and £- 
emmissions from -^S being screened out. The strategy adopted 
involved labelling control cells with [^^Sjmethionine and 
androgen insensitive cells with [^Sejselenomethionine; the 
optimum conditions for detecting possible mutant receptor 
proteins. A spot missing from the autoradiograph would suggest a 
lack of receptor synthesis, while a shifted spot due to a size 
and/or charge change would be indicative of a structurally 
abnormal receptor. This latter conclusion would have to be 
confirmed experimentally by reversing the labelling strategy
b?
outlined aoove. Furthermore, the technique is also suitable for 
studying the effects of hormonal manipulation on newly 
synthesised fibroblast proteins, and it should therefore be 
possible to identify androgen dependent or regulated proteins by 
comparing normal and androgen insensitive cultured GSF.
2-DGE was the ideal technique for the type of study 
undertaken, as it exploits differences in charge (first 
dimension) and size (second dimension) to give high resolution of 
complex protein mixtures (O’Farrell 1975; O'Farrell, Goodman U 
O’Farrell 1977). The types of protein mutation that can be 
discriminated by this procedure fall into three groups:
1. Ho protein synthesised.
2. Protein synthesised in abnormal amounts.
3. Structurally abnormal protein: 
a) charge shift, o) size shift.
As was discussed in Section 1.2C, [-^ Hjligand binding assays 
have highlighted abnormalities in receptor levels suggestive of 1 
and 2 above. Although qualitatively or structurally abnormal 
receptor forms have also been identified by ligand binding 
studies, there has been no direct evidence to show that the 
mutation resulted in a charge or size variant. However, by 
considering the genetic code it has been estimated that one third 
of all point mutations, the most frequent type of mutation, will 
result in a charge change (Harris 1983). Furthermore, analysis of 
normal and variant forms of the glucocorticoid receptor has shown 
the potential for changes in steroid receptor size.
Gustaffson and co-workers (V/range and Gustaffson 1976; 
Carlstedt-Duke et al 1982) using limited proteolysis showed thac 
the glucocorticoid receptor could be selectively cleaved intc
discrete domains (Fig.1.2a). It is therefore not difficult do 
imagine a mutation affecting an inter-domain region, rendering 
the receptor protein more susceptible to partial or complete 
proteolytic digestion, which in turn would give rise to an 
unstable and/or size variant of the normal protein.
Direct evidence for the existence of size variants of the 
glucocorticoid receptor came from studies on glucocorticcid- 
insensitivity clones of the mouse lymphoma cell line, S49.1 
(TB4.1A). These hormone resistant variants fall into one of three 
phenotypes: "receptorless" (r“); "nuclear transfer deficient" 
(nt“); or "increased nuclear transfer"(nt1)(Gehring & Tomkins 
1974; Sibley and Tomkins 1974; Westphal et al 1984; Yamamoto et 
al 1974). The latter mutation has been found to contain a 
hormone-binding species (40000-daltons), which does not react 
with monoclonal antibodies raised against wild-type receptor 
(94000-daltons); however a 94K protein can be pulled out using an 
immuno-competition assay (Weptphal et al 1984). This latter 
protein was believed to be a defective receptor protein, that was 
unable to bind hormone, common to the parent S49.1 wild-type 
cells which were known to be hemizygous for the glucocorticoid 
receptor (Westphal et al 1984). These findings were confirmed by 
the studies of Miesfeld et al (1984) and Northrop, Danielson and 
Ringola (1986). Characterization of the glucocorticoid receptor 
gene and mRNA in wild-type and mutant cells revealed that the 
receptor was encoded by a single-copy gene which specified a 6kb 
transcript in rat and mouse cells. Furthermore it was suggested 
that the 40K nt1 receptor was encoded for by a nt1-specific
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transcript, wnile reduces levels of the okb mR.t'A ceded for the 
non-functional 94K protein.
It was concluded from the above that both charge and size 
mutations of the androgen receptor were likely to exist, and that 
the combination of dual-labelling and 2-DGE had the potential to 
discriminate between normal and variant receptor polypeptides.
Finally, it is of interest that apparent differences in the 
whole cell 2-D protein patterns from control and androgen 
insensitive cells have already been observed. Funder and co­
workers (Risbridger et al 1982; Warne et al 1983) reported two 
proteins (45000- and 85000-daltons, p-I ~5) that were apparently 
more prominant in control cultures, a subsequent study using non- 
equiibrium pH gradient electorphoresis (NEPHGE) in the first 
dimension, revealed a third protein (41000-saltons, pi ~ 6) 
which was again more prominant in contol cells.
The second study was initially concerned with identifing 
mutant proteins in Duchenne Muscular Dystrophy (DMD) fibroblasts 
(Rosenmann et al 1982). However a 55K dalton protein thought to 
be absent from DMD cells was subsequently shown to be specific 
for biopsy site, and was found only in GSF (Thompson et al 1983). 
Furthermore this protein was apparently absent from fibroblast 
cultures derived from androgen insensitve patients (Wrongeman et 
al 1984). The relationship between this protein and the androgen 
receptor remain to be determined, it may be the receptor, a pool 
of pro-receptcr molecules, or a receptor mediated protein.
In conclusion, variants of the androgen receptor in androgen 
insensitive GSF have oeen searched for by combining 2-DGE with a 
dual-labelling technique, and partial purification of the
receptor. The latter was believed necessary because of the low 
abundance of the androgen receptors in GSF. By assuming a 
relative molecular weight of 100000-daltons and a basal level of 
50fmoles/mg cell protein (34.0+10.1 fmcles/rag protein (mean+SD, 
n=15; Hodgins et al 1984) it was esitmated that the receptor 
would represent only 0.0005/> of the total cell protein at best.
B. Photoaffinity-labelling of the Fibroblast Androgen Receptor.
Photoaffinity labelling of steroid receptors has been 
successsfully achieved for the avian progesterone receptor (Dure, 
Schrader & O'Malley 1980; Horwitz L Alexander 1983), the 
glucocorticoid receptor (Kordeen et al 1931), and the androgen 
receptor (Brinkmann et al 1985b, 1986). In the absence of poiy- 
or monoclonal-antisera to the receptor, the covalent linking of a 
radiolabelled ligand to the receptor "would be of consideraole 
advantage, allowing analysis of the receptor protein under 
denaturing conditions.
Although the use of the synthetic steroid methyltrienolone 
(R1881) as a photoactive ligand has been questioned, because of 
the inefficiency of the reaction (Mainwaring and Randall 1984) 
and the tendency of the ligand to self-polymerise on U.V.- 
irradiation (Williams et al 1986), Brinkmann and associates have 
been successful in covalently labelling the androgen recepccr 
from a number of sources, including rat prostate (46K-daltons), a 
human prostatic carcinoma cell line (50K-daltons), and calf 
uterus (95K-daltons)(Brinkmann et al 1985b, 1986). The success 
of these studies can be attributed tc partial purification of she
androgen receptor ana to adequate control of non-receptor binding 
of [^H]R1881 before attempting the irradiation and SDS-PAGB 
analysis.
The two strategies adopted in attempting to photoaffinity 
label the androgen receptor from human GSF were: U.Y.-
irradiation of [^H]R1881-receptor complexes after partial 
purification, or _in situ U.V.-irradiation of receptor complexes 
followed by extraction and partial purification. Subsequent 
analysis involved either SDS-PAGE or High Performance Liquid 
Chromatography (HPLC)-gel filtration.
The main disadvatage of the photoaffinity labelling 
procedure was thought to be the inefficiency of the photo-linking 
reaction. Brinkmann et al (1985b) estimated an efficiency of 
about 0.25, while Horwitz and Alexander (1983) reported an 
efficiency of 155 for the in situ photo-labelling of the nuclear 
progesterone receptor; a ten-fold increase over tne earlier study 
by O’Mally and co-workers (Dure et al 1980). It was essential 
therefore, that sufficient starting material was used and that 
some degree of purification was included in the protocol. 
Therefore, confluent cultures were incubated with [^Hlsteroid for 
24 hours prior to irradiation to stimulate the levels of androgen 
receptor (See Section 1 .IF: Kaufman et al 1981; Ring and Hodgins 
1984 A unpublished observations; Syms et al 19c5), and receptor 
complexespartially purified by ammonium sulphate precipitation 
and/or anion exchange chromatography.
C. Miscellaneous,
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Fast Protein Liquid Chromatography (FPLC) anion exchange on 
Mono Q column and 2,5,-ADP-Sepharose chromatography were used as 
possible purification steps. The latter was also used to compare 
receptors from a control and androgen insensitive cell line.
HPLC-size exclusion chromatography and sucrose density 
gradient analysis were used to determine some physical paramaters 
for the fibroblast androgen receptor; and as a possible means of 
detecting subtle differences between normal and variant forms of 
the receptor.
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METHODS
&
MATERIALS
2.1 Chemicals.
All chemicals used were of AR or BIOCHEMICAL grace, except: 
for acryiamide, agarose, HU'-methylenebisacrylatnide (ELECTRAU), 
and urea (ARISTAR), and supplied by SDH chemicals unless other­
wise stated; a full list of names and addresses of suppliers is 
given in Appenaex 5.1.
2.2 Cell Culture.
Fibroblast cultures derived from genital skin biopsies 
(Hodgins 1382), were routinely grown as monolayers in bottles, 
flasws or petri dishes, in Eagles Minium Essential medium 
(Glasgow modified; MEM) supplemented with 103 newcorn calf serum 
and penicillin (10Gunits/ml) and streptomycin (0.1 mg/ml): EC1C 
medium. Cells were wept at 37 C in a humidified, 5% 
environment.
When cultures reached confluence, a solution of 
trypsin(C.253):EDTA (0.2g/l) (1:5, by volume) was used to detach 
cells from culture flasks. The action of the trypsin -was 
subsequently stopped by the addition of EC10 medium, and the 
cells seeded in clean, sterile, culture dishes as required.
Medium, serum, antibiotics and other reagents were obtained 
from GI3C0; through the Biochemistry Department of Glasgow 
University. Plastic culture flasks (80c:n^ ), petri dishes (6C...m, 
100mm, 140mm a lame ter) and 24 well plates were supplied by HU EC 
(Inter Med), Falcon (Div. Becton Dickinson and Co.) and COSTAR.
2.3 Whole Cell Binding Studies.
A. Receptor concentration (Braax) and Equilibrium dissociation 
constant (Kd) (Hodgins 1982; Hodgins et al 1984).
Whole cell binding studies wereunder taken as previously 
described. Briefly, 2x 1CP cells were seeded in 60nw., plastic 
dishes and grown to confluence. Cultures were then placed in MEM 
+ \% newborn calf serum (EC1) for 24 hours prior to incubation 
for 30 minutes at 37°C with 5ml of serurn-free medium containing 
[^Hl-DHT or -mibolerone at concentrations ranging from 0.05 to 
3.20nM (Total binding, B~). A parallel set of cultures contained 
[^H]steroic with an excess of unlabelled ligand, to give the 
level of non-specific binding (B»j). The cell monolayers were 
subsequently washed extensively with Dulbecco’s phosphate 
buffered saline (PBS), harvested, centrifuged down and extracted 
with chloroformrmethanol (1:1, by volume). Extracts were then 
assayed for cell bound radioactivity (supernatant) and for 
protein (pellet). From linear plots of specificly bpund
r  ^  T[-'Hjsteroid (B^B^-S.t) versus free radioactvity (Scatchard 
1949), the concentration of receptors (Bmax) and the equilibrium 
dissociation constant (Kd) were determined.
B. Rate of dissociation of androgen-receptor complexes (Hodgins 
1982).
Dishes of cells were prepared and incubated at 37°C for 30 
minutes with MEM containing 1n!I [-^ HJ-DHT or -Mibolerone ±  1000- 
fold excess of cold ligand. The medium was then removed and 
replaced with MEM containing 1000nM-unlabelled steroid, and the 
incubation continued at 37°C; dishes were removed (in triplicate)
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at different times for detorm ina t ion oei-ular sound 
radioactivity. Bc was calculated os above. 3y clotting the 
logarithm of the ratio of E<- (time t)/Bg (time G) against time, 
it was possible to calculate the half-life of steroid-receptor 
dissociation.
C. Augmentation of androgen receptor binding (Kaufman et al 1981; 
Ring a Hodgins 1983; Rowney & Hodgins 1985).
Dishes of cells were grown to confluence in EC10 medium and 
incubated at 37°C for 24 hours with EC1 medium containing 3nM 
[^H]-DHT or -mibolerone + an excess of unlabelled ligand. 
Cellular bound radioactivity was measured as described above, and 
Bg was calculated by subtracting Bj.t from 3-p. The basal level of 
receptor binding was measured in parallel cultures incubated with 
3nit [^n]steroid + unlabelled ligand for 30 minutes, with no 
previous exposure to androgens.
2.4 Receptor Preparation.
All preparative procedures were carried out at 0-4 C, unless 
otherwise stated. Extraction and partial purification of androgen 
receptor complexes was followed by labelling in situ with a 
[^Hjsteroid: 5CC-dihydro[ 1,2,4,5,6,7 , ]  testosterone (100- 
150Ci/mmol; Amersham) (DHT) or the synthetic androgens 
% ] -dimethy 1-19-nortestosterone (70-85Ci /mmol; Amersham) 
(Mibolerone) or [ H^] 17^-hydroxy-176(-methylestra-4,9,11-triene-3- 
one (86Ci/m:nol; Du Pont)(Methyltrienolone or R1 8£ 1). Confluent 
cultures were placed in EC1 medium for 24 hours, oefore being 
incubated with 1nM [^Hjsteroid, for 30 to 40 minutes at 37°C. 
Cultures w ere t ne n placed on ice and the cell monolayers washed
—  roo
twice with PBS to remove free steroid. The cell a were then 
scraped off in PBS and collected by centrifugation at 3>C (Oxg for 
10 minutes (Px50r.il fixed angle rotor, Hi-spin 21; MSE).
The pelleted ceils were then disrupted by sonication 
(Ultrasonic Processor V/-375) in PEM ouffer [ 1 0 m 1:.;' 
EDTA, 12mM-nionothioglycerol], pH7.4, containing 500mM-KCi. During 
sonication samples were placed in a Cup-Horn (4313) ana wept on 
ice and subjected to 3x10-30 second bursts (at 50 cycles/full 
power) with 30 seconds cooling periods. Alternatively ceils were 
broken up by 20 stokes with a hand-homogeniser (2mi Tissue 
grinder Oounce/Pestle) and osmotic shock (PEM buffer), and the 
salt concentration adjusted to 500mM-KCl. All buffers contained 
the protease inhibitors phenyl methyl sulphonyl fluoride (0.1 nk; 
PMSF) and leupeptin (5uM). From the study of Kovacset al 09:4) 
leupeptin seems to be particularly good for androgen receptor 
recovery. Nuclear bound receptors were extracted using high salt 
(500mM-KCl), and the 105000xg (1 hour:Type 65 rotor; Beckman LB- 
55 ultracentrifuge) salt extract prepared. In a preliminary 
experiment this extract was fractionated with solid ammonium 
sulphate as follows: 0-152, 15-305 and 30-452 saturation (0*0). 
In all subsequent protocols this salt extract was brought to 355 
saturation with 0.194g (NHjj^SO^ per ml (Data for Biochemical 
Research), and left for 30 minutes on ice. The precipitated 
proteins were collected by centrifugation (50000xg for 1C-15min.) 
and resuspended in the appropriate buffer.
Radioactivity remaining in the 105000xg cell pellet was 
investigated further for specfic binding that coulc be resistant
-C salt, extraction (Clan; u  Pea,: 1 975; Davies 1983; sc el
1973). The pellet v / as resuspended in PEM buffer (+500mH-:(CI) and 
re-sonicated as before, anc centrifuged at 105000xg for 1 .'.cur. 
This second pellet was resuspendec in PEM buffer anc extracted 
with 0.55(v/v) Triton X-100 for 5-10 minutes, and the 105G00xg 
supernatant prepared. These steps were repeated with DiiAase I 
(50ug/tr.l) and trypsin (3rng/ml) digestions of successively 
pelleted material. The supernatant fractions were assayed for 
total and bound radioactivity recovered.
To give a quantitative estimate of non-specific binding the
1 A ^androgen precursor [ ' C]dehydroepiandrosterone (5^01/mmol;
Amersham)(DHA) was added to the cell extract during sonication or
homogenisation, to a final concentration of between 25-1OOnM. The
rationale for using DHA as a means of showing the level of non-
specfic binding was based on the following assumptions: 50WHT
and DHA, because of similarities in structure and polarity (i.e.
very similar elution characteristics on paper and thin layer
r
partition chromatography (Hodgins 1971)), would show a similar 
degree of non-spcific binding; non-specfic binding would be a 
linear function of steroid concentration, therefore the fraction 
of DHA bound would be equivalent to the fraction of DHT non- 
specificly bound; and finally, DHA would lack competition for the 
androgen receptor (Shain a. Boesel 1975). If the latter did not 
hold then the degree of non-specific binding would be over 
estimated. However, by following the proportions of -H and 1l+C 
during the suocellular fractionation i z  was possible to determine 
the degree of specific binding in the 355 ammonium sulphate 
orecisitate.
2.5 Sucrose Density Gradient Analysis.
Sucrose gradients were layered oy hand from the bottom of 
the tuoe, starting with the lowest density of sucrose (5, 10, 15, 
202); the final gradient (4x1.6ml) approximately half-filled the 
centrifuge tube (Ultra-clear, 14x95mm; 3eckman). The gradients 
were allowed to stand at room temperature for 2-3 hours to 
equilibrate, and then cooled (0-4 °C). Just prior to sample load­
ing the remainder of the tube was filled, carefully, with 5nl of 
PEM buffer (+500mM-KCl), lightly coloured with bromophencl blue 
to show the gradient/buffer interface. The sample (0.2-0.5ml) 
containing 0.5mg of a fluorescein isothiocyanate conjugates sheep 
antihuman IgG (Scottish Antibody Production Unit) (FITC-I;G) as 
an internal nar.-cer and 2-32(w/v) sucrose was loaded at the inter­
face between she gradient and the buffer overlay solution using a 
syringe 'with a piece of teflon tubing attached to the neecle. A 
second gradient containing the marker proteins FITC-IgG (5-7S) 
and either oovine serum albumin (BSAX4.6S) or ovalbumin (3.6S) 
was prepared in the same way. Gradients were routinely 
centrifuged at 30000rev/min (SV/40 Ti rotor; Beckman) for 1c to 20 
hours (4°C), and subsequently fractionated from the bottom 
(Beckman fraction recovery system); eight drop fractions were 
assayed directly for radioactivity or for protein markers.
The formation of a linear gradient at room temperature was 
confirmed by using the dye bromophenol blue. Proportionate 
amounts of the dye were added to the sucrose stock solutions 
prior to layering the gradient. The gradient was left for two
hours at room temperature ana fractionated as above. Tne amount 
of dye in each fraction was measured at O^6Q0nn ana relat,e:: 
the % of sucrose from standard readings (Appendix5.2).
2.6 2T5‘-ADP-Sepharose Chromatography.
Proteins precipitated by 3 5 % ammonium sulphate -were 
resuspended in 2ml of PEM buffer containing 10mM-KCl (low ionic 
strength buffer). 0.375g of 2,5,-ADP-sepnarose MB (Pharmacia fine 
chemicals) was reconstituted with the same buffer to give a 1.5ml 
slurry (1g reconstituted approximately 4 ml gel; about 2 mol 2’5‘- 
ADP/ml:Pharmacia). The resuspended ammonium sulphate fraction anc 
the gel slurry were mixed and dialysed against PEM (+10mM KC1) 
buffer for 3 to 4 hours at 4°C, and then packed into a 1ml glass 
syringe column. The column was washed with about five column 
volumes of low ionic strength buffer before the receptor was 
eluted with a stepped salt gradient (0.1, 0.2, 0.3, 0.4, 0.5, ana 
1.0M-KC1). Either 1.0 or 2.0ml fractions were collected and 200ul
r•
and 50ul samples were removed for liquid scintillation counting 
and protein determination respectively.
The following modifications were introduced in later 
experiments: 400ug of BSA was added to the collected fractions to 
stabilise binding activity, and peak fractions were incubated 
with 0.1nM (^H]DHT for 3 hours at 4°C ana bound steroid assayed 
by the dextran coated charcoal (DCC; Methods 2.12) method.
2.7 FPLC-Ion Exchange Chromatography.
2x10^ cells (P.M & SU) were seeded in 140mm plastic dishes (4 
or 6 per experiment), grown to confluence, and incubated at 37 °C
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with EC1 meoium containing 2nM [^H]mibolerone, in order to 
stimulate the levels of androgen receptor binding (Introduction
1.1F, Methods 2.30.
The soluble salt extract and ammonium sulphate fractions 
were then prepared as described above, and chromatographed on a 
Mono 0 (Pharmacia) anion exchange column, using the Pharmacia 
FPLC system. The pH of all buffers used was 7.7. The 105000xg 
salt extract was de-salted using centricon-10 microconcentrators 
(Amicon) and dilution, prior to FPLC. 1ml of extract together 
with 0.5ml of PEM buffer were mixed in the microconcentrator 
unit, and centrifuged at 5000xg for 30-60 minutes (8x50 Hi-spin 
21); a volume of 0.5ml of sample was recovered, which was further 
diluted 1:2 with PEM buffer to give a final volume of 1.5ml. The 
ammonium sulphate precipitate was gently washed with PEM buffer 
and resuspended in 1.0 to 1.5ml of the same buffer, and 
chromatographed with or without prior de-salting. Samples were 
loaded on to the column via a 500ul sample loop and a manually 
operated valve. Initially 1005 Buffer A (PEM) was pumped through 
the column (0-10min.), followed by increasing amounts of Buffer B 
(PEM +0.35!' or 1.00M-KC1) to produce a linear salt gradient. 1005 
Buffer 3 was then maintained for five minutes , before returning 
to 100% Buffer A. FPLC was carried out at room temperature, at 
a flow rate of 1 ml/minute, and 1ml fractions were collected and 
placed immediately on ice. Fractions were assayed for 
radioactivity, protein, and the linearity of the salt gradient 
was checked by measuring the conductivity of each fraction 
compared to solutions of known KC1 concentration.
61
2.8 HPLC-Size Exclusion Chromatography.
High Performance Liquid Chromatography (HPLC) gel filtration 
separation of the androgen receptor from control and androgen 
insensitive GSF was carried out on the LKB HPLC-system, using a 
TSKG3000 SW (7.5x300mm) column, preceeded by TSKP SW (7.5x7.5mm) 
precolumn.
Cells (4x140mm dishes) were incubated for 24 hours in EC1 
medium with either 2nM [^H]mibolerone or [^H]R1881. The ammonium 
sulphate fraction was prepared as above and resuspended in PEM 
buffer containing 500mM-KCl and 10%(v/v) glycerol (pH7.4). The 
sample was then centrifuged at 105000xg for 10 to 15 minutes to 
remove insoluble material before HPLC analysis. The samples were 
loaded on to the coiumn(s) via a 200ul sample loop and a manually 
operated valve, and the receptor complexes eluted with PEM buffer 
(+500mM-KCl, 10% glycerol), at a maxium flow rate of
0.5ml/minute. The separation was carried out a£ room temperature 
and took between 30 and 60 minutes, and 0.5 and/or 1.0ml 
fractions were collected and assayed directly for radioactivity. 
Protein elution profiles were obtained by continuous monitoring 
of the eluate at 280nm (2151 variable wavelength monitor;LKB).
The elution of free steroid was determined in a separate 
experiment, by injecting 10000-15000d.p.m. of [^Hlmibolerone, in 
PEM buffer (+500mM-KCl, 10% glycerol): 0.5ml fractions were 
collected and assayed for radioactivity.
Calibration of the G3000 SW (7.5x300mm) column.
The column v^ as calibrated by resolving mixtures of standard
62
proteins of wncwn molecular weight ana Stokes radius (Sr,Rs): 
Alcohol dehydrogenase (15CK, 4.55nm), BSA (66K, 3.55nm), 
Ovalbumin (45K,2.9nm), Carbonic anhydrase (29K), Trypsin 
inhibitor (20.1K), and Cytochrome c (12.4K, 1.7nm). From these 
data, physical paramaters of the human GSF androgen receptor 
were calculated. The void volumn (Vo) and the total volumn (Vt) 
were measured using Blue dextran (2x10^) and Phenol red (or 
C^Hlleucine) respectively.
All suffers and protein standards were passed through 0.2 
micron membrane filters (Whatman) before chromatography, and all 
buffers were degassed under vacuum before use.
2.9 Photoaffinity Labelling Studies.
A. Rat Prostate Cytosol Androgen Receptor.
The procedure followed was a modification of the method of 
Brinkmann et al (1985b). All procedures were carried out at 0-4 
°C, unless otherwise stated. The prostates from six rats, 
castrated 24 hours earlier, were dissected out, washed, and 
homogenised in 4ml of TEGl'i buffer [40mM-Tris-HCl, ImM-EDTA, 
10>b(v/v) glycerol, 20mM-sodium molybdate; pH7.7l, containing 0.1% 
monothioglycerol and 0.6mK PMSF: 3 x 10 second burst with a 
U1tra-turrax, with 30 second cooling intervals. After 
centrifugation at 105000xg for 1 hour (SW 60 rotor; Beckman), 3ml 
of cytosol were recovered, 1mi was incubated with 15nM [^H]R1881 
for 2 hours at 4 °C, while the remaining fraction was stored at - 
80 °C until required.
The labelled cytosol was then centrifuged in a Beckman 
Airfuge (at maximum 30 psi) for 15 minutes, prior to loading on
£O 3
to a Mono Q anion exchange column via a 500ul sample loop and a 
manually operated valve. The column was washed with at least 10ml 
of TEGM buffer before elution of the receptor with a linear salt 
gradient (O-350mM-NaCl). Forty 1ml fractions were collected and 
100ul removed from each for liquid scintillation counting.
The peak fractions, once identified, were pooled and 
irradiated using an Osram HBO 100 W/W-2 high pressure mercury 
lamp (Oriel Scintific Ltd.) for 10 minutes. The sample was placed 
on ice approximately 5cm from UV source, with a saturated 
solution of copper sulphate placed in between to filter out 
wavelengths below 300nrn. The photolinked receptor complexes were 
subsequently precipitated overnight with trichloroacetic acid 
(10 % w /v).
The remainder of the prostate cytosol was thawed and treated 
in the same way as above; the trichloroacetic acid precipitates 
were then pooled. The trichloroacetic acid insoluble material was 
washed with 10% trichloroacetic and extracted with ethylacetate, 
70% ethanol and finally diethlyether. The precipitate was then 
dried and redissolved in 200ul of SDS-sample buffer (Methods 
2.11B) at room temperature, and analysed on a 8% polyacrylamide 
gel by the method of Laemmlli (1970) (See Methods 2.11B for 
details). The sample was then loaded in a 2cm well, with 20ul 
mixture of high molecular weight standards (30000-200000 daltons; 
Sigma) in an adjacent well; the gel was run (in Bio-rad PROTEAN I 
electrophoresis tank) at 20mA/gel constant current after stacking 
at 10mA/gel.
On completion of electrophoresis the region of the gel
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containing the molecular weight maker proteins was fixed and 
stained (0.0255 commassie blue), while the track containing the 
sample was sliced into 2mm pieces which were incubated with 1ml 
of the following solution; diaminoheptaneffriton X-100:distilled 
water (1:1:10 by volume: Dr A.O.BrinKsann personal
communication), in order to swell the gel and elute the protein. 
After an overnight incubation with this solution, at room 
temperature, 10ml of Pico-fluor (Packard Instument Company Inc.) 
scintillation cocktail was added and the samples counted for 30 
minutes each.
B.Calf Uterus Androgen Receptor.
The method used to photoaffinity label the calf uterus 
androgen receptor was essentially identical to the one described 
by Brinkinann et al 0985b). Calf uterus tissue was stored at -80°C 
until required: 15g of tissue was thawed in 60ml of TEG buffer 
[40mM-Tris-Cl, 1mM-EDTA, 105(w/v) glycerol; pH7.4], containing 
10mM-sodium molybdate and 0.1mM-dipyridyldisulphide. Tissue was
f'
homogenised using an Ultra-turrax homogeniser: 3x10 second burst 
at maxium setting, with 30 second cooling peroids. After 
centrifugation at 10000xg (HB-4 rotor; Sorvall) for 10 minutes
to remove cell debris and lipid material, the 105000xg (SW40 
rotor, 1 hour;Beckman) cytosol fraction was prepared. The volume 
of the recovered cytosol was adjusted to 15ml and incubated with 
7.5uM triamcinolone acetonide (SigmaXTA) for 30 minutes at 4 °C 
to block progesterone receptor binding sites (Asselir. et al 1979; 
Wilbert, Griffin & Wilson 1983), followed by a 2 to 3 hour 
incubation with 10 to 15nM [^H]R1881 + 3• 0uId cold DHT. The 
labelled cytosol was then brought to 405 saturation with ammonium
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sulphate (left for 30 minutes), and the precipitated proteins 
collected OOOOOxg for 10 minutes) and stored at -80 °C.
The precipitate was later thawed, washed with TEGD buffer 
[TEG + 10mM-dithiothretol; pITMl and solubilised in 6ml of the 
same buffer containg 7.5uM TA, and [^H]R1881 + 3.0uK 3HT. The 
redissolved precipitate was then mixed with a slurry of DHA- 
cellulose [The Dk’A-cellulose had already been prepared by the 
method of Alberts 6c Herrick (1971), using calf thymus 
DKA(Sigma)](about 500fmoles of receptor per g DNA-cellulose) and 
the volume adjusted to 120ml with TEGD buffer. The mixture was 
left for 2 hours (^°C) with gentle mixing (Roto-rack) before 
being packed into a column (with a bed volume of 10-15ml), and 
washed with 50 to 100ml of TEGD buffer until the run through 
fraction contained less than 500c.p.m./ml. The androgen receptor 
was then eluted from the column with TEGD buffer containing 15mM 
MgCl2. Thirty 1ml fractions were collected and 50ul was removed 
from each fraction for liquid scintillation counting.
The peak fractions from the “HOT" sample and the equivalent 
fractions from the "HOT+COLD" incubation were pooled separately 
and irradiated as described for the rat prostate receptor. The 
trichloroacetic acid insoluble material from the two incubations 
were treated as described above, and analysed on a 85 poly- 
acralyamice gel as above.
C. Human GSF Androgen Receptor.
Three methods were followed during photoaffinity labelling 
studies of the human fibroblast receptor (Fig.2.1).
In protocols I and Ila control cells were incubated with EC1
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Fig.2.1 Photoaffinity labelling of the human GSF androgen 
receptor.
medium containing 2nM [-M-i] mibolerone for 24 hours, prior p c  
receptor extraction and partial purification. Mibolerone was the 
ligand of choice during the early stages of protocol I because 
the FPLC-anion exhange chromatograpny was at room temperature 
(Methods 2.7), and ’whole cell binding studies had shown shat 
mibolerone-receptor complexes dissociated more slowly than DHT- 
recptor complexes (t-j/ 2  ^  an° 2h respectively at 37 *C: Dr
M.B.Hodgins personal communication), and the latter are known to 
dissociate more slowly than R1881-receptor complexes (Brown, 
Rothwell & Migeon 1981; Pinsky et al 1985; Traish, Muller <1 
Wotiz 1984). It was therefore necessary to exchange the bound 
mibolerone for [^H]R1831 before attempting the U.V.-irrabiation: 
the pooled peak fractions from the Mono Q column (I) or the 
ammonium sulphate fraction (Ila) were incubated with 5 to 15nM 
[^H]R1881 + 100-fold excess of cold steroid for at least 21 hours 
(4°C). In protocols lib and III cells were incubated for 24 
hours with 2nM PHJR1881 and no exchange assay was required
r>
before U.V.-irradiation of R1881-androgen recptor complexes.
In protocols I and II, samples (either peak fractions from 
ion-exhange column or ammonium sulphate precipitates) were 
treated with DCC (Methods 2.13) prior to irradiation, to remove 
free steroid and reduce the opportunity for non-specific covalent 
binding. Samples, were kept on ice, and irradiated with 110',/ high 
pressure mercury lamp (Hanovia Slou; Kindly supplied by Dr hill, 
Department of Organic Chemistry, University of Glasgow) for 10 to 
15 minutes. The samples were approximately 5cm from one U.V. 
source and a saturated solution of copper sulphate was placed in 
between. In addition the lamp was enclosed in a quartz cooling
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jacket (running tap Jater was used as coolant during 
irradiation). After irradiation proteins were precipitated with 
trichloroacetic acid (5-10Xw/v) overnight (4 C), and treated as 
described above. The resolubilised samples were then analysed on 
8% polyacrylamide gels.
The third method investigated was based on the irj situ 
irradiation procedure described by Horwitz and Alexander (1983), 
for photoaffinity labelling of the avian progesterone receptor. 
After incubating cells with 2C1 containing 2nM [%]R1881 for 24 
hours, the culture medium was removed and the cell monolayer 
washed 2 to 3 times with PBS (0°C). The culture dishes were then 
inverted on a U.V. transilluminator (TM36 series max.302nm; U.V. 
Products Inc.) for 2 minutes (room temperature) and then replaced 
on ice. The cells were then scraped off the dish into PBS (0 C), 
and the (0-35?) ammonium sulphate fraction prepared. In some 
experiments, laoel remaining in the 105000xg pellet after salt 
extraction was investigated (Fig.2.1). The pellet was resuspended 
in PEM buffer using a small Dounce hand homogeniser, and 
extracted with 1?(v/v) Triton X-100 for 30 minutes, followed by 
centrifugation at 105Q00xg. The resulting pellet was then 
digested with DNAase I (25ug/ml) for 60 minutes (on ice), and 
centrifuged at 1C5000xg. The Triton extract was treated with 
trichloroacetic acid prior to further analysis. All subcellular 
fractions to be analysed further were resolubilised in either PEM 
buffer (+500mK KC1, 10? glycerol) or SDS-sample buffer for HPLC- 
size exclusion chromatography or SDS-PAGE respectively.
2.10 Metabolic Ladelling of GSF Proteins.
Control and androgen insensitive cells were seeded at a 
density of 1x10  ^to 2x10  ^cells, in either 60mm or 100mm diameter 
plastic petri dishes and grown to confluence. The cultures were 
then incubated with either [^S]met’nionine (>1000Ci/mmol; 
Amersham) or [^^Se3selenomethionine (30-50Ci/mmol; Amersham) for 
between 8 and 12 hours: isotopes were usually added to a final 
concentration of 50uCi/ml.
Incubation Medium:
MEM (w/o methionine and glutamine)..8.70ml
New born calf serum........ ..... 1.00ml
E C 1 0 medium..................... 0.10ml
Glutamine(x100)..................... 0.10ml
Penicillin and Streptomycin(xlOO)...0.10ml
Total=10.00ml
Tim e-course of isotope incorporation.
Cells were seeded in 24 well plates (22000 cells/well) and 
grown on coverslips; the latter were cleaned with sodium 
hydrochlorite ("CHLOROS", industrial grade) and 100* ethanol and 
sterilised before use. This procedure offered a fast and simple 
method for measuring the incorporation of labelled methionine or 
selenomethionine into total newly synthesised fibroblast protein. 
Cells were collected and washed with PBS (0 ° C:2x250ml), 
precipitated with 5*(w/v) trichloroacetic acid (0°C:2x250ml), and 
extracted with 95*(v/v) ethanol (room temperature:2x250ml). The 
trichloroacetic acid insoluble material w a s mixed with hyamine 
hydroxide (0.5ml/vial; Packard) prior to liquid scintillation 
counting.
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During toe tir.:e coarse study, cells were indicated with the 
above medium containing 10uCi of either [^^Slmethionine or 
[^JSe]selenomethionine. Cells were harvested, in duplicate, after 
4, 8, 12, 16, and 24 hours, 2nd treated as described above.
The effect of cold methionine concentration on isotope 
incorporation.
The effect of cold methionine on the incorporation of 
labelled methionine into total cell protein was investigated in 
the same way as the above time-course. Cells were grown on cover- 
slips and incubated for 10 hours with 10uCi of [3^S]methionine or 
[^-*Se]seleno:nethi onine in methionine-free medium containing: 
0.744 (10Sserum + 12ZC10), 0.260 (Userum + 12EC10), 0.207
(13EC10), or C.0. pmoles of cold methionine respectively. Cells 
■were incubates for 10 hours at 37 C, and subsequently collected 
and treated as in the time-course study.
2.11 Two-dimensional Gel Electrophoresis and Double-label 
Autorad iography.
Proteins from control and androgen insensitive GSF were 
metabolically labelled with [^^S]methionine and [^DSe]seleno­
methionine respectively, as described in Methods-2.10: cell mono­
layers were then washed 2-3 times with PBS (0*C), scraped off the 
dishes and collected by centrifugation (Methods 2.4). Carrier 
cells or protein was then added during sonication to ensure that 
there was sufficient protein in the 105000xg salt extract for 
ammonium sulphate precipitation. Ammonium sulphate, receptor 
enriched fractions 'were then mixed and resolved by 2-DGE.
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Proteins from control (->-'S) ana androgen insensitive (^ 3e) cells 
were then distinguished by fluorography and ^^Se) a n d
subsequent autoradiography (^Se) (Lecocq et al 1982)(Fig.2 .2).
Ammonium sulphate precipitated proteins were resuspended in
PEM buffer (and mixed with an equal volume of lysis buffer) or
directly into lysis buffer [O'Farrell 1975; 9.5M-urea, 25(w/v)
HP-40, 2% Arnpholines (1.65 pH5-7 + 0.45 pH3.5-10; LKB), 55 j3 -
mercaptoehanol: stored at -20°C until required].
A.
First Dimension: Isoelectric Focusing.
IEF rod gels were cast in glass tubes (180 x2-3mm internal 
diameter) sealed at the base with parafilm; 125mm long gels were 
routinely prepared. Table 2.1 describes the composition of the 
gel mixture used. The solution was loaded into the gel tubes 
using a 146mm long steel syringe needle (0.5-1.0mm internal 
diameter), and overiayed with "Gel overlay solution" [O'Farrell 
1975; 8M-urea: stored at -20°C], ana left to polymerise for 1 to 
2 hours; the overlay solution was then replaced with 20ul of
r>
lysis buffer and a similar volume of distilled water. The gels 
were left for at least two more hours before the base was 
unsealed and the rod gels placed in a standard tube gel 
electrophoresis apparatus (Shandon Tube-gel Electrophoresis 
Tank). 20ul of fresh Lysis buffer was added to the top of the 
gels, and the top buffer reservoir (cathode) filled with 0.02M- 
NaOH (degassed under vacuum) and the lower compartment (anode) 
with O.OIM-H3PO4. The gels were pre-run at: 200 volts for 15 
minutes, then 300 volts for 30 minutes, and finally 400 volts for 
a further 30 minutes. Lysis buffer and NaOH were then removed and 
samples loaded. The samples were overiayed with 10ul of "Sample
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Figure 2.2 Double-label autoradiography 
proteins. 1-2x10 cells were seeded in i
md 2-DGE of fibroblast 
i uut:jlijs. i iu u n i c ccucu x 60mm or 100mm plastic 
dishes, _and grown to confluence in EC10 medium. Cells were then 
incubated with either [33S]methionine or [7->Se]selenomethionine 
(50uCi/ml) for 10h at 37 C. Cell monolayers were then rinsed, and 
the cells collected: carrier cells or protein was added just 
prior to sonication. 35? ammonium sulphate precipitates were 
prepared, mixed and co-electrophores ed. Control and androgen 
insensitive proteins were subsequently distinguished by 
differential exposure of the gel with X-ray film. (See text for 
experimental details)
Table 2.1 First dimension (IFF) gel composition.
Component Amount/lOml gel mixture.
Urea
Acrylamide Stock* 
Ampholines:
pH range 5-7 
pH range 3.5-10 
NP-40 (10%)
Distilled Water
5. 5g
1.33ml (4%)
0.40ml 
0.10ml 
2.00ml (2%) 
1.97ml
10%(w/v) ammonium persulphate 
TEPFD
lOul
7ul
*, 30% acrylamide stoeksolution: 28.38%(w/v) acrylamide,
1.62%(w/v) DP'-methylenebisacrylamide. Stored in the dark, 
over mixed bed ion-exchange resin (Amberlite FB-3; Sigma) at 
4 C.
Table 2.2 Second dimension (SDS-PAGE) gel composition.
Component
Acrylamide Stock*
Distilled Pater
Lower Gel Buffer0 
Upper Gel Buffer
10% (w/v)ammoni urn
persulphate
TFFFD
Amount .
Funning Gel/25ml Stacking Gel/10ml
5.83ml (7.0%) 
6.67ml (8.0%) 
8.33ml ( 10%) 
12.92ml (7.0%) 
12.08ml (8.0%) 
10.42ml ( 10%) 
6.25ml
82.50ul 
12.50ul
1.50ml (4.75%)
6.00ml
2.50ml
30.OOul 
lO.OOul
*, 30% acrylamide stock: 29.2%(w/v) acrylamide, 0.8% (w/v)
N N 1-methylenebisacrylamide. Stored as above.
0, Lower gel buffer: 1 ,5M-Tris-HCl (pH8.8), 0.4%(w/v)SDS 
Upper gel buffer: 0.5M-Tris-KCl (pH6.8), 0.4%(w/v)SDS 
(O'Farrel).
overlay solution" [O'Farrell 1975; 9M-urea, Ampholines] and 
the upper buffer compartment refilled with fresh 0.02M-KaOH. The 
gels were then run overnight at 400V constant voltage (or 
constant power) for a total of 7500 volthours. In some cases the 
voltage was increased to 1000V for the final hour to sharpen the 
resolution of the bands.
The gels were removed from the tubes using a disposable 
syringe (with 21G 0.8x40mm neadle) and water pressure, and
placed directly into 5ml SDS-sample buffer [O'Farrell 1975; 
10%(v/v) glycerol, 5%(v/v)p-rnercaptoethanol, 25(w/v) SDS, and 
0.0625M-Tris-HCl, pH6.8]. The gels were then equilibrated for 
either a total of 30 minutes (15 minutes before and after 
strorage) or 2 hours; gels were kept at -20 or -70°C until 
required. The equilibration time of the gel was reduced inorder 
to minimize the loss of protein at this stage (Bravo 1984).
The pH gradient was measured by slicing a gel (run under
identical conditions, minus sample) into 5mm segments and eluting
the Ampholines in 1.5ml boiled distilled water in 1.5ml sealed
plastic micro test tubes (Brand), at room temperature for about 2
hours. The pH was then measured using a micro-pH electrode (Type
CMAWL; Russell) (See Appendex 5.3 ).
B.
Second Dimension:SDS-PAGE.
The second dimension was based on the Laemmli (1970) 
discontinuous SDS-gel system (O'Farrell 1975).
Table 2.2 describes the gel mixtures used: slab gels were 
cast in home-made cassettes consisting of tv/o glass plates 
(200x 175x3mm) kept apart with 0.8mm plastic spacers and sealed
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with adnesive tape and clips. The running gel (150x155x0.8mrn) was 
poured, overiayed with distilled water, and allowed to polymerise 
overnight. After removing the overlay solution, the Stacking gel 
(50x155x0.8mm) was cast on top and allowed to polymerise for one 
hour. The whole cassette was then placed in a Pharmacia gel 
electrophoresis apparatus (GE-2/4 LS); the base of the gel being 
unsealed beforehand. The IEF tube gel was then positioned on top 
of the Stacking gel and held in place with a plastic wedge 
(Pharmacia) or a 1%(w/v) agarose gel. Running buffer [O’Farrell 
1975; 0.025M Tris base, 0.192M-glycine, and 0.1S(w/v) SDS] was 
added to both upper and lower reservoirs. Protein stacking was 
achieved at 15-20mA/gel, with subsequent separation at a constant 
current of 20mA/gel. Bromophenol blue was added as tracking dye, 
and 10ui of standard protein mixture (Dalton Mark VII, 14000- 
70000 daltons, or High Molecular Weight standards, 30000-200000 
daltons; Sigma) were resolved concomitantly.
Electrophoresis was stopped when the dye front had travelled 
at least 100mm into the separating gel. The region containing the 
molecular weight markers was cut out and stained with 0.25% 
coomassie blue solution. The remainder of the gel was fixed in a 
solution of 50£ methanol:7 .5% acetic acid (overnight), and 
subsequently impregnated with a commercial fluorographic agent 
(Amplify; Amersham) for 20 to 30 minutes (room temperature) with 
constant agitation. The gel was then dried down on to 3fnm chroma­
tography paper (Whatman) using a Bio-Rad slab gel drier (Model 
224) under vacuum; the dried gel was then exposed to X-AR5 
medical X-ray film (Kodak), sandwiched between two glass plates, 
covered with tin foil, and placed in a light-prooi box. Alter a
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fluorographic image was obtained by exposing the gel at -70°C, 
the gel was re-exposed at room temperature, with a piece of 
blackened film placed between the gel and the x-ray film to 
screen out the light and £-emmissions from the ^ S - l a b e l l e d  
proteins (autoradiograph). The "blackened film" was prepared by 
exposing a piece of XAR-5 film to the white light from an 
enlarger for approximately 30 seconds and then developing the 
film as normal. This method of screening-out the was found to 
be more effective than using tin-foil. All films were processed 
by standard procedures.
2.12 2-DGE of Whole Cell GSF Protein.
6 A0.5x1 0 -1.0x10 cells were seeded in 30mm plastic dishes, 
and incubated with [^Sjmethionine (50uCi/ml) as previously 
described (Methods 2.10). Cultures were then rinsed three times 
with PBS (0°C) and scraped off in 100-200ul of lysis buffer 
(Methods 2.11), and stored at -7Q°C until required. Proteins were 
then resolved by 2-DGE as described in Section 2.11. In addition 
to analyse the more basic proteins, samples were resolved by 
NEPHGE (O'Farrell et al 1977) in the first dimension. The gel 
mixture for NEPHGE gels was similar to that described for IEF 
gels (Table 2.1), with the exception that Ampholines in the pH 
range 7 -9 (0.25ml) and 8-9.5 (0.25ml) were used, because of the 
more basic Ampholines, these gels required douole the quntities 
of ammonium persulphate and TEMED inorder to polymerise. The gels 
were cast in same way as the IEF rod gels (Methods 2.11). Once 
polymerised, NEPHGE rod gels were placed in a tube-gel
7 n
electropnoresis tank (Shandon); the lower reservior was filled 
with 0.02M-Na0H (Cathode) and the upper reservior with 0.01 M- 
H^PO^ (Anode), the reverse of IEF. There was no pre-focusir.g of 
the gels. Samples were loaded immediately, and resolved at 
constant voltage (400 volts) for a total of 1600Vhours (O’Farrell 
et al 1977). After electrophoresis the gels were treated as 
described for IEF first dimension gels. The second dimension, 
SDS-PAGE, was as described before (Methods 2.10), with the 
exception that proteins were resolved on 5-15% linear gradient 
polyacrylamide gels (Bio-Rad Gradient Former, model 385). 
Detection of the proteins by fluorography was as described 
previously (Methods 2.10).
2.13 Miscellaneous.
A. Liquid Scintillation Counting.
Radioactivity was routinely measured using a Packard Tri- 
carb 300 series scintillation counter. Samples were mixed with 
either 10ml of a toluene based scintillation cocktail [10% 
methanol, 0.5%(w/v) 2,5-diphenyloxazole (Sintran grade)] or 2.5 
to 10ml of Ecoscint (national Diagnostics) for liquid 
scintillation counting.
was determined using either a single nuclide or a dual 
nuclide program, with an efficiency of about 40% for both; 
was measured using a dual label program (with ^H) witn an 
efficiency of around 80%. The isotopes ^5S and 75Se were measured 
independently using a single nuclide program (Lecoq et al 
1882); counting efficiencies of 90% were obtained for both 
isotopes.
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B. Protein Measurements.
Protein estimations were determined from duplicate or 
triplicate samples by the method of Bradford (1976). Samples were 
diluted to a final volume of 100ul with distilled water and 
either 1 or 3ml of "Bradford’s regeant" [0.01 $(w/v) coomassie 
blue G-250, 4.7%(v/v) ethanol, 8.55&(w/v) phosphoric acid] added. 
Samples were mixed vigorously and the absorbance measured at 
595nm. A standard calibration curve was prepared in parallel 
using BSA. From this data it was possible to calculate the amount 
of protein present in whole cell and sub-cellular fractions.
C. Dextran Coated Charcoal Assay (DCC).
Samples were incubated with a charcoal suspension [155 Activ­
ated charcoal (Sigma), 0.155 dextran (Pharmacia); equilibrated in 
assay buffer 24 hours before use] at a ratio of 2:1 for 5 to 1C 
minutes (0 °C). The charcoal was then pelleted by centrifugation 
(2000xg, 10 minutes) and a sample removed from the supernatant 
for liquid scintillation counting.
D. Hydroxyapatite Assay.
An alternative to the DCC technique for measuring bound 
steroid involved absorption of receptor complexes by 
Hydroxyapatite (Williams & Gorski 1975; Clark a Peck 1976).
The hydroxyapatite (Type I; Sigma) was washed extensively 
with PEM buffer (+10%(v/v) glycerol) until the pH of the 
supernatant was 7.4. The volume of the slurry was then adjustec 
so that 0.5ml contained 0.3 to 0.35ml of packed hydroxyapatite, 
and stored at 4 *C.
Samples (50- 200ul) were incubated with 250ul of
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hydroxyapatite slurry for 15 to 20 minutes (0*C), with mixing. 
PEM buffer (+10% glycerol) was then added (4ml) and the contents 
of the assay tube vortexed and centrifuged at 2000xg for 2 
minutes. The pellet was mixed with 4ml of buffer, vortexed and 
centrifuged. This was repeated a total of four times, the 
supernatant fractions being discarded after each wash. The final 
hydroxyapaptite pellet was then extracted with 4ml of ethanol 
(room temperature) for 10 to 15 minutes, and the total alcohol 
extract assayed for radioactivity.
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RESULTS
&
DISCUSSION
3.1 Cell Lines and Binding Studies.
Figure3.1a and b shows a representive Scatchard analysis 
and Dissociation time-course, respectively, for androgen receptor 
binding in intact human cultured GSF: cell lines RM and CD. From 
such data, the concentration of receptor (Bmax), the equilibrium 
dissociation constant (Kd), and the half-life (t1/2) of steroid 
dissociation were calculated. Table 3.1 summarizes the findings 
of such whole cell assays for the cell lines used in this study; 
the data was taken from the relevant references or supplied by 
Dr.M.B.Hodgins (personal communication).
The control cell lines RM, S’.7, and CD all showed binding 
kinetics within the normal range (Bmax=34.0+10.1fmoles/mg 
protein, Kd=0.27±0.22nM:mean+S.D.;Hodgins et al 1984). A fourth 
cell line GR, also used as a control for androgen receptor 
binding, was from a patient with perineal hypospadias: cells were 
kindly supplied by Dr.P.Smial, Royal Aberdeen Sick Childrens 
Hospital).The patient was 46 X,Y, and a study of his family 
pedigree revealed his father was similarly affected, suggesting 
the hypospadias was paternally inherited, and arguing strongly 
against androgen resistance. Furthermore a number of other 
genetic abnormalities were present in this pedegree: polydactyly 
and epidermolysis bullosa.
Tne androgen insensitive cell lines T4, Matheson, and TCF 
also showed normal whole cell binding kinetics (Table 3.1). The 
cell line T4 (material supplied by Professors R.Scott ana
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R.mtitcn, University of Leeds), was derived from a post pubertal 
patient with a female phenotype and complete androgen 
insensitivity. The X-linkage of the disorder was supported oy the 
observation that a maternal half sister was found with androgen 
insensitivity. The Matneson cell line (cells supplied by 
Professor C.R.W.Edwards, University of Edinburgh), was from a 
patient with a male phenotype similar to that seen in the 
Refeinstein syndromes, and was diagnosed as having partial 
androgen insensitivity. No obvious defect in ligand binding or 
augmentation was seen for the receptor complexes from T4 or 
Matheson; however; the receptor complexes from TCF failed to "up- 
regulate" and showed abnormal dissociation kinetics in both whole 
cell and cell free extracts, suggesting an underlying structural 
defect in the receptor protein (Kaufman et al 1981, 1962a).
Quantitative binding defects were found for both the cell 
lines 4479 (unmeasurable), 605 (unmeasurable) and la (Deficient).
In all cell lines with measurable receptor binding, except 
TCF, the level of basal binding was found to increase in response 
to prolonged (24 hours) incubation with [^Hjandrogen. The cell 
lines RM, CD, GR increased receptor binding with both DHT and 
mibolerone; however, with SW, T4, Matheson and la, augmentation 
was seen only with the synthetic androgen Mibolerone. In the case 
of SW and T4 this was shown to be due to the high rate of 
metabolism of DHT by these cells (Rowney and Hodgins 1985), ana 
with the la cell line, the problem was the high level of non­
specific binding. It is now widely accepted that [^H]mibolerone 
is a very useful ligand for androgen receptor binding studies 
because of high affinity binding to the receptor, lower ncn-
79
speciiic binding and greater in stability (ncn-
metabolizable) over [3H]DHT (Evans u Hughes 1965; Rowney 
Hodgins 1965; Dr.M.B.Hodgins personal communication).
3-2 Partial Purification of the Human Androgen Receptor.
Precipitation of a 0.5M-KC1 extract of GSF with 15-307, 
ammonium sulphate resulted in a 3-4 fold enrichment of the 
recovered counts over the total cell sonicate fraction (Table 
3.2); in all subsequent experiments the 105000xg salt extract was 
brought to 35% saturation with ammonium sulphate. A number of 
groups have suggested that the proportion of radioactive counts 
that are non-extractable in high salt (0.3-0.5M) Duffers, may 
have a functional significance in terms of receptor-acceptor 
binding (Clark & Peck 1976; Davies 1983; Kaufman et al 1963), and 
more recently with prostatic disease (Kyprianou & Davies 1986; 
Kyprianou et al 1986). The present study does not attempt to 
address the above questions, as the methodology used, differs 
from those described above. However, further analysis of the 
105000xg salt extracted pellet, showed that 69% of the 
radioactivity was recovered after repeated sonication in 0.5M- 
KC1 buffer (19%) and subsequent Triton X-100 extraction (50%); 
this suggested that at least 75% of the salt extractable 
radioactivity was solubilised by a single round of sonication, 
and at least 50% of the 105000xg pellet d.p.m. were associated 
with membrane material (Table 3.3). A further 3% of the 
radioactivity was released by DNAase I and trypsin digestion; it 
should be noted that although only a small iractio.n of the pellet
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Table 3.2 Ammonium sulphate fractionation of GSF salt extract.
Fraction C3H]
Total
d.p.m.
Bound
Protein
(mg)
Specific Activity 
(dpm/mg protein)
Cell Sonicate 102360 ND 4.52 22600
Cell Pellet 58260 ND 3.50 16700
KC1 Extract 44000 13000 ND -
0-15% AS 1048 ND # -
15-30% AS 7000 ND 0.08 87500
30-45% AS 6354 ND 0.32 19900
Supernatant 12000 2400 0.62 19400
A confluent monolayer of SW cells was incubated with 1nM [3H]DHT 
for 30-40min. at 37 °C. The cells were then harvested and 
disrupted by sonication and receptor complexes extracted with 
0.5M-KC1 in PEM buffer. The 105000xg salt extract was then 
brought to 15%, 30%, and 40% saturation with ammonium sulphate: 
precipitates were then collected and analysed for total and bound 
radioactivity (DCC assay, see Methods 2.13)» and protein 
recovered.
AS=ammonium sulphate precipitate.
ND=Not determined.
* =To low for accurate measurement.
Table 3.3 Extraction of 105000xg pellet associated counts.
Treatment Volume
(ml)
Radioactivity Recovered (d.p.m.) 
Total Bound
Pellet I 1.0 58350
Sonication/Salt 1.0 10932 560
Triton X-100 1.0 29182 22077'
DNAase I 1.0 1151 151
Trypsin 1.0 479 248
Pellet V 0.5 1423 231
Radioactivity associated with the 105000xg salt extracted pellet 
was investigated further by: re-sonication and 0.5M-KC1 
extraction; extraction with 0.5% (v/v) Triton X-100; 
digestion with DNAase I (50ug/ml), and finally trypsin (3rng/ml). 
After each treatment the 105000xg supernatant was assayed for 
total and bound d.p.m. recovered; as described in Methods 2.4.
(«=This figure was thought to be an over estimation of the 
bound d.p.m. in this fraction, as in the presence of detergent
20.1 $ of free steroid was found not to be precipitated by 
charcoal treatment.)
a.p.m. (0.8'P) was released by trypsin digestion, 52% of these 
d.p.m. were bound (Table 3.3). Although the functional 
significance of this fraction, for androgen action was not 
determined in the present study, it is possible that this small 
fraction of salt and DIJAase I resistant d.p.m. could represent 
receptor-acceptor interactions.
From these studies it was concluded that the combination of 
sonication in Q.5M-KC1 PEM buffer was a fast and useful system 
for extracting nuclear bound fibroblast androgen receptor 
complexes. Table 3.4 summarizes the salt extraction and partial 
purification data for the androgen receptor from control and 
androgen insensitive cell lines. Enrichment of d.p.m.by 35$ 
ammonium sulphate precipitation ranged from 0-4 fold, and 
reflected the binding cnaracteristics of the cell lines studied. 
Furthermore analysis of the d.p.m. recovered after ammonium 
sulphate treatment, in t a e  precipitate and supernatant fractions, 
shows that for the control cell lines (RM, SW 1 CD) and the 
androgen insensitive cell lines with normal or deficient binding 
(T4 & la): 34+13% and 11.6+1.5% (Mean+SD) of total cell sonicate 
d.p.m. was recovered in the precipitate and supernatant fractions 
respectively. For the other cell lines, 4479 (unmeasurable 
binding) and TCF (unstable binding) only 9% and 13% of the total 
sonicate d.p.m. was recovered in the precipitate, while 39% and 
16% was found in the supernatant fraction respectively.
From the proportion of [^CjDHA recovered after ammonium 
sulphate precipitation it was estimated that about 40-50% of the 
[3H]DHT d.p.m. and 70-80% of the [3H ]mibolerone d.p.m. 
represented specific binding (Table 3.5); as expecoed a similar
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Table 3.5 Measurement of non-specific binding.
(a) 3H 30-40 minute incubation.
Fraction Proportion of Radioactivity Recovered (d.p.m.)
„ DHT CSV,r»n=?2 „ DHT (T4,n=6)
% C 3H Y4C
Total Sonicate 1.00 1.00 1.00 1.00
Pellet 0.46+0.13 0 .30+0.10 0.37+0.11 0.31+0.09
KC1 Extract 0.49+0.10 0.60+0.08 0.49+0.04 0.54+0.08
A.S.0 0.21+0.10 0.11+0.05 0.28+0.04 0.17+0.03
Supernatant 0.21+0.08 0.36+0.08 0.12+0.03 0.33+0.06
Specific 3inding0 118% 39%
(b) 3H Mibolerone.
Fraction Proportion of Radioactivity Recovered (d.p.m.) 
30-40 minute incubation 24 hour incubation 
RM & CD, n=3 _ RM/SW, n=5„
1 Hp 3u * ^ r3u
Total Extract 
Pellet 
KC1 Extract 
A.S.0
Supernatant 
Specific Binding0
1.00
0 .31+0.02
0.70+0.20
0.42+0.16
0.15+0.03
71%
1.00
0.47+0.16
0.55+0.12
0.12+0.01
0.34+0.02
1.00
0.38+0.08
0.61+0.08
0.35+0.18
0.12+0.04
77%
1.00
0.58+0.17
0.43+0.02
0.08+0.02
0.30+0.05
The androgen precursor C4-^ C3DHA was added to the total cell 
extract, and the proportion recovered in each subsequent fraction 
determined. As non-specific binding will be linear with respect 
to steroid concentration the proportion of 
be equivalent to the proportion of n 
non-specificly.
C DBA was assumed to 
DHT or mibolerone bound
A.S.= 35% ammonium sulphate precipitate.
level cf specific binding was seen after 24 hour incubation with 
2nM-[3H]mibolerone (Table 3.5). It is proposed, that the use of 
[^C]DHA binding, probably gives a more realistic estimate of 
non-specific binding in sub-cellular extracts than the 
conventional method of adding cold steroid to the whole cells. 
After washing of cell monolayers very little radioactivity will 
be cellular bound, and will be reduced further during sub- 
cellular fractionation, thus underestimating the level of non­
specific binding. The observed difference between the levels of 
DHT and mibolerone non-specific binding fits well with the 
findings of whole cell studies, where non-specific binding was 
measured by incubating cells with [ *'H]steroid+100-fold excess 
unlabelled steroid (Evans 1 Hughes 1985; Dr.M.B.Hodgins personal 
communication); it is therefore clear, that mibolerone is a 
superior ligand to DHT for in vitro studies of the androgen 
receptor.
3.3 Sucrose Density Gradient Analysis.
In order to demonstrate that the ammonium sulphate fraction 
contained androgen receptor, and as way of comparing the receptor 
complexes from control and androgen insensitive cell lines, the 
re-suspended ammmonium sulphate precipitate was analysed on 5- 
20*(w/v) linear sucrose density gradients. In the presence of 
0.5M-KC1 the androgen receptor complex from the control cell 
lines CRM, SVJ, 1 CD) sedimentec at about 4S (3.6-4.6SXFig.3-2), 
as did the receptor from the androgen insensitive cell line T4 
(Fig.3.3). Under identical conditions, the corresponding peak was
Figure 3.2. Sucrose density gradient analysis of the androgen 
receptor from control GSF cell lines. 5-20£(w/w) linear sucrose 
density gradients were prepared in PEM buffer containing 0.5K- 
KC1. Ammonium sulphate precipitates were resuspended in 0.5ml of 
the same buffer containing 2-3%(w/v) sucrose and FITC-IgG as a 
marker: a second gradient containing the proteins FITC-IgG (6-7S) 
and either BSA (4.6S) or Ovalbumin (3.6S) was prepared in the 
same way. Gradients were centrifuged at 30000 rev./min. (SW40 
rotor, Beckman) for 18-20h. at 4 C; eight drop fractions were 
then collected from the bottom of the gradient and assayed 
directly for radioactivity or protein. Arrows indicate the 
position of the marker proteins. (See Methods 2.5 for details)
(Note. All cells were incubated with mibolerone, except for SW 
T4 which were incubated with DHT.)
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Figure 3.3. Sucrose density gradient analysis of the androgen 
receptor from androgen insensitive GSF cell lines. For details 
see the legend to Fig.3.2.
diminishea or absent from the androgen insensitive cell lines la, 
TCF and 4479 respectively (Fig.3.3). It was concluded from these 
studies that the observed sedimentation profiles reflected the 
findings of whole cell binding assays (Table 3.1), with the 
exception of TCF, and also the levels of radioactivity recovered 
in the ammonium sulphate fractions (Table 3.4). It is believed 
that this is the first report of a correlation between the 
sedimentation pattern of partially purified receptor complexes 
and whole cell binding kinetics.
3.4 ^'-ADP-Sepharose Chromatography.
Figure 3.4 (a & b) shows the elution of the SW and T4 
receptor complexes from 2'5,-ADP-sepharose: both control and 
androgen insensitive complexes eluted at a peak between 0.5 and 
1.0M-KC1 (fractions 10 <1 11). No enrichment of the counts in the 
peak fractions was seen, however in the fractions 9-12 the amount 
of protein recovered was 20-30-fold lower than in the total 
sonicate extract, and 2-4-fold lower than the 355® ammonium 
sulphate fraction.
This technique has been used successfully by Mulder et al 
(1984) to partially purify the androgen receptor from rat 
prostate tissue. In that study, washing the gel apparently 
removed more than 955£ protein, and the receptor was purified 50- 
fold with a recovery of 1 0 % . Studies with the human fibroblast 
receptor failed to show similar results, although both rat 
prostate cytosol and human fibroblast ammonium sulphate fractions 
gave qualitatively similar elution profiles for labelled 
receptor. Using the ammonium sulphate fraction irom human
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Figure 3.4. 2’5l-ADP-Sepharose chromatography of the GSF androgen 
receptor. Ammonium sulphate precipitates were resuspended in 2ml 
PEM buffer containing lOraM-KCl, mixed with a slurry of 2,5,-ADP- 
sepharose (1g/4ml) and dialysed against the above buffer for 3- 
4h. at 4 C. After washing the column with 5-10ral of the above 
bufferthe androgen receptor was eluted with a discontinuous salt 
gradient (0.1M, 0.2M, 0.3M, 0.4M, 0.5M & 1.0M-KC1); 2ml fractions 
were collected and assayed for protein (a) and radioactivity (b). 
The results shown are the mean of three (T4; peak fraction 11 
each time) or two (SW; peak fraction 10) separate experiments. 
(See Methods 2.6 for details)
(Note, Cells were incubated with H DHT)
fibroblasts, washing the gel removed between 19-642 of the total 
protein. Only 20-502 of the total d.p.m. incubated with the ADP- 
sepharose was recovered by elution with KC1. It was concluded 
from these data, that binding was lost during the dialysis 
incubation and/or radioactivity was remaining bound to the 
column. Therefore in an attempt to determine if more receptor was 
being eluted than suggested by the recovered d.p.m., fractions 
were incubated with 1nM [^H]DHT for 3-4 hours at 4°C, and bound 
counts assayed by DCC (Methods 2.13). The "binding" observed was 
difficult to interpret, probabably due to non-specific binding. 
It was concluded from these studies that: the fibroblast receptor 
lost steroia binding activity, probably irreversibly, and 
therefore further purification of the receptor complexes by this 
protocol was not feasible; however this method was useful for 
comparing the receptor complexes from a control and androgen 
insensitive cell line, both showed similar binding and elution 
characteristics.
3.5 Augmentation of the GSF Androgen Receptor.
Table 3.5 shows the partial purification of the androgen 
receptor from control cultures (pooled SW and RM cells) after 
incubation of the cells with 2nM [^Hlmibolerone or [^H]R18S1 for 
24 hours. There was no change in the proportion of d.p.m. 
recovered in the KC1 extract (682) or the ammonium sulphate 
precipitate (402), however there was a 2-3-fold increase in the 
yield of radioactivity in these fractions (see Table 3.4 fcr 
comparison). It was therefore concluded that this was a superior
C Io4
Table 3.6 Extraction of GSF androgen receptors after 24h 
incubation with 2nM PH]mibolerone ©r Methyltrienolone (R1881).
Fraction
[^H]Mibolerone:
Mean + SD (n=7) 
d.p.m. Protein Specific activity
______________ (mg)______ (dpm/mg protein)
Cell Hornogenate 
Pellet
Salt extract 
AS
Supernatant
[3H]R1881:
Cell Hornogenate 
Pellet
Salt Extract 
AS
Supernatant
259193+57082
97554+37991
176357+54520
103193+55499
70464+71813
228533+46774
93017+30816
169367+67642
91667+24384
72700+62253
5.42+1.76
2.32+0.72
2.94+1.21
0.78+0.30
2.18+0.93
5.00+1.27
2.20+0.62
2.87+0.67
0.67+0.23
2.33+0.71
49400+ 8600 
42000+10500 
63000+14400 
148000+71100 
27500+16900
46100+2200
42300+8900
57600+9600
143600+45800
30400+15200
2x10^ cells (SW and RM cell lines) were seeded in 140mm plastic 
petri dishes (four/experiment), and grown to confluence. The 
cells were then incubated in EC1 medium containing 2nM 
[^Hlmibolerone for 24h at 37 C, prior to salt extraction and 
partial puification of the androgen receptor. See Methods 2.3 and 
2.4 for details).
(The data represents the mean+standard deviation (SD): 
n=7, Mibolerone binding; n=3, R1881 binding.)
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Figure 3.5 Sucrose density gradient analysis of the GSF androgen 
receptor after incubating cell for 24 hours with 2nM 
PH]mibolerone. Cells were collected and sonicated in PEM buffer 
containing 0.5M-KC1: the 105000xg salt extract was then layered 
on toa 5-20%(w/v) linear sucrose density gradient, and 
centrifuged overnight at 40000 revJmin. (SV/40 rotor). Four drop 
fractions were collected from the bottom of the tube and assayed 
for radioactivity. O  , 0.5-1.0 hour incubation; #  , 24 hour 
incubation. The marker proteins IgG (6-7S) and BSA (4.6S) were 
centrifuged in a parallel gradient. Data kindly supplied by 
Dr.M.B.Hodgins.
method for labelling receptors than the shorter 30-40 minute 
incubation. Ammonium sulphate precipitation resulted in a 3-fold 
enrichment of the counts; and Figure 3.5 shows a representive 
sucrose density gradient of the 105000xg KCl-extract before and 
after androgen receptor augmentation.
3.6 FPLC-Anion Exchange Chromatography of the Human Androgen 
Receptor.
After incubating control cultures (RM & SW) for 24 hours 
with 2nM [.^H]mibolerone, the receptor complexes from the 105000xg 
salt extract (desalted first; Methods 2.7 ) and the
ammonium sulphate fraction, eluted from a Mono Q column as 
single peaks, at 0.13-0.18M-KC1 (Fig.3.6 a,b,c). Of the loaded 
radioactivity 30-45? was recovered by eluting with KC1, the 
remaining d.p.m. could then be recovered by washing the column 
with 80?(v/v) methanol and 75?(v/v) acetic acid. These latter 
d.p.m. were thought to represent non-specific interaction between 
the ligand and the column, as extending the salt gradient to 
1.0M-KC1 failed to elute any other peaks of ^H binding 
(Fig.3.6c).
The androgen receptor from rat prostate, epididymis and calf 
uterus cytosol have been partially purified by FPLC-anion 
exchange on a Mono Q column (Brinkmann et al 1985a). All three 
forms of the receptor eluted as sharp peaks at 0.32M-NaCl; this 
would suggest that there was a weaker interaction between the 
human fibroblast receptor (0.13-0.18M-KC1) and the anion exchange 
resin. This finding is in agreement with a recent study by Keenan 
et al (1986), who reported that the activation of the receptor
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Figure 3.6 FPLC-anion exchange chromatography of the GSF androgen 
receptor. Confluent cultures of SW and RM cells were incubated 
with 2nM[%]mibolerone for 24h. and the 105000xg salt extract (a) 
or 35% ammonium sulphate fraction (b & c) chromatographed on a 
Mono Q anion exchange column. The androgen receptor was eluted 
with a linear salt gradient, 0-0.35M-KC1 (a & b) or 0-1.0M-KC1 
(c), at a flow rate of 1ml/min.; 1ml fractions were collected and 
assayed for radioactivity. (See Methods 2.7 for details)
complex from human GSF was associated with, among other things, a 
loss of negative charge. The work of Brinkmann and assoaciates 
(Brinkmann et al 1985a) was carried out on the unactivated 
molybdate-stabilised receptor form, while the present studies 
were on the salt-extractable nuclear receptor form. It is 
possible therefore, that the difference in salt concentration 
required to elute the GSF androgen receptor may be due to 
receptor activation.
In the study of Brinkman et al (1985a) the rat prostate 
receptor was purified 75-fold with a recovery of 71 %, while the 
receptors from rat epididymis and calf uterus had recoveries of 
85%. Similar results could not be achieved with the human GSF 
receptor complexes. In the peak fraction, there was a 4-6-fold 
enrichment of d.p.m./mg protein over the total sonicate, with a 
recovery of 3-7% (of a.p.m. loaded onto the column): extending 
the analysis to cover fractions 18-28, the recovery of d.p.m. 
increases to 17-33% but the enrichment^is decreased to 0.8-3.0- 
fold. Therefore, it would seem that under these experimental 
conditions (working at room temperature), receptor binding was 
impaired so that the degree of purification and yield of receptor 
complexes was much poorer than expected.
Finally, in one experiment, the amount of bound counts in 
the ammonium sulphate and FPLC peak fractions (19-23) was 
determined (hydroxapatite assay; Methods 2.13), and found to be 
31.4% and 14.6% of the total d.p.m. recovered in these fractions 
respectively. It seemed likely that these were underestimates of 
the binding, possibly due to the interference of salt in the
oinding assay ana/or are less of bound radioactivity during the 
anion exchange chromatography.
3.7 HPLC-Size Exclusion Chromatography.
The androgen receptor from control cells (pooled SW and RM 
cultures) eluted from a gel filtration column as two distinct 
peaks; with relative molecular masses (Mr.) of 63.1K (I) and 13K 
(II), and Stokes Radii (Rs) of 3.16nm and 1.58nm respectively 
(Fig.3.7a). The Mr. and Rs were calculated using standard 
proteins resolved under identical conditions (Fig.3.6). A smaller 
amount of the larger species was recovered. The receptor 
complexes from another control cell line, GR, also resolved into 
two "peaks” of radioactivity: at Mr. 63K and 15K, and Rs 3.16nm 
and 1.78nm respectively (Fig.3.7c). HPLC-gel filtration of the 
androgen receptor from two androgen insensitive cell lines gave 
quite different results. The receptor from Matheson showed a 
similar elution profile to that of the control cell lines; two 
"peaks" of activity were seen at Mr. 89.1K and 15.8K, and Rs 
3.98nm and 1.78nm respectively. However, with the cell line la 
only a very small fragment, eluting close to the total volume of 
the column was seen (Fig.3.7). Table 3.7 summarizies this data, 
together with the Mr. and the f/f0 ratio calculated from the 
Stokes radius and sedimentation coefficient. The values obtained 
for sedimentation coefficient, Mr., Rs and f/f0 of the human GSF 
androgen receptor are in close agreement with those reported 
recently for the calf uterus androgen receptor (de Boer et al 
1986). However the results of Keenan et al (1956) suggested that 
the human GSF a n d r o g e n  receptor 'was larger, with a calculated
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Figure 3.7 HPLC-size exclusion chromatography of the androgen 
receptor from normal and androgen insensitive GSF. Confluent 
monolayer cultures of SVJ and RM cells were incubated with 
PHJR1881 for 24h.The 35$ ammonium sulphate precipitate, of the 
salt extract, was re-suspended in 0.3-0.5ml of PEM buffer 
containing 0.5M-KC1 and 10$(v/v) glycerol and resolved on a TSK 
G3000 SVJ column; 1ml fractions were collected and assayed for 
radioactivity (a). The androgen receptor complexes from the 
control (GR) and the androgen insensitive (Matheson and la) cell 
lines were also chromatographed on the TSK G3000 SVJ column, with 
the modifications that cells were incubated with 2nM PH] 
mibolerone and 0.5ml fractions were collected up to 15ml and 
thereafter 1ml fractions collected to the end (b). The elution of 
free steroid (v) was determined in a separate experiment by 
loading 100000 d.p.m. of PH] mibolerone. (see Methods 2.8 for 
details)
Ve=Elution volume
Vo=Void volume; elution volume of Blue Dextran
Vt=Total volume; elution volume of Phenol Red
(See legend to Figure 3.8 for details on column calibration)
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Figure 3.8 Calibration of the HPLC-gel filtration column (a). The 
column was calibrated using mixtures of proteins of known 
molecular weight (b) and Stokes radius (c), resolved under 
identical conditions to the ammonium sulphate fractions (See 
Methods 2.8 for details). The position of the peaks of bound 
radioactivity (I and II) has been superimposed on the standard 
curves (b & c).
Table 3*7 Physicochemical parameters of the human GSF androgen 
receptor.
Cell line Sedimentation 
Coefficient (S)
Rs.
(n m )
Mr.
a . b.
f/f0 Axial
Ratio"
RM/ SVJ 4.4 3.16 63-1K 60K 1.21 3.00
1.58 13.OK - - -
GR 4.0 3.16 63.1K 54K 1.43 6.75
1.78 15.OK - - -
Matheson 4.0 3.98 89-1K 68.5K 1.46 6.75
1.66 15.8K
Sedementation coefficients derived from sucrose density gradient 
centrifugation; except for Matheson, 4.0S assumed value. Stokes 
radius (Rs) measured from HPLC-gel filtration, as was Mr. (a); 
Mr. (b) was calculated using the the sedimentation coefficient 
and the Rs:
Mr= 6.*f.p.N.Rs.S/(1-vp) - 1.
f/f0= Rs/(3.v.M/4.ji.N)1/3 - 2.
Where: 
tf= 3.14
p= viscosity= 0.914 (calculated using ovalbumin in equation 1)
S= sedimentation coefficient (x10"^S) 
v= partial specific volume= 0.74cm-* 
p= density of the medium= 1.0259g/cnP ^  f
M= Mr. and N= ava^adro*s Humber (6.02x10 ) j
* Axial ratio for prolate ellipsoid (a>b) was calculated from 
the frictional ratio (f/fQ), assuming solvation of 0.2g/g of 
protein, and published tables (Oncley 1941).
molecular weight of between 114300-134500-daltons.
The elution of free steroid (large open arrow), unaer 
identical conditions, occured after the elution of Phenol red 
(21ml) at between 26.5-30.5ml (peak at 27.5ml).
3.8 Photoaffinity Labelling Studies.
A. Rat prostate.
The rat prostate cytosol receptor was partially purified by 
FPLC-anion exchange chromatography; eluting as a single peak at 
0.26M-NaCl (Fig.3.9a). After U.V. irradiation and SDS-PAGE a peak 
of bound radioactivity believed to be the androgen receptor was 
recovered at Mr. 56K (Fig.3.9b).
B. Calf uterus.
The calf uterus androgen receptor was partially purified by 
DNA-cellulose chromatography; eluting with a recovery of 10?, as 
a relatively broad peak (Fig.3.10a). After U.V. irradiation and 
SDS-PAGE a peak of bound radioactivity was seen at about 100K Kr. 
(Fig.3.10b). The peak from both the DNA-cellulose column and the 
polyacrylamide gel could be completely surpressed if excess cold 
steroid was present throughout the experiment.
These findings were in close agreement with those already 
reported by Brinkmann et al (1985a,b), and confirmed the 
usefulness of this protocol for studing the androgen receptor in 
different tissues.
C. Human GSF.
Control cultures, RM and SW, were incubated with either 
C^H]mibolerone or [ ] R1881 for 24 hours. Androgen receptor
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Figure 3.9 Photoaffinity labelling of the rat prostate androgen 
receptor. Prostate cytosol from 24h castrated rats was incubated 
with 15nM PH]R1881 for 2h and the labelled androgen receptor 
partially purified by FPLC-anion exchange chromatography. The 
receptor complexes were eluted with a linear salt gradient (0-
0.35M-NaCl), and 1ml fractions collected and assayed for radio­
activity: the result shown is the mean from three separate 
experiments (a). The peak fraction (fraction 27) was irradiated, 
and the photolinked [^H]R1881-receptor complexes were then 
precipitated with 10%(w/v) trichloroacetic acid. The trichloro­
acetic acid insoluble material from three separate experiments 
was then pooled and analysed by SDS-PAGE (b). The arrows indicate 
the position of the marker proteins: Phosphorylase b (97.4K), BSA 
(66K), Ovalbumin (45K), and Carbonic anhydrase (29*0. (See 
Methods 2.9A for details)
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Figure 3.10 Photoaffinity labelling of the calf uterus androgen 
receptor. Labeled calf uterus cytosol ([^H]R1881 with (O) or 
without (#) 3uM-DHT) was brought to 40? saturation with ammonium 
sulphate; and the receptor further purified by DNA-cellulose 
chromatography (a). Fractions 13-18 were pooled from both 
incubations (Hot + Cold) and irradiated; the photolinked receptor 
complexes were then precipitated with 10?(w/v) trichloroacetic 
acid and analysed by SDS-PAGE (b). The arrows indicate the 
position of the marker proteins: -galactosidase (1160,
Phosphorylase b (97.410, BSA (660, Ovalbumin (450, and Carbonic 
anhydrase (190. (See Methods 2.9B for details)
complexes were then partially purified by FPLC-anion exchange 
chromatography and/or 35£ ammonium sulphate precipitation and 
irradiated with a high pressure mercury U.V. lamp for 10-15 
minutes (bound rnibolerone had to be exchanged for R1881 prior to 
irradiation) (Methods 2.9). Irrespective, of the protocol 
followed (I, II a or b; Methods 2.9C), after trichloroacetic acid 
precipitation and extraction with ethylacetate, no photolinked 
material was recovered on 8% polyacrylamide gels, except at the 
dye front (Fig.3.11 a & b). On this % gel it is difficult to 
resolve proteins of Mr. below 2M-29K; therefore it is possible 
that a small fragment of the receptor, containing covalently 
linked [^H]R1881 (Mereoreceptor ?), is running with the eye 
front. Furthermore, it would be interesting to see if the peak 
of radioactivity seen at 13-15K, after HPLC-gel filtration 
related to this material that runs coincident with the dye front 
on SDS-geis. However, it should be pointed out, that this 
material could simple be cross-linked steroid (William et al 
1986) and/or non-extractable (in organic solvents), non- 
specifically associated steroid (Mainwaring & Randall 1984).
In situ U.V.-irradiation. Table 3.8 shows the extraction and 
partial purification of the androgen receptor after in situ U.V.- 
irradiation of human GSF cells (RM &SW): there was a reduction in 
the total number of d.p.m. recovered in the total cell homogenate 
(4-fold) and ammonium sulphate (about 20-fold) fractions, and no 
enrichment of counts in the latter (see Table 3.6 for 
comparison). Analysis of the ammonium sulphate precipitated 
material by SDS-PAGE (Fig.3.11c) and HPLC-gel filtration 
(Fig.3.12a) failed to detect a peak of photolinked receptor
89
Table 3.8 Extraction of the GSF androgen receptor after in 
situ U.V. irradiation.
Fraction Mean+SD (n=3)
d.p.m. Protein Specific activity
(mg) (dpm/mg protein)
Cell Homogenate 52610+1886 4.71+0.49 11400+3600
Salt extract 19691+7864 1.45+0.40 14900+4300
AS 2205+ 227 0.37+0.18 7400+4300
Supernatant 14162+5594 1.17+0.18 12800+6000
Pellet I 37153+7377 3.43+0.45 10900+2200
Triton X-100 23661+1734 2.02+0.79 13400+6800
DNAase I 1880+ 971 0.39+0.26 5100+1000
Pellet III 3528+2743 0.32+0.25 11300+4300
2x10° cells (SW and RM cell lines) were seeded in 140mm plastic 
petri dishes (four/experirnent) and grown to confluence. The 
cells ijere then incubated in EC1 medium (15ml/dish) containing 
2nM [^H]R1881 for 24h. The cell monolayers were subsequently 
rinsed with ice cold PBS and the dishes inverted on a U.V.- 
transiluminator for 2 min. A salt extract and a 35% ammonium 
sulphate fraction were prepared. Label remaining in the 105000xg 
pellet I after salt extraction was further investigated by 
1%(v/v) Triton X-100 extraction (30min.) and subsequent DNAase I 
(25ug/ml) digestion (60min.). See Methods 2.9 for details.
Figure 3.11 SDS-PAGE of the fibroblast androgen receptor after 
U.V. irradiation. Cells were incubated with 2 nM PHlmibolerone 
for 24h and the androgen receptor partially purified (FPLC-anion 
exchange and/or 35% ammonium sulphate precipitation). The sample 
was then incubated with 15nM PHJR1881 for 20h at 4 C, to 
exchange the bound mibolerone for the photoactive ligand R1881, 
and irradiated. Photolinked receptor complexes were recovered by 
5-10% trichloroacetic acid precipitation, and resolved on an 8% 
polyacrylamide gel (a). Alternatively, cells were incubated with 
2nM PH]R1881 for 24h. The ammonium sulphate fraction was then 
irradiated directly, and the trichloroacetic acid insoluble 
material resolved on an 81 polyacrylamide gel (b). Lastly, cells 
were incubated with 2nM PH]R1881 for 24h and irradiated jj} situ 
using a U.V. transilluminator. After salt extraction the receptor 
complexes were precipitated with 35% ammonium sulphate and 
resolved on an 8% polyacrylamide gel (c).
(a) cells labelled with [^H]Mibolerone, and receptor complexes 
exchanged with [%]R1881 prior to irradiation.
(b) as a, except cells labelled with PH]R1881 (no exchange 
necessary).
(c) cells incubated with [^H]R1881, and irradiated directly.
(See Methods 2.9C 2nd Fig.2.1, for details)
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complexes; HPLC-gel filtration cf the residual pellet (after 
Triton extraction and DHAase I digestion) gave a similar result 
(Fig.3.12c), (to that of the ammonium sulphate fraction). However 
gel filtration of the Triton X-100 extracted radioactivity (after 
trichloroacetic acid precipitation) revealed a peak cf 
radioactivity at, or very close to the void volume, which would 
suggest an aggregate of Mr. >300K (Fig.3.12b). The significance 
of this species is not clear, and it may simply be an artefact of 
the experimental procedure. The lack of success with the ir} situ 
U.V.-irradiation protocol for the human fibroblast androgen 
receptor, as compared to the avian oviduct progesterone receptor 
(Horwizt & Alexander 1963), may reflect a general instability of 
the androgen receptor. It is cf interest, therefore, that without 
in situ U.V.-irradiation, 50-502 of the salt extracted d.p.m. 
were precipitated and about 402 remained in the supernatant 
(Table 3.6), whereas after in situ U.V.-irradiation only 11.22 of 
r, salt extracted radioactivity was precipitated and 71.92 remained 
in the supernatant. It is possible therefore, that U.V. 
irradiation has resulted in receptor degradation to a fragment(s) 
that is(are) no longer precipitated by 352 ammonium sulphate. It 
would be of interest to analyse the ammonium sulphate supernatant 
fraction by SDS-PAGE and/or HPLC-gel filtration, to see if any 
peaks of radioactivity could be recovered. Comparison of
Tables 3.6 and 3.8. suggested that in situ U.V.-irradiation of 
fibroblast cultures resulted directly or indirectly in a loss of 
receptor bound d.p.m. This was investigated by incubating the 
cells with [3H]R1881+200-fold excess of cold steroid (Table 3.S).
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Figure 3-12 HPLC-size exclusion chromatography of the GSF 
androgen receptor after jjj situ U.V. irradiation. Cells were 
incubated with 2nM C^H]R1881 for 24h, and irradiated in situ. 
The 35% ammonium sulphate precipitate was prepared, and label 
remaining in the 105000xg pellet after salt extraction further 
investigated by extraction with 1% Triton X-100 and subsequent 
DNAase I (25ug/ml) digestion. All samples were suspended in PEM 
buffer containing 0.5M-KC1 and 10% (v/v) glycerol, and resolved 
on TSK G300GSW column; 0.5ml fractions (up to 15ml) and 1ml 
fractions were collected and assayed for radioactivity.
(a) Amooniixn sulphate fraction.
(b) Triton extract
(after trichloroacetic acid precipitation)
(c) Residual pellet.
} See Methods 2.9C 
(Fig.2.1)
xMtnough saturable binding was demonstrated, there was no 'de ­
r e g u l a t i o n  of the androgen receptor and no enrichment of specific 
binding after 35% ammonium sulphate precipitation (actually a 
reduction, only 21% of the "specific binding" of the total cell 
homogenate was recovered in the precipitate). However, as was 
discussed previously, Methods 3.2, incubating whole cells with 
cold steroid probably underestimates the level of non-specific 
binding in sub-cellular fractions due to the redistribution of 
label, so that the apparent "specific binding" may be much lower 
than indicated (Table 3.9).
It can be concluded from these experiments, that the yield 
of receptor was reduced after in situ U.V.-irradiation, due 
directly or indirectly to the harmful affects of the U.V. light. 
This loss of receptor binding, coupled with the inefficiency of 
the photolinking reaction could explain the difficulty 
encountered in detecting photolinked receptor complexes after 
SDS-PAGE or KPLC-gel filtration.
r-
3.9 2-D Gel Electrophoresis Studies.
A. The use of Dual-label autoradiography and 2-DGE to compare 
receptor enriched fractions, from control and androgen 
insensitive GSF.
i. Time course of isotope incorporation (Methods 2.10). The
incorporation of [^^Sjmethionine and of the methionine analogue 
[^^Se]selenomethionine, into total newly synthesised protein, 
reached a maxiura between 8 and 12 hours (Fig.3.13). About owice 
as much ^ S  as 75^ was incorporated at all the time
points studied.
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Table 3.9 Effect of in situ U.V.-irradiation on Specific 
Binding.
Fraction Volume d.p.m. Protein (mg) "Specfic 
(ml) Total NS Total NS Binding"
Cell Homogenate 1.00 33760 16350 2.84 2.89 32.5
Salt Extract 1.00 12650 4150 1.34 1.42 34.0
AS 0.25 2338 1300 0.36 0.25 6.8
Supernatant 1.00 8650 3000 0.54 0.49 51.8
Pellet I 0.50 25225 12725 2.54 2.61 26.2
Triton X-100 0.50 14575 6225 0.92 0.94 48.2
DNAase I 0.50 1575 850 0.21 0.26 22.0
Pellet III 0.50 5675 3950 0.72 0.61 7.3
Cells from control cell lines (RM and SW) were seeded in 140]
dishes, and grown to confluence. Cells were then incubated with 
2nM PH]R1881 + 200-fold excess of cold R1881 for 24 hours, at 37 
C, the cell monolayers were then rinsed three times with ice cold 
PBS and inverted on a U.V.-transilluminator for 2 min., and then 
scraped off in PBS. Cells were then fractionated as decribed in 
the legend to Table 3.8.
Specific Binding= Total-Non specific (US): fmoles/mg protein.
ii. Composition of the labelling medium (Methods 2.10). The
labelling medium was originally choosen to ensure that the level 
of methionine would not become a limiting factor during the 
metabolic labelling of fibroblast proteins; it was therefore 
necessary to check that the level of cold methionine used did not 
inhibit the incorporation of label into newly synthesised 
protein. Table 3.10 shows that altering the cocentration of cold 
methionine between 0 and 3.72uM did not significantly affect the 
recovery of labelled methionine or methionine analogue in the 
trichloroacetic acid insoluble material. However, slightly more 
35S was incorporated at the highest concentration of cold 
methionine, with the opposite being true for ^Se.
Again, as was noted above, twice as much 35$ appeared to be 
incorporated; this was observed for all concentrations of cold 
methionine used. A similar trend was seen in all subsequent 
labelling experiments, and was not due to differences in protein 
content of the different fractions. The difference could notrbe 
accounted for soley in terms of the different specific acivities 
of the two isotopes (Methods 2.10 ), as in the labelling medium 
used there was at least a 1000-fold molar excess of unlabelled 
methionine. Therefore contrary to the findings of Lecocq et al 
(1982), [35s]methionine and [^Sejselenomethionine were not 
incorporated with equal efficiency, into newly synthesised 
proteins by human GSF.
The discrepancy in isotope incorporation did not affect 
subsequent 2-DGE studies directly, as the ammonium sulphate 
fractions were routinely mixed (Methods 2.11) at a ratio of 1:2
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F i g u r e  3.13 T i m e - c o u r s e  of [ ^ S ] r a e t h l o n i n e  and 
['DSe]selenomethionine incorporation into newly synthesised 
protein by GSF cultures. About 20000 cells were seeded in each 
well of a 24 well plate and grown to confluence on coverslips. 
The cells were then incubated with either [-^S]methionine (#) or 
['^Se]selenomethionine (A) for 4, 8, 12, or 24h. Samples were 
then collected in duplicate and assayed, after rigorous washing 
in PBS (0 C) and ethanol (room temperature), for total 
radioactivity recovered after 5% trichloroacetic acid 
precipitation. (See Methods 2.10 for details)
Table 3.10 Effects of cold methionine on the incorporation of 
labeled methionine into newly synthesised GSF protein.
MEM (w/o met)* [cold met] 
(uM)
Incorporated d.p.m. (x10“ )^
35S 75Se
+ n ecio, 10% cs 3.72 2.46 1.05
+ n ecio, n cs 1.30 2.24 0.78
+ 1% EC10 1.02 2.13 1.10
No addition 0 1.99 1.35
Cells were seeded in 24 well plates and grown to confluence on 
coyerslips, in EC 10 medium. The cells were then incubated with 
P^simethionine or C'->Se]seleneomethionine (50uCi/ml) for 10 
hours, in 200ul of the methionine free medium with the above 
additions. Samples were collected in duplicate and after rigorous 
washing, assayed for total radioactivity incorporated into tri­
chloroacetic acid insoluble material. The concentration of cold 
methionine was calculated assuming that newborn calf serum (CS) 
and GMEM contained 4mg/l (Documenta Geigy 7 edition) and 15mg/l 
(Gibco) respectively. See Methods 2.10 for details.
* = The basic medium was MEM (w/o methionine) supplemented with 
glutamine, and antibiotics (penicillin/streptomycin).
.  ^ ~ 7 5^m  mvour 01 1 - 's e  a.p.m.
iii. Screening of emmissions for autoradiography (Methods
2.11). Plate 3.1 (a & b) shows that the use of a blackened film 
was more efficient than a double layer of tin-foil at screening 
out the light and j2-emmissions from ^S, during the relatively 
long exposure times required (i.e. 1 to 3 months) for the 
detection of [^^Se]selenomethionine labelled proteins. Further­
more, the double layer of tin-foil caused a loss of 
definition(sharpness) in the final autoradiograph image (Plate 
1.3b).
iv. 2-DGE of receptor enriched fractions (Methods 2.11). Control 
and androgen insensitive cells were incubated with 
[3^S]methionine and [^Selseleomethionine respectively: receptor 
enriched fractions were prepared, mixed, and resolved by 2 -D G E . 
Plates 3.2 to 3.2 illustrate the results of seven separate 
comparisons between control and androgen insensitive cell lines.
Before considering the 2-D analysis in detail, it will 
perhaps be useful to briefly reconsider the rationale for using 
dual labelling autoradiography and 2-DGE to look for mutations of 
the androgen receptor. By differential labelling and subsequent 
detection, control and androgen insensitive proteins could be 
resolved on the same gel under identical experimental conditions 
(Fig 2.1). Therefore, any observed differences between the 
fluorograph and autoradiograph could be correlated with the 
underlying defect in the androgen insensitive cells. Figure 
3.14a, illustrates what might be expected: from a consideration 
of labelling scheme 1, it can be seen that a mutation affecting 
receptor levels would result in the loss of a spot(s) from tne
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Plate 1. Screening out [^S] light and^-emraissions. A  single 
dimension SDS-gel with alternating tracks of P^S] and ['-^ Se] 
labelled protein was impregnated with a fluorographic agent, 
dried down and exposed to XAR-5 X-ray film at -70 C: FLUOROGRAPH
(A). Half the gel was then covered with a double layer of tin­
foil and the other with a piece of blackened film, and the gel 
re-exposed with XAR-5 film at room temperature: AUTORADIOGRAPHY
(B).
Plate 3.1
m
A: FLUOROGRAPH (1-2 Days exposure)
B: AUTORADIOGRAPH (1-2 Months exposure)
Tracks 1-4; Tin-foil used to screen out -^S
Tracks 5-8; Blackened film used to screen out 3 %
Tracks 1,3,5 d 7; [*^Se] labelled protein.
Tracks 2,4,6 d 8; C^5S] labelled protein.
(a)
A: Receptor Negative or
Receptor Deficient Resistance
FLUOROGRAPH AUTORADIOGRAPHY 1. Control 
Androgen 
Insensitivity
35<
75Se
2. Control Se
Androgen
Insensitivity S
B: Receptor Positive Resistance.
V
1. Control 
Androgen 
Insensitivity
2. Control 
Androgen 
Insensitivity
35S
75Se
75Se
35.
(b)
U- act imj ^  92-5 K
J * *  il-Uibulin B_tubulin
m  • •• ^
vimen
4  55K
b. -
B-actin
A 43K
Figure 3.14. The principle behind using double-label 
autoradiography and 2-DGE to detect variant forms of 
the androgen receptor (a)• Schematic representation of 
mouse kidney fibroblast cytoskeletal proteins,& the 
position of the 85K - (arrow a) and 45K (arrow b) 
proteins reported to be diminished in the cultured GSF 
of patients with androgen insensitivity (b). See Text 
for discussion.
autoradiograph (Example A), while a structural defect (i.e. 
resulting from a charge change cr increased susceptibility to 
protease activity) would produce two androgen receptor spots on 
the fiuorograph but only one on the autoradiograph (Example E). 
However, in practice it would be very difficult to distinguish 
between mutations A and B on the evidence of a single experiment; 
it would therefore be necessary to repeat the comparison under 
labelling scheme 2, which would then allow the discrimination of 
a qualitative or quantitative defect. For simplicity, we looked 
initially for the loss or reduced intensity of spots on the 
autoradiograph under labelling scheme 1 (Methods 2.11).
Figure 3.1Mb shows a schematic representation of mouse skin 
fibroblast cytoskeleton proteins, resolved by 2-DGE (taken in 
part from Fey et al 198M): under the extraction and partial 
purification protocol described previously (Methods 2.M) it was 
estimated that actin, actinin and possibly small amounts of 
tubulin and vimentin would be present in the 35% ammonium 
sulphate prec ipitate (based on information given in Frederiksen 
and Cunningham, Methods in Enzymology vol.85). Since actin 
appeared to be a major constituent of all gels analysed (Plates 
3.2-3.8), and was adjacent to the M5K protein (arrow b, 
Fig.3.1Mb) reported by Risbridger et al (1982) to be abnormal in 
GSF from androgen insensitive cells, it proved a useful internal 
reference point.
To facilitate the comparison of control and androgen 
insensitive proteins, the fiuorograph and autoradiograph images 
were placed on a light box and copied onto acetate sheets. This
then allowed tne two images to oe s u p e r i mposed and any
differences in the protein patterns recorded. Figures 3.15 to
3.21 illustrate the comparisons for the seven separate
experiments; the autoradiograph image has been photocopied for
ease of presentation. Table 3.11 summarizes the differences
observed in the protein patterns. One of the criteria laid down
by Lecocq et al (1982) for the optium comparison of -^S- ana 
75Se-labelled proteins was that the intensity of spots on the 
autoradiograph equalled that of the corresponding spots on the 
fiuorograph. It is of significance that for the three experiments 
(Fig.3.15, 3.18, <1 3.21) where most (17-46) "differences'1 were 
seen, that the autoradiograph was underexposed relative to the 
fiuorograph. It was therefore not possible to correlate the 
differences observed with the condition of androgen 
insensitivity. In the four remaining experiments the exposure of 
the autoradiograph was not considered to be a limiting factor, 
and the observed differences (2-4) in the protein patterns from 
androgen insensitive proteins were noted (Table 3-11 s&b). From 
Table 3.11b it is clear that although relatively few differences 
were seen for each comparison, there were no consistent changes 
between experiments. It therefore seemed unlikely that these 
differences were related to the androgen receptor or to androgen 
dependent proteins. However, it is also clear that for the RF7TCF 
(Fig.3.19) and SW/Matheson (Fig.3.20) comparisons that the 
resolution of proteins (in either IEF and/or SDS-PACE dimensions) 
has been hampered. While this does not invalidate the comparison 
(both sets of proteins subjected to the same artefact) it does 
make it difficult to know the significance of the differences
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Table 3.11 Summary of the differences seen in the protein patterns of ammonium, 
sulphate fractions from Control and Androgen Insensitive GSF, after dual­
labelling and 2-PCF.
(a) •
Control/Androgen Hormone 
Insensitivity Binding* 
Comparison
Fig. Differences Seen in
75Se-labelled proteins 
(Autoradiograph Image)
Overall Intensity 
of spots on the 
Autoradioaranh*
Sty 47 7 p Absent 3.15 23 spots "absent"-all over Less
s r / 6 0 5 Absent 3.16 17 spots "absent"-all over "Less"
P.F /605 Absent 3.17 3 spots absent F12,B17,CP Equal
1 spots intensity E12
St-'/Ib Deficient 3.18 2 spots absent PIS Equal
PF/TCF Unstable 3.IS 3 spots absent P4 Equal
s r / r a t heson Formal 3.20 A spots absent C3,C11 Equal
SF/T4 Formal 3.21 46 spots "absent"-all over Less
o , Data from whole cell binding assays (Table 3.1).
*, relative to the fiuorograph image
(b)
Ccnpar ison Fig. Position of Difference on 2-D Pattern Description
Pef. pH Hr.
PI’/ 605 3 .17 E17 Basic 3 OK Absent
CP Pasic/Acidic 7 OK Absent
B12 Basic 45K Absent
F12 Easic 4C-50K Intensity
SW/Ib 3.IP DIP (2) Acidic 3 OK Absent
PI'/TCF 3.19 D4 (3) Basic 100K Absent
SV-/1' atheson 3.20 C3 (4) Acidic > 10 OK Absent
Plate 3.2
* Basic IEF Acidic
SDS
A: FLUOROGRAPH, proteins fron SA + ^^79 cell lines,
B: AUTORADIOGRAPH, proteins from W 9  cell line only.
<66K 
<45K
029K
Figure 3.15. Comparison of ammonium sulphate fractions 
from SW and 447 9 cell lines labelled withes methionine 
and 75se selenomethionine respectively. The fiuorograph 
image (control and androgen insensitive proteins) has 
been superimposed on the autoradiograph (androgen 
insensitive proteins only). (See* Methods 2.11 for 
details.)
O f proteins missing from the autoradiograph.
Figure 3.16. Comparison of ammonium sulphate fractions 
from SW and 605 cell lines labelled with 35s methionine 
and 75se selenomethionine respectively. The fiuorograph 
image (control and androgen insensitive proteins) has 
been superimposed on the autoradiograph (androgen 
insensitive proteins only). (See Methods 2.11 for 
details.'
Or proteins missing from the autoradiograph.
Plate 3.4
Acidic
A: FLUOROGRAPH, proteins from RM + 605 ceil lines,
B: AUTORADIOGRAPH, proteins from 605 cell line only.
<66 K 
<45K 
<29K
Figure 3.17. Comparison of 
from RM and 605 cell lines 
and 75cg selenomethionine r 
image (control and androge 
been superimposed on th 
insensitive proteins only 
details.)
ammonium sulphate fractions 
labelled with 35s methionine 
espectively. The fiuorograph 
n insensitive proteins) has 
e autoradiograph (androgen 
). (Fee Methods 2.11 for
©, proteins missing from the autoradiograph.
Arrow a I intensity of spot decreased on the 
autorad iograph.
Plate 3.5
Acidic
A: FLUOROGRAPH, proteins from SW + lb cell lines,
B: AUTORADIOGRAPH, proteins from lb cell line only.
<66K
«45K
«29K
Figure 3.18. Comparison of ammonium sulphate fractions 
from SW and Ih cell lines labelled with 35s methionine 
and 75se selenomethionine respectively. The fiuorograph 
image (control and androgen insensitive proteins) has 
been superimposed on the autoradiograph (androgen 
insensitive proteins only). (See Methods 2.11 for 
details. )
O , proteins missing from the autoradiograph.
Plate 3.6
Acidic
<I66K
<145K
A: FLUOROGRAPH, proteins from RH + TCF cell lines,
B: AUTORADIOGRAPH, proteins from TCF cell line only.
Figure 3.19. Comparison of ammonium sulphate fractions 
from RM and TCF cell lines labelled with-35s methionine 
and 75se selenomethionine respectively. The fiuorograph 
image (control and androgen insensitive proteins) has 
been superimposed on the autoradiograph (androgen 
insensitive proteins only). (See Methods 2.11 for 
details.)
O , proteins missing from the autoradiograph.
Plate 3.7
Acidic
<66K
<45K
<29K
A: FLUOROC-RAPH, proteins from SW + MATHESON cell lines,
B: AUTORADIOGRAPH, proteins from MATHESOH cell line only.
Figure 3.20. Comparison of ammonium sulphate fractions 
from SW and Matheson cell lines labelled v/ith 35s 
methionine and 35se selenomethionine respectively. The 
fiuorograph image (control and androgen insensitive 
proteins) has been superimposed on the autoradiograph 
(androgen insensitive proteins only). ( See Methods 2.11 
for details.)
Of proteins missing from the autoradiograph.
Plate 3.8
Acidic
«66K
<45K
<29K
A: FLUOROGRAPII, proteins from SW + TL\ cell lines,
B: AUT0RADI0GRAP1I, proteins from T4 cell line only.
Figure 3.21. Comparison of ammonium sulphate fractions 
from SW and T4 cell lines labelled v;ith 35g methionine 
and '^Se selenomethionine respectively. The fiuorograph 
image (control and androgen insensitive proteins) has 
been superimposed on the autoradiograph (androgen 
insensitive proteins only). (See Methods 2.11 for 
details. )
o f proteins missing from the autoradiograph.
observed. Finally, the comparison Rli/605 (Fig.3.1?) deserves 
special consideration: (a) the region [312] corresponds to the 
position of the 56K (pKa 6.7) protein reported to be absent from 
NGSF (Thompson et al 1983) and GSF from patients with androgen 
insensitivity (Wrongemann et al 1984); (b) the intensity of one 
spot (Fig.3.17, arrow a) was decreased on the autoradiograph. 
The significance of the loss and/or the reduction in intensity of 
spots is difficult to evaluate from a single experiment. While it 
is possible that these changes were due to the androgen 
insensitive phenotype of the 605 cell line, similar differences 
were not seen for the SW/605 comparison. This suggests that these 
changes were specific for the RM ceil line, and unrelated to the 
androgen insensitive mutation in the 605 cells.
The conclusion from these studies using double-label 
autoradiography and 2-DGE, was that no consistent differences 
between control and androgen insensitive proteins in receptor 
enriched fractions could be found. It was therefore not possible 
to locate the position of the androgen receptor polypeptide(s) on 
2-D protein patterns using these comparisons, or assign the 
observed differences to the androgen insensitive phenotype. Where 
underexposure of the autoradiograph and resolution artefacts 
could be e liminated, the differences seen between control and 
androgen insensitive cells may have been due to genetic variation 
in the human population.
35Finally, it was observed curing these studies that J S- 
labelled proteins were detected more efficiently by fluorography 
than ^Se-labelled proteins. This phenomena was seen most clearly
in Plate 3.1a, wrier e equal amounts of radioactivity was loaded 
per track and the exposure time was not long enough for the half- 
life of the isotopesto have any significant influence.
B. 2-DGE of whole cell protein labelled with [^S]methionine.
As the above studies, comparing receptor enriched fractions, 
failed to show reproducible differences (for different 
comparisons) of the type described by others, a retrospective 
study was under taken to compare the 2-DGE pattern of total ^S- 
labelled fibroblast proteins from control (RM), androgen 
insensitive (la, TCF, & Mathesison) and a NGSF (HF/E,JP) cell 
lines (Methods 2.12). The rationale for this was that the 45K, 
56K, and 85K proteins (Risbridger et al 1982; Thompsom et al 
1983; V/rongemann et al 1984) could have been selected out during,, 
the salt extraction and/or ammonium sulphate steps.
A comparison of Plate 3.9 with Plates 3.10-3.13 showed that 
the resolution of labelled human fibroblast whole cell protein 
gave reproducible 2-D patterns. However, the relatively large 
number of apparent differences seen prevented the delination of 
specific changes, that could be correlated with the androgen 
insensitive mutation or with the body site of the skin biopsy 
(Areas a, b & c), suggested by others ( Risbridger et al 1982; 
Wrongemann et al 1984). These studies did however serve to 
confirm that the double-label autoradiography and partial 
purification protocol (described above) was the best approach to 
detecting the androgen receptor and/or androgen dependent 
proteins by 2-DGE, as the complexity of the whole cell protein 2- 
D patterns and experimental variations made whole cell protein 
comparisons very difficult (at least for a small sample number).
Plates 3.S-3.13. Represent the 2-D electrophoresis 
patterns of whole cell proteins labelled with 35S 
methionine (See Methods 2.12 for details) . The letters 
a, b,andCrepresent the approximate positions of the 
45K/pI5.0 and 85K/pI5.0 (P.isbridger et al 1982) and 
also the 56K/pI6.7 (Thompson et al 1983; V7rongeman et 
al 1984) proteins reported to be absent or diminished 
in GSF from androgen insensitive patients. Relative 
molecular weight markers (xlO ) are shown on the far 
right of each gel. 1
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Plate 3.13. HF/E , JP cell line (Normal NGSF).
CONCLUSIONS
4.1 The Androgen Receptor from Control and Androgen 
Insensitive Cultured Human GSF.
3
After incubating confluent cell monolayers with InM [ K1
steroid (DHT or Mibolerone), for 30-40 minutes at 37 °C, the 
3
H steroid-receptor complexes were extracted by sonication 
in PEM buffer containing 0.5F-KC1, and partially purified by 
35% ammonium sulphate precipitation of the 105000xg salt 
extract (Table 3.4). There has been considerable interest in 
the functional significance of salt extractable and salt 
resistant nuclear bound steroid (Brown et al 1981? Clark & 
Peck 1976? Davies 1983? Kaufman et al 1983? Mainwaring 1969a? 
Fainwaring & Irving 1973). In a recent study, Erown and 
Migeon (1986) compared the binding of the androgen receptor 
to the nuclear matrix fraction of human GSF, from controls 
and patients with androgen insensitivity. In normal human
r-
GSF about 50% of the total binding was found in the nucleus,
and of this 28-49% was associated with the nuclear matrix. A
similar distribution of androgen receptor binding was
observed in two (unrelated) patients with receptor positive
complete androgen insensitivity. However, the binding
affinity of these receptor complexes to the nuclear matrix
was three-fold lower than controls. It is of significance
that in the present study, after sonication and salt
extraction, between 30%&50%of the total radioactivity v/as
recovered in the 105000xg salt extracted pellet (see Table
3
3.5, the proportion of H d.p.m. recovered in the Pellet and
Salt Extract fractions) . Further studies showed that this 
was mainly nonspecific binding; 68.7% of the pellet 
associated radioactivity was recovered after repeated salt 
extraction and subsequent extraction of pelleted material
(105000xg for lh.) with 0.5% Triton X-100 (Table 3.3). 
Furthermore, a recent study by Kaufman et al (1986) has
implicated the formation of disulphide bonds Id vitro (i.e. 
during nuclei manipulation) on rendering between 50-70% of 
the rat liver glucocorticoid receptors resistant to nuclease 
and salt (1.6M-NaCl) extraction in the absence of 
sulphydryl-blocking agents in the preparation buffer. In the 
present study 12mK-monothioglycercl was included at all 
stages of receptor preparation (Methods 2.4), which may have 
aided the recovery of soluble (salt extractable) receptor by 
protecting the free sulphydryl groups on the receptor
molecule.
Qualitative defects of androgen receptor function 
(Introduction 1.2, Table 1.2) have been identified by 
several different methods, such as thermolability of steroid 
binding, an increased Kd (decreased affinity), and failure 
to up-regulate basal binding levels in response to hormone, 
using intact cultured GSF. However, very few studies have 
been undertaken to investigate receptor integrity in a cell 
free system.
In the present study, sucrose gradient analysis has 
been combined with a partial purification protocol (Methods 
2.5) to compare the receptor complexes from control
(Fig.3.2) and androgen insensitive (Fig.3.3) cell lines. The 
observed sedimentation profiles were in good agreement with 
the data from whole cell binding assays (Table 3.1) and with 
amounts of radioactivity recovered after salt extraction and 
ammonium sulphate precipitation (Table 3.4). The value of 
the procedure was seen during the analysis of receptor 
complexes from the TCF cell line. In whole cell binding 
assays (Table 3.1) the levels of receptor were within the 
normal range, giving a diagnosis of receptor positive 
resistance. However, after partial purification and sucrose 
density gradient centrifugation, the profile observed 
resembled that of a receptor negative cell line (Fig.3.3). 
This procedure could be useful in determining or confirming 
quantitative and qualitative mutations of the androgen 
receptor complex. Interestingly, Griffin and Durrant (1982) 
described the use of sucrose density gradient 
centrifugation, and the failure of molybdate to stabilise 
the 7-8S form of the receptor complex, as a sensitive probe 
for qualitative defects. More recently, Hirst et al (1985) 
also used sucrose density gradient analysis in the study of 
a kindred with vitamin D resistance but normal 1,25- 
dihydroxyvitamin D binding: the complexes of two individuals 
failed to aggregate as 6S forms on low salt gradients.
A later modification to the above protocol was the
3
incubation of confluent cultures for 24 hours with 2nMC r3 — 
mibolerone or -R1881, prior to receptor extraction and 
partial purification, in order to exploit the phenomenon of 
"up-regulation" of androgen receptor binding. This proved to
be a successful way of increasing the yield of soluble 
receptor (Table 3.6) without the increase in tine and 
expense of culturing more cells per experiment. Augmentation 
of receptor binding levels did not affect the dissociation 
constant (Kd)(Kaufman et al 1981r 1983; Syms et al 1983,
1984; Dr M.B.Hodgins unpublished data) or the sedimentation 
coefficient of the receptor on sucrose gradients (Fig.3.5, 
Dr.W.B.Hodgins personal communication).
In my hands, further purification (as shown by an 
increase in specific activity) of the receptor, beyond the 
ammonium sulphate step, using either 2,,5*-ADP sepharose 
(Fig.3.4) or FPLC-anion exchange chromatography (Fig.3.6) 
proved unsuccessful. The most likely explanation for this 
seemed to be the loss of steroid binding activity during 
these manipulations. However, both techniques proved useful 
in further qualitative characterisation of the human GSF 
androgen receptor complex.
It is of interest that the human GSF androgen receptor 
complex (Fig.3.4) and the rat prostate receptor (Fig.3.10a; 
Brinkmann et al 1985a) exhibited apparently different 
affinities for the Mono Q anion exchange column, as shown by 
the concentrations of salt required to elute the receptors. 
This could reflect slight differences in the receptor 
preparations or possible species and/or tissue specific 
receptor forms. However, another possibility is that the 
weaker interaction of the GSF receptor complexes (C.13-
0.18M-KC1 v*s 0.26M-NaCl) was as a result of receptor
1 : i
activation. If this was the case, then the use of FPLC-anion 
exchange chromatography would be an alternative means of 
detecting mutations affecting receptor activation. At 
present, such qualitative defects have been suggested from 
DNA-cellulose binding (Kovacs et al 1983) and kinetic 
studies (Kaufman et al 1S83). Interestingly, Mainwaring and 
Irving (1973) reported that the isoelectric point of the rat 
prostate receptor increased from 5.8 to 6.5 on activation 
(accompanied by 8S to 4.2S conversion). More recently Keenan 
et al (1986) have shown that activation of the human GSF 
androgen receptor was concomitant with the loss of negative 
charge (binding of the receptor to DEAE-sepharose and 
hydroxyapatite columns) and a reduction in the molecular 
radius. The activation of the glucocorticoid receptor has 
also been associated with alterations in chromatographic 
behaviour (DEAE-cellulose) and increases in pi, suggesting 
the unmasking of "+" or the loss of charges (Een-or &
Chrambach 1983? Holbrook et al 1983a; Milgrom et al 1973; 
Munck & Foley 197 9? Parchman & Litwack 1977? Wrange 1979). 
However, a recent study by Smith and co-workers 
(Smith,Elsasser and Harmon 1986), using 2-DGE (after immuno- 
purification & affinity labelling), found that activation 
did not affect the isoelectric point of two isoforms of the 
glucocorticoid receptor, and concluded that confromational 
change rather than covalent charge modification was involved 
in receptor activation.
The results from 2',5*-ADP sepharose chromatography 
were of interest since the complexes from a control (SW) and
a androgen insensitivity (T4) cell line gave very similar 
elution profiles (FIG.3.4a and b). While it may be 
reasonable to assume that this interaction involved the 
DMA/nuclear binding domain of the receptor complex 
(Fig.l.2b)f there is no direct evidence to support this. 
However, it is of interest that Mulder and associates 
(Mulder et al 1983,84) found that a 3S androgen receptor 
species (from the rat prostate) bound to ADP-sepharose but 
not to DNA-sepharose, while a 4S receptor form bound to 
both. Furthermore, only the binding of the 4S species to 
ADP-sepharose could be competed out by double stranded DMA. 
These data would suggest, that the receptor nuclear binding 
site can have an indirect effect on the interaction of 
receptor complexes with ADP-sepharose.
The cell line T4, derived from a patient with complete 
testicular feminization ( Results 3.1), deserves special 
consideration, since the findings of the whole cell (Table
3.1) and in vitro (Table 3.2, Figs.3.1,3.3,3.4) receptor 
studies were indistinguishable from controls (although a 
possible "ligand specific" defect was observed during the 
augmentation studies; Introduction 1.2, Rowney & Hodgins 
1984). The implication of these results, was that the 
mutation in these cells occurred distal to steps involving 
the receptor (Receptor Positive Resistance). Alternatively, 
the methods used may not have been sensitive enough to probe 
for subtle defects in receptor structure. The androgen 
dependent expression of a reporter gene, linked to an
■ j
androgen responsive element, transfected into T4 (and 
control) cells may provide a more sensitive means of 
assaying for normal receptor function. Unfortunately such an 
experiment was not possible in the present study, as the 
cell line T4 was difficult to grow and maintain; making it 
impractical to pursue this line of research.
Table 3.7 summarizes the physical properties of the 
human GSF androgen receptor derived from sucrose density 
gradient centrifugation and HPLC-size exclusion 
chromatography. The 4S form of the receptor appeared to be a 
protein with a molecular weight of around 60000-daltons, a 
Stokes radius of 3.16nm, frictional ratio of between 1.21- 
1.43 which corresponded to an asymmetric protein with an 
axial ratio of 3.00-6.75. The significance of the apparent 
larger receptor form (90000-daltons) seen for the Mathesion 
cell line is not known. However, it could be due to the fact 
that this analysis was carried out without a Guard column
r
preceeding the TSK3000 SV7 column, resulting in a more 
compact profile and possible alterations in the resolution 
obtained.
Mainwaring and Irving (1973), showed that there was no 
evidence for tissue or species -specific forms of the 
androgen receptor in the male accessory glands, although as 
was discussed earlier (Table 1.1) there is a decree of 
variation in the data reported from different groups. In the 
classical androgen target tissue of the rat ventral 
prostate, the size of the activated receptor complex has 
ranged from 4.0-4.5S with a relative molecular mass of 50K-
1 Q ' 4
100K (Chang et al 1983; Goueli et al 1984; Mainwaring 1969a; 
Mainwaring & Irving 1973). The above data for the human GSF 
androgen receptor is in good agreement with that reported 
for the steer seminal vesicle receptor (a protein 
sedimenting at 3.8S, with Mr. and P.s of 57K and 3.50nm 
respectively and f/fo=1.42: Chang et al 1982) and also with
the receptor from calf uterus (4.5S, Mr. and Rs of 85K and 
4.40nm respectively and f/fo=1.39, axial ratio of 7.4: de
Boer et al 1986). Most striking perhaps were the 
discrepancies with the recent findings of Keenan et al 
(1986). These workers described a 5.IS protein with Mr./Rs 
of 143K/6.00nm and 114K/4.80nm for the unactivated and 
activated forms of the human GSF androgen receptor 
respectively, in the presence of 0.5M-KC1. The finding of a 
larger receptor species by these workers may refect a 
difference in receptor preparation compared with the present 
study, as these workers routinely used lOmM sodium molybdate 
in their extraction buffers and gel filtration eluent. This 
compound has been found by a number of groups to stabilise 
receptors (usally unactivated form) as large oligomeric 
aggregates (Noma et al 1980; Rowley et al 1984; Hilbert et 
al 1983). In the present study, preparation of receptor 
complexes prior to HPLC-gel filtration was done at C-4°C, in 
the presence of the protease inhibitors PMSF and Leupeptin 
(Methods 2.4). However the gel filtration step was done in 
the absence of protease inhibitors and at room temperature. 
It is possible therefore, that some degradation of the
receptor could occur at this point, and indeed in all 
experiments with control or a receptor positive mutant cell 
line a second peak of about 15K was seen (Fig.3.7). Although 
the relationship between peaks I and II was not examined 
further, it is interesting that for one androgen insensitive 
cell line (la, receptor deficient) only the second smaller 
peak was observed (Fig.3.7b). This suggests that the 
mutation in these cells affects the stability of the 
receptor comlexes and/or renders the receptor more 
susceptible to proteolytic degradation.
In conclusion the combination of sonication in 0.5M-KC1 
containing buffer followed by 35% ammonium sulphate 
precipitaion of the 105000xg salt extract was found to be a 
useful method for the extraction and partial purification of 
the human GSF androgen receptor. This protocol was 
subsequently used in all further studies of the receptor 
complexes: FPLC-anion exchange chromatography, HPLC-gel
r-
filtration, photoaffinity labelling, and 2-DGE stud ies. 
Furthermore, the use of sucrose gradient analysis of salt 
extracts (from human GSF) demonstrated a defect in the TCF 
receptor complex that was not apparent from whole cell 
binding studies of steroid binding levels. Finally, the use 
of FPLC-anion exchange chromatography to distinguish 
activated and unactivated receptor complexes from cultured 
GSF, may prove a quick and efficient method for detecting 
mutations affecting receptor activation.
4.2. Photoaffinity Labelling of the Androgen Receptor using
3
the Synthetic Steroid I H]R1881.
In a recent review Gromemeyer and Govindan (1986) 
summarised the main advantages of affinity labelling steroid 
hormone receptors, and also highlighted some of the problems 
that could be encountered. The advantages include: detection 
of the steroid binding domain, detection of receptors under 
denaturing conditions, allowing more versatility in receptor 
isolation and purification schemes (leading to the raising 
of antibodies against the receptor protein), comparison of 
different receptor forms, and finally, the identification of 
chromatin binding sites. It is obvious therefore, that 
affinity labelling of the human GSF androgen receptor 
complex would be a very useful tool in dissecting the 
molecular defects underlying androgen insensitivity: 
directly, by allowing the comparison of control and variant 
receptor complexes by high voltage IFF and SDS-PAGE, and 
indirectly by aiding in the purification of the receptor 
protein.
Tindall and coworkers (Chang et al 1982, 1983, 1984)
have successfully covalently labelled the androgen receptor 
from rat ventral prostate and steer seminal vesicle with 
the affinity ligand 17/S- (bromoacetyl)-oxy -5 0C-androstane- 
3-one, and the photoactivated ligand R1881. R1881 has also
been used by Brinkmann and coworkers (Brinkmann et al 1985b, 
1986) to characterise the receptor complexes from the rat 
prostate, calf uterus and a prostatic carcinoma cell line. 
In a recent study, Mainwaring and Randall (1984) highlighted 
the limitations of photoaffinity labelling receptor
1 0 7
complexes with B1881; the low level of covalent attatachment 
and non-specific binding of the steroid.
Using the photoactivated ligand, R1881 it was possible 
to covalently label the receptor proteins from rat prostate 
(Fig.3.9) and calf uterus (Fig.3.10); so confirming the
findings of Brinkmann et al (1985bf 1986). The difference in 
size (50K vs 100K respectively) of the receptor from these 
tissues was thought to be the result of high levels of 
proteolytic activity present in prostate tissue (Brinkmann 
et al 1985b)
Attempts to repeat the above procedure with the human 
GSF androgen receptor from control cells (pooled cultures of 
RM and SW cells), were less successful (Figs.3.12 and 3.13). 
This may have been due to I
1. The low efficiency of the photoactivation reaction (
1.e 0.2-8.0%: Erinkmann et al 1985b; Mainwaring &
Randall 1984) meant that sufficient starting material 
and some purification procedure(s) were necessary.
Therefore any loss of receptor binding activity during 
the pre-irradiation steps (i.e. FPLC-anion exchange 
chromatography) would lead to further reductions in the 
overall efficiency, and subsequent chances of detecting 
specific receptor binding above background (non­
specific ) levels.
3 3
2. Inefficient exchange of f Himibolerone for[H]R1881,
in earlier experiments (Fig.2.2, Scheme I), may have 
adversely affected the procedure. Subsequent studies
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suggested that exchange assay conditions were not 
optium (Appendex 5.4).
3. The U.V. source and the period of irradiation used 
for Schemes I and II(a & b)(Fig.2.2) may also have 
affected the efficiency of the covalent linking of 
R1881-receptor complexes. Although the lamp was used 
successfully to covalently link a diazo-steroid
derivative to the rat liver 5 OC-reductase enzyme 
(Eeattie, Fodgins & Nimmo 1986).
Attempts to photoaffinity label the human GSF androgen 
receptor using the in situ U.V. irradiation procedure 
(Fig.2.2, Scheme m )  described for the chick oviduct 
progesterone receptor (Horwitz and Alexander 1983) were also 
unsuccessful- (Figs.3.12, 3.13). Since these workers
estimated the efficiency of this technique to be about 15%, 
the observed results may reflect an increased sensitivity of 
the R1881-androgen receptor complex to damage by U.V. 
energy, compared to the R5020-progesterone receptor complex. 
Another possibility is that the nature of the receptor 
complex was so altered by the irradiation that it was no 
longer precipitable by 35% ammonium sulphate (Tables 3.8, 
3.9: counts remaining in the supernatant fraction).
Before leaving these studies it is intriguing to 
speculate on the peak of radioactivity that was consistently 
observed at the dye front on 8% SDS-polyacrylamide gels 
(Fig.3.12). Since it is difficult to resolve proteins below 
30K on this percentage of gel and the trichloroacetic acid 
precipitated material was washed and extracted thoroughly
(Methods 2.9) before electrophoresis, it is conceivable that this 
material represents a fragment of the receptor containing the 
steroid binding domain (a similar "peak” was observed during the 
studies on the rat prostate and calf uterus receptor (Figs.3.10 &
3.11; and Brinkmann et al 1985a, 1986), but itrs significance was not 
determined). However, from the work of Mainwaring and Randall
(1985), it is possible that this simply represents steroid that was 
trapped in the protein structure and only released under the 
denaturing conditions of SDS-PAGE.
The conclusion from the above studies was that the loss of 
receptor binding activity prior to irradiation, together with the 
inefficiency of the photolinking reaction made it impossible to gain 
any consistent results with the human GSF androgen receptor. 
Recently Gyorki et al (1986) claim to have covalently labelled the 
androgen receptor from normal foreskin tissue and from cultured 
fibroblasts. Two peaks of binding were observed under denaturing 
conditions, at 40K- and 85K-daltons. However, despite the use of an 
affinity chromatography step to partially purify the receptor 
complexes, the peaks shown were not as convincing as those for the 
rat prostate or calf uterus (Fig. 3.10 & 3.11; Brinkmann et al 
1985b, 1986), due mainly to the high levels of non specific binding.
4.3 Double-label Autoradiography and 2-DGE Studies.
The high resolution of proteins by 2-DGE (OfFarrell 1975;
O'Farrell et al 1977) is a very powerful tool for comparing
different populations of proteins, and has been used in a wide
number of applications: identifying changes in protein synthesis in
disease, after neoplastic transformation and during differentiation;
studying the heat
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shock response in humans cells; identification of primary 
defects in inborn errors of metabolism; measuring the degree 
of genetic polymorphism in the human population ("Two- 
dimensional Gel Electrophoresis of Proteins, Methods and
applications", Celis & Bravo 1984; and Clinical Chemistry 
(1982) volume 28, part 4) . Although there are now a number 
of systems (i.e GELLAB, TYCHO) for computerised 
densitometry, these may not be readily available, and the 
comparison of complex 2-D protein patterns can be a time 
consuming exercise subject to errors. An added complication 
is the occurrence of non-reproducible differences between 
samples. These difficulties can be overcome by
double-label autoradiography (Lecocq et al 1982; McConkey 
197 9) , where both sets of proteins are coelectrophoresed
on one gel. Two independent autoradiographic images of the 
final gel are then produced, specific for one or both sets 
of proteins, which can then be superimposed for easy 
comparison. Another problem with the type of study being
undertaken, is the possiblity that differences unrelated to
the problem being addressed could be observed due to genetic 
polymorphism in the human population. However,
two independent groups (FcConkey, Taylor & DucPban 197 9; 
VJalton, Styer & Gruenstein 1979) found that the average
difference in whole cell labelled protein from normal
individuals was less than or equal to 1%, using 2-DGE. This 
was a much lower figure than had been expected, based on the 
data from enzyme studies (i.e. 6%). Both groups concluded
that this was because using 2-DGE, a different subpopulation 
of cellular proteins was being studied, namely the more 
abdundant and conserved structural proteins. Therefore,
because of the relatively low % of differences due to 
genetic variations between normal individuals seen on 2-D 
gel patterns, this is a powerful technique for identifying
specific differences due to point mutations.
Therefore, using a modification of the procedure of
Lecocq et al (1982), control and androgen insensitive GSF
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proteins were labelled with [ S3 methionine and C Se]
selenomethionine respectively and receptor enriched
fractions resolved by 2-DGE (O'Farrell 1975)(Methods 2.11).
Using this method it was believed that differences in the
autoradiograph (androgen insensitive proteins) could be
correlated with the androgen insensitive mutation.
Furthermore, it was thought that the procedure could be
sensitive enough to pick up normal and variant forms of the
androgen receptor protein.
The main problem encountered in this study was the
large number of differences that were seen between control
and androgen insensitive cells, which were not consistent
between the different comparisons (Table 3.11a). In the
earlier studies (Plates 3.2, 3.3, 3.8; Figs.3.15, 3.16,
3.21) the problem was a technical one in that insufficent 
75
Se a.p.m. were loaded on the first dimension gel to allow 
for decay and the relatively long exposure times required 
for the autoradiograph of the final gel. In the later 
experiments (Plates 3.4-3.7; Figs.3.17-3.20) the ratio of
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Se to S d.p.m. was increased. However, although fewer 
differences were seen (2-4 spots), these still varied 
considerably between the different comparisons (Table 
3.11b). It was concluded that these changes were unlikely to 
be related to the androgen receptor or the primary androgen 
insensitivity mutation. Other explanations for the observed 
differences include:
75
1. Selective loss of Se-labelled proteins during the 
preparative steps up to IEF.
2. Differences in the incorporation of
75
Se selenomethionine into newly synthesised protein 
by GSF.
3. Differences could be related to cell 
age and/or passage number.
4. Differences may be due to genetic polymorphism in 
the human population.
75Selective loss of Se-labelled proteins seems
unlikely, since both control and androgen insensitive 
samples were treated in exactly the same manner (in 
parallel,Fig.2.2), and no changes were seen in the 
fluorograph image to suggest loss of control proteins. 
Similarly, the second possibility seems unlikely, as such an 
effect might be expected to be more specific and/or to 
affect all proteins. Point "3", remains a possibility, since 
these factors are known to affect protein synthesis in 
cultured cells. However, all cultures were labelled at the 
same stage of growth (on reaching confluence) and cells were
used at equivalent passages as far as possible. The last 
possiblity, that these difference v/ere due to genetic 
variations in the human population, seems most likely. The 
observed difference of 2-4 spots out of 100-150 may seem 
rather high (an average of 3%) compared to the above studies 
of NcConkey et al (1979) and T’7alton et al (1979) ( average
0.5-1.2%). However these gels represent a specific 
subfraction (35% ammonium sulphate precipitate) of the total 
cell protein, and so genetic differences may have been 
preferentially selected for during the preparative stages 
and/or at the detection levels (i.e. less abundant proteins 
should be detected more readily in the present study).
Since these comparisons were between receptor enriched 
fractions (Table 3.4) the proteins of 45K and
85K (Risbridger et al 1982) and 56K ( 17rongemann et al 1984) , 
which were apparently less abundant in androgen insensitive 
cells, were unlikely to represent the androgen receptor as 
was suggested. The possibility that these were androgen 
dependent or regulated proteins, which v/ere selected out 
during the salt extraction and partial purification steps in
the present study, was tested by looking at whole cell
35protein labelled only with C Slmethionine. The complexity 
of the patterns, and again the apparent variable differences 
between the 2-D protein patterns (Plates 3.9-3.13), made it 
difficult to assign a given difference to the androgen 
insensitive phenotype. Futhermore it was not possible to 
identify the three proteins (of 45Kr 56K and P5K) that were 
apparently absent from androgen insensitive cell lines and
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non genital skin fibroblasts (Pisbridger et al 1982; 
Thompson et al 1983; VTrongemann etal 1984).
Summary.
1. Properties of the human GSF androgen receptor complexes:
Control Cells.
-extracted by sonication and 0.5M-KC1 
-precipitated by 35% saturated ammonium 
sulphate
-sedimented at 4S (5-20% linear sucrose 
gradients)
-Mr. of about 60K (HPLC-gel filtration) 
-Eluted from ADP-sepharose at 0.5-1.0M-KC1 
-Eluted from FPLC, Mono 0 at 0.13-0.18M-KC1
Androgen Insensitive Cells.
-receptor from a receptor positive cell 
line sedimented at 4S (T4 cell line) 
-receptor from receptor negative and 
receptor deficient cells, showed
quantitatively abnormal sedimentation 
profiles
-apparent Mr. of 90E (Matheson cell line) 
-eluted fron ADP-sepharose at 0.5-1.0M-EC1 
(T4 cell line)
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2. Photoaffinity Labelling of the androgen receptor with C PJ
P1881
Rat Prostate.
-Mr. of 5OK (SDS—PAGE)
Calf Dterus.
-Mr. of 100K (SDS—PAGE)
3. 2-DGE Studies:
Receptor enriched fractions (Dual labelling of control and
androgen insensitive cells) .
-no differences were found that could be 
directly correlated with the androgen 
receptor or the androgen insensitive
phenotype
Khole cell studies.
-again the differences seen could not be 
related to the androgen insensitive 
mutation or the anatomical origin of the 
cells. However, these studies did show the 
advantage of the dual-labelling technique 
for comparing complex protein samples by 
2-DGE.
4.4 Prospects for future research into the molecular defect 
of androgen insensitvity.
A. Direct follow up to the above study.
Since the rationale for using double-label 
autoradiography and 2-DGE to search for the androgen 
receptor remains valid, a possible improvement to the 
protocol used above (Fig.2.2) would be to attempt to purify 
the receptor protein further prior to 2-DGE. Control and
androgen insensitive proteins could be mixed after ammonium 
sulphate precipitation, prior to additional purification 
(i.e. FPLC-anion exchange, affinity chromatography) which 
would reduce the work involved and also avoid the 
preferential loss of material from either sample.
The search for androgen dependent proteins could also 
be pursued further by analysis of the other fractions, which 
was not carried out in the present study; 105000xg salt 
extracted pellet, the supernatant fraction after 35% 
ammonium sulphate preceipitation and culture medium after 
labelling incubation ( secreted proteins). An interesting 
facet of this work would be to identify a possible 
physiological response of fibroblasts to androgens. That 
such a reponse(s) exists, has been suggested by the work of
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Ozasa et al (1981), who found that protein synthesis and 
collagen production by cultured human fibroblasts were both 
slightly elevated in response to DHT.
B. Sequence data from the oestrogen, glucocorticoid,
/
progesterone, and vitamin D recptors.
As was discussed earlier (Introdutionl.1) comparison of 
the amino acid sequences of the oestrogen and glucocorticoid 
receptors from human and other sources, has revealed three 
domains which have a relatively high degree of homology. 
Using site directed mutagenesis, Kumar et al (1986) have 
confirmed that two of these domains at the C-terminus are 
involved in steroid and nuclear binding. It could be 
speculated therefore that using this tool of site directed 
mutagenesis specific mutations could be introduced into the 
oestrogen and/or glucocorticoid sequences that would mimic 
the findings of androgen receptor binding studies (Table 
- 1.2), and thus suggest the type of mutation that occurs in
vivo.
Furthermore, as was discussed earlier (Introduction
1.2) variant forms of the glucocorticoid receptor have been 
associated with abnormalities in receptor message (Niesfeld 
et al 1985? Northrop et al 1986). It is of considerable 
interest therefore, that a recent study by Danielsen et al
(1986), mapping functional domains of the mouse 
glucocorticoid receptor, found that two receptor cDNA clones 
could be isolated from the nt- phenotype: one coded for a
protein which was deficient in steroid binding and the
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other, a protein with steroid binding activity but reduced 
affinity for nuclear structures. The lesions in these two 
variant receptors were mapped to the replacement of glu
545
with aly and arg with his respectively. It is possible
458
that similar mutations could account for the receptor 
negative (no steroid binding) and deficient nuclear binding 
reported for the androgen receptor (Table 2.2 and 3.1).
Finally, the sequence of the vitamin D receptor is 
awaited with keen interest (Haussler et al 1987), since a 
number of receptor defects associated with vitamin D 
dependent rickets (Introduction 1.2) have been reported 
which appear (from steroid binding studies) to be very 
similar to the types of mutation seen in androgen 
insensitivity. This might provided the best model for site 
directed mutagenesis studies.
C. Isolation of the androgen receptor gene.
The best way to probe the molecular defects responsible 
for androgen insensitivity, would be to study the receptor 
gene and gene product directly. It is the aim of several 
groups to purify the receptor protein, raise polv and/or 
monoclonal antisera and isolate the receptor message and 
ultimately the gene. Since attempts to purify the androgen 
receptor, using conventional procedures have had mixed 
success, an alternative approach is to use the information 
from the steroid and/or the nuclear domains of the oestrogen 
and glucocorticoid receptors to synthesis short 
oligonuceotides, which could then be used to "fish out" the
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receptor r.essage directly without the need for a pure 
receptor preparation (Evans et al 19P7). However, it should 
be stressed, that identifying point nutations that give rise 
to abnornal receptor function is only part of the answer. 
Further studies would be required to relate these changes 
with the phenotype of the individual, and so obtain a 
clearer understanding of structure-function relationships of 
steroid receptors.
In conclusion, it is believed that future developments 
in the above areas (E anc C) will have important 
implications for steroid hormone action, and for gene 
regulation and cell differentiation in general, while a 
better understanding of androgen action and androgen 
receptor function (A and C) could aid in the diagnosis and 
early managment of patients with androgen insensitivity.
APPENDIX 5i1 
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Appendix 5.1 Tares and Addresses of Suppliers.
A.
A/S TUTC Aldrich Chemical Co.Ltd.
Kamstrupvej 90, The Old Prickyarc-Fev Poad,
Kamstrup, Gillingham-Dorset,
DK-4000 Roskilde. SP8 4JL.
Denmark. Fnaland.
Amersham International pic. 
Fhite Lion Poad, Amersham, 
Buckinghamshire FP7 9LL-. 
Fngland.
BDF Chemicals Ltd. 
Poole,
Dorset.
England.
Bio-Pad Laboratories Ltd. 
Caxton oay,
Fatford Business Park, 
Fatford,
Hertfordshire FD1 FPP. 
Fngland.
Ar.icon Ltd.
Upper Fill Stonehouse, 
Clos. Clio 2PJ•
Fngland.
Peckman-PIIC Ltd.
Turnpike Poad,
Cressex Industrial Estate, 
High Tycombe HP12 3TP. 
Pucks.
Fngland.
Costar
205 Broadway, 
Cambride FA02139.
Du Pont
Few England Fuclear (UK) 
Du Pont (UK) Ltd.
2 Few Poad,
Southhampton,
Hampshire S02 OAA. 
Fngland.
Fissons pic.
(Hi Spin-21 FSF) 
Catwick Poad, 
Crawley,
Sussex PHI0 2UL. 
Fngland.
G.
GIPCO Europe Ltd. 
P.O. Pox 35, 
Trident House,
Penfrev/ Road, 
Paisley PA3 4EF• 
Scotland.
H.
Hanovia
(High Pressue Hg-lamp),
Slough.
England.
Feat Systems-Ultrasonics Inc. 
(see Life Science Laboratories)
K.
Kodak
Eastman Kodak Company, 
Rochester, N.Y. 14650. 
England.
Kontes
(Small Dounce homogenizer) 
Glass Company,
Vine land.
New Jersey.
Life Science Laboratories
(Hodel F-375 Sonicator, with cup horn 1431A). 
Biotechnology Division,
Sorum Road,
Leagrave, Luton,
Beds. LU3 2RA.
England.
LKB Instuments Ltd.
232 Addington Poad,
South Croydon.
Surrey CR2 PYD•
England.
Hay & Baker (M & B) Ltd. 
Dagenham,
England.
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N.
National Diagnostics 
Unit 3,
Chamberlain Road, 
Aylesbury,
Bucks. HP19 3DY. 
England.
Packard
(see United Technologies Packard).
Pharmacia (GP) Ltd.
Pharmacia House,
Midsummer Boulevard,
Central Milton Keynes,
Bucks. MK9 3HP.
England.
Scottish Antibody Production Unit (SAPU)
Glasgow & T,7est of Scotland Flood Transfusion Service. 
Law Hospital,
Carluke, MLS 5ES 
Lanarkshire.
Scotland.
Sigma Chemical Co.Ltd.
Fancy Road,
Dorset, BH17 7NH.
England. r.
P
S
U
United Technologies Pakard 
Parkard Instrument Co.Ltd. 
2200 Farrenville Road, 
Downers Grove 111.60515. 
U.S.A.
U.V. Products Inc.
(U.V. Transilluminator) 
5100 TTalnut Grove,
San Gabriel.
U.S.A.
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Formation of a Linear Sucrose Gradient,
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Appendix 5.2 The Formation of a Linear  ^ Sucrose 
Gradient.
This was checked by adding proportionate amounts of the 
dye bronophenol blue to the sucrose stock solutions* 
prior to layering the gradient. The gradient was then 
left for two hours at room temperature, and 
fractionated as described previously (Fethods 2.5). The 
amount of dye in each fraction was determined from the 
measured O.P.PPCnm, and the percentage of sucrose 
calculated from standard data.
(*, 10,20,30 and 40ul of 0.05% bromophenol blue
solution was added to the 5,10,15 and 20% (w/w) sucrose 
stocks respectively.)
APPENDI X 5.3 
Electrophoresis Standards.
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Appendix 5.3
(a) The pF gradient was measured by slicing a gel (run 
under identical conditions, without sample) into 5ntt» 
segments, and eluting the Ampholines in 1.5nl of boiled 
distilled water. This was done in a sealed plastic 
micrc testube at room temperature, for at least two 
hours. The pH of each sample was measured using a 
ir.icrc-pF electrode.
(b) Molecular weight size markers (I>alton Mark VII, 
Signa) resolved on an P% pclyacralamide gel; data shown 
is the Mean + the standard deviation (number of 
observations).
APPENDIX 5.4
C^HlP1881 Exchange Assay.
Appendix 5.4 Fxcbange Assay. (0-4°C)
Control cells (RM & SW) were seeded in 140mm 
diameter petri dishes, and crov?n to confluence. After 
incubating the cells with 2nF (cold) Mibolerone in EC1 
medium for 24 hours, the cells were collected and the 
35% ammonium sulphate fraction was prepared (Methods 
2.4) . The ammonium sulphate precipitate was resuspended 
in 0.5ml PEG buffer (lOmF-KF^PC^ , lml'-FPTA, 10%(v/v) 
Glycerol) containing 15nF 881, and divided into
two equal amounts (A & P). Fcnothioglycerol (final 
concentration 12mF) and rersalyl acid (final 
concentration In?') vzas added to A and B respectively. 
The mercurial sulphydryl blocking agent, mersalyl acid, 
has been used to reversibly dissociate steroid from the 
progesterone and vitamin D receptors (Coty 1980). After 
a 30 minute incubation, the inhibitory effects of the 
mersaly acid were overcome by the addition of monothio- 
glycerol (final concentration 24mF) (Coty 1980) . From 
samples A and P 50ul was removed at 0, 2, 8, 21 and 3 0
hours, and the amount of bound radioactivity determined 
by hydroxyapatite (Methods 2.10).
Results:
Time Cample Volume d .p.n ./SOOul*
(h) (ul) A P
0 250 2 9 80 4130
2 200 1520 7030
8 150 2700 -
21 100 4180 4270
30 50 3080 2740
(*Expected value for a 100% exchange> 15000 d.p.m.)
Conclusions:
1. Exchange of bound Mibolerone for [3f3p 18P1 was
not optium under the conditions choosen. This could be
due to the loss of receptor binding activity during the
exchange assay, and/or the length of time allowed
(maxium 30 hours) was insufficent to allow dissociation
\
of the tightly bound Mibolerone.
2. The dissociation of androgen receptor complexes 
under the influence of mersalylacid was not reversible 
(i.e sample E) under the above assay conditions.
As this v/as a single experiment it is felt that 
further studies would be required to determine the 
optimal conditions for exchanging Mibolerone for P1PP1. 
For example, if the receptors were labeled in situ with 
[3p]m  ibolerone and then incubating with or without cold 
F1P81, it would be possible to check if receptor binding 
was stable for the time course being used, aswell as 
determining the optimal conditions for R1P81 exchange. 
The effects of mersalylacid on androgen receptor binding 
could best be studied in a separate seres of 
experiments.
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